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1 Introduction and Goals 
The discovery of non-proteinogenic (di)amino acids among natural products has significantly 
increased interest in this class of compounds as they may possess interesting biological activity and 
could also serve as valuable building blocks in the synthesis of new classes of bioactive compounds.1 
Furthermore, these non-proteinogenic (di)amino acids can be used for the design and synthesis of 
peptides, as substitutes of the original α-amino acids in order to modulate their structure and 
activity.2 An important example is L-2,4-diaminobutyric acid 1 (DAB), which is a naturally occurring 
α,γ-diamino acid, present in certain Lathyrus species, and causes a type of neurolathyrism.3 DAB has, 
among other effects, an antitumor effect, and is used in peptide design.4 DAB residues are also found 
in polymyxins 2, a family of cationic lipopeptide antibiotics produced by Gram-positive bacteria and 
active against many Gram-negative bacteria (Figure 1).5  
 
Figure 1 
Recently, it was found that 2,4-diaminobutanoylpiperidines and analogues are excellent inhibitors of 
the enzyme dipeptidyl peptidase II (DPP II, also known as DPP7 and QPP).6 Proline-specific dipeptidyl 
peptidases (DPPs) are enzymes that are capable to cleave off dipeptides at the N-terminus of 
peptides with preferentially proline at the penultimate position. Due to the unique structure of 
proline, relatively few enzymes are capable of doing so which makes this group an important 
protease family that may play an important role in the regulation of biological processes. Inhibitors 
of these DPPs have an interesting therapeutic potential, particularly in diabetes, oncology and 
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hematology. DPPIV is by far the most studied enzyme of this family and, therefore, other dipeptidyl 
peptidases with overlapping substrate specificities are often referred to as DASH-proteins (“DPPIV-
activity and/or structure-homologues”) and include DPPII, DPP8, DPP9 and Fibroplast Activation 
Protein α (FAP α). It is a successful target for drug design and several DPPIV inhibitors have already 
been accepted or are under review for the treatment of type 2 diabetes. Inhibition of DPPIV stops 
DPPIV-mediated degradation of incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-
dependent insulinotropic polypeptide (GIP), involved in the regulation of glucose homeostasis via 
stimulation of insulin secretion, inhibition of glucagon release and delay of gastric emptying, with an 
overall decrease of blood glucose levels. 
(S)-2,4-Diaminobutanoylpiperidine (Dab-Pip) 3 was described as the first highly selective DPP II 
inhibitor and was used as lead compound for the synthesis of new derivatives (Figure 2).6b,7 Very 
recently, the structure of the complex of human DPP II with Dab-Pip 3 was determined after co-
crystallization.6c Although the exact function of the enzyme remains largely unknown, its widespread 
distribution in the human body suggests a general role for DPP II as one of the house-keeping 
proteins.6a The design of new highly selective inhibitors may be of great importance to unravel the 
exact mode of action of the enzyme and can give rise to new biomedical applications of these 
inhibitors.  
 
Figure 2 
Conformationally constrained carbocyclic and heterocyclic α-amino acid derivatives also received 
increased attention because of their unique biological activities and conformational properties that 
are useful in fundamental research on structure-activity relationships.8 Linear peptides are highly 
flexible molecules that can adopt many conformations in solution of which only a few are responsible 
for their biological activity. The construction of novel peptide sequences, so-called foldamers and 
peptidomimetics, with incorporation of rigid amino acid surrogates to fold with predetermined 
secondary and tertiary structures provides very useful information on the bioactive conformation 
and results in beneficial physiological effects.  
Aziridine-2-carboxylates9 have shown their utility as inhibitors of diaminopimelate (DAP) 
epimerase10, a key enzyme in lysine biosynthesis in higher plants and bacteria, and aspartic acid 
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protease,11 whereas peptidic or peptidomimetic sequences containing an aziridine-2,3-dicarboxylate 
moiety are known cysteine protease inhibitors.12 A representative example is miraziridine A 4 (Figure 
3), found in the marine sponge Theonella mirabilis, being a nearly perfect "protease killer" which not 
only inactivates cysteine proteases but also reversibly inhibits aspartate proteases and serine 
proteases. Homologues of aziridine-2-carboxylates, such as β,γ- or γ,δ-aziridino acids, i.e. 2-
(carboxymethyl)- and 2-(carboxyethyl)aziridines, have been far less studied as biologically active 
constrained heterocyclic amino acids.13 Examples are 2-benzyl-3,4-aziridinobutanoic acid 5, known as 
an inhibitor of carboxypeptidase A,14 and aziridino-glutamate 6, which is an inhibitor of glutamate 
racemase.15 
 
Figure 3 
None of the naturally occurring amino acids containing a cyclopropyl group is proteinogenic, but 
most of them are associated with some interesting and important biological activity, which is also the 
case for some of the cyclopropyl analogues of the proteinogenic amino acids. Cyclopropylamino acids 
are often classified as “methanoamino acids”. 1-Aminocyclopropanecarboxylic acid 7, an 
intermediate in the biosynthetic conversion of methionine to ethylene in higher plants, is also known 
as 2,3-methanoalanine, but it is mostly just called α-ACC or ACC (Figure 4). The α-ACC constituent can 
also be found in some natural products such as cytotrienins 8, an apoptosis inducing metabolite 
isolated from Streptomyces species.8g  
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Figure 4 
Generally, related amino acids bearing a cyclopropyl substituent are classified as substituted 1-
aminocyclopropanecarboxylic acids. The plant toxin coronatine 9, produced by Pseudomonas 
coronafacience, is an example of a natural product containing a substituted 2,3-methanoamino acid 
as constituent (Figure 5).8e,8g A naturally occurring 2-aminomethyl-substituted ACC derivative is 
carnosadine 11, isolated from the red algae Grateloupia carnosa.8e,8g,16 Replacement of arginine with 
these 2,3-methano-analogues 10 and 11 leads to peptide conformations with increased stability,17 
whereas spirocyclic peptidomimetics containing these residues tend to preclude ideal bioactive 
conformations for binding to the vitronectin receptor.18 Other 2-substituted ACC derivatives also 
have been incorporated in peptides to study the conformational bias they impart to the peptide 
chain.19 
 
Figure 5 
In light of the ubiquitous applications of the above described diamino and conformationally 
constrained amino acid derivatives as building blocks in organic chemistry and as biologically active 
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molecules, the synthesis of new representatives of these interesting classes of non-proteinogenic 
amino acids and their further transformations will be dealt with in this PhD-thesis. 
Within a first part of this doctoral study, new synthetic routes towards γ,δ-aziridino α-amino acid 
derivatives 15 will be developed, starting from aziridines 12, bearing a functionalized methyl 
substituent, suitable for nucleophilic substitution, at the 2-position (Scheme 1). Indeed, previous 
studies at the Department of Sustainable Organic Chemistry and Technology (UGent) have proven 
that non-activated 2-(bromomethyl)aziridines 12 are valuable synthons for the preparation of a wide 
variety of azaheterocyclic compounds and ring opened amines.20 Substitution with deprotonated 
protected glycine derivatives 13 would give access to 2-(carboxyethyl)aziridines 15 as a new class of 
conformationally constricted α,γ-diamino acids, which may possess interesting biological activities 
and could serve as building blocks for a variety of natural products. Indeed, having introduced the 
2,4-diaminobutanoyl functionality, these compounds now could serve as scaffolds for the synthesis 
of new DPP II inhibitors. Ring opening of aziridines 15 with appropriate nucleophiles should lead to 
amines 16, which can be further functionalized to the desired potential DPP II inhibitors 18. In a 
second approach, amides 18 will be synthesized via functionalization of aziridines 15 to the 
corresponding amides 17, followed by ring opening. Deprotection of aziridines 17 would lead to the 
conformationally constrained analogues 19 of Dab-Pip 3. Finally, γ,δ-aziridino-α-amino amides 17 
could be directly obtained via nucleophilic substitution of aziridines 12 with deprotonated N-
protected glycinamides 14. 
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Scheme 1 
In a second part of this PhD thesis, the application of constrained γ,δ-aziridino α-amino acid 
derivatives 15 as synthetic building blocks will be further investigated (Scheme 2). The utility of 
aziridines as valuable substrates for ring transformation to cyclopropanes has already been 
demonstrated.21 Treatment of γ,δ-aziridino α-amino esters 15 with benzyl bromide will allow access 
to 2-(aminomethyl)-substituted ACC derivatives 20 as precursors for the synthesis of the 
corresponding amides 21, which should also be directly available via ring transformation of γ,δ-
aziridino α-amino amides 17. Finally, deprotection of cyclopropanes 21 would lead to the 2,3-
methano analogues 22 of (S)-2,4-diaminobutanoylpiperidine Dab-Pip 3. 
Chapter 1  Introduction and Goals 
 
 
7 
 
 
Scheme 2 
Having the conformationally constrained cyclopropylamino acid derivatives 20 hopefully in hand, 
these amino acid residues will be incorporated into selected short model peptides 23a,b containing 
alanine and homopeptides 23c-f containing a small number of residues to investigate their 
conformational preferences and opportunities in the design of peptidomimetic drugs (Scheme 3).  
 
Scheme 3 
Within the general objective to synthesize functionalized aziridines as building blocks for a variety of 
nitrogen-containing compounds, the asymmetric synthesis toward chiral aziridines 25 will be 
investigated, applying the tert-butanesulfinyl group as the chiral directing and protecting group at 
nitrogen (Scheme 4). Since its introduction by Ellman and co-workers, enantiopure tert-
butanesulfinamide has been utilized quite extensively in the asymmetric synthesis of a variety of 
biologically interesting molecules, including amino acid derivatives.22 The commercially available 
sulfinamide can be easily used in condensation reactions with aldehydes or ketones. Addition of 
different nucleophiles across the corresponding imines proceeds with high diastereoselectivities due 
to the powerful stereodirecting effect of the chiral sulfinyl group. Furthermore, the tert-
butanesulfinyl group can be selectively deprotected with (dry) HCl.  
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Previous research at the Department of Sustainable Organic Chemistry and Technology (UGent) has 
shown that reaction of aromatic α-halo N-(tert-butanesulfinyl)imines 24 with vinylmagnesium 
bromide resulted in situ in N-sulfinyl 2-aryl-2-vinylaziridines 25, which spontaneously rearranged into 
biologically interesting 3-aryl-3-pyrrolines 26.23 The scope of this Grignard addition reaction was 
extended within a last part of this PhD-thesis and the addition of other alkenylmagnesium bromides 
was evaluated to verify the possible isolation of 2-alkenylaziridines 25. Indeed, 2-vinylaziridines and 
related aziridines have proven to be suitable substrates for transformation into a variety of 
heterocycles.24 
 
Scheme 4 
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2 Literature overview 
Many synthetic strategies for the synthesis of aziridines are described within literature and also in 
our research group several routes have been developed which include the “De Kimpe aziridine 
synthesis”, starting from α-haloimines and reaction of 2-aza-1,3-dienes with diazomethane.25 Within 
this chapter, a literature overview will be given of the main synthetic routes towards  
2-(carboxyethyl)aziridines 27 (Figure 6) and, if relevant, their ring transformation into heterocyclic 
and carbocyclic ring systems such as lactones, lactams, 3-pyrrolines and cyclopropanes. The presence 
of both the strained aziridine ring system and the functionalized side chain makes these compounds 
excellent building blocks for the synthesis of many synthetic and natural products of biological 
importance. A division has been made, based upon the different synthetic approaches towards  
2-(carboxyethyl)aziridines, involving different bond connections or functional group transformations. 
To make a clear distinction between the assignment of absolute and relative stereochemistry, (R) or 
(S) were added as stereodescriptors to the stereogenic center in the case of enantiopure compounds. 
In the case of racemates (±) was added to clarify that the assigned stereochemistry refers to the 
relative configuration. 
 
Figure 6 
2.1 Synthesis of 2-(carboxyethyl)aziridines through N1-C3 bond formation 
γ-Azido carboxylic acid derivatives bearing a leaving group in the δ-position can easily be transformed 
into the corresponding aziridines via intramolecular nucleophilic substitution. A first example 
describes the addition of bromine azide to diene 28 to afford brominated azide 29 in 80% yield 
(Scheme 5). Subsequent ring closure to the corresponding aziridine 30 was performed by treatment 
of the β-bromoazide 29 with trimethyl phosphite.26 
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Scheme 5 
In a next example, vinylic aziridines (±)-37 were synthesized, starting from allylic alcohols 31 (Scheme 
6).27 Epoxidation of 31 with m-CPBA gave epoxy alcohols (±)-32, which were oxidized to the 
corresponding epoxy aldehydes (±)-33 using the TEMPO/PhI(OAc)2 method. Subsequent Horner-
Wadsworth-Emmons reaction with triethyl phosphonoacetate afforded α,β-unsaturated epoxy esters 
(±)-34, which underwent regio- and stereoselectively ring opening with TMSN3, in the presence of 
BF3.Et2O as Lewis acid. The resulting anti-azido alcohols (±)-35 were ring closed to the corresponding 
aziridines (±)-36 via a Staudinger reduction. In a final step these aziridines were protected as ethyl 
and t-butyl carbamates (±)-37. Stereoselective dihydroxylation of the double bond using OsO4 yielded 
diols (±)-38 and (±)-39 in 70-75% yield. The presence of the aziridine N-protecting group was of 
utmost importance for the stereochemical control since no stereoselectivity was observed after 
hydroxylation of the unprotected aziridines (±)-36 (1:1 mixture of diastereomers). 
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Scheme 6 
In a similar way, starting from epoxy alcohol 40, the synthesis of enantiopure aziridine 41 has been 
described by Geib and co-workers in 13% overall yield (Scheme 7).28  
 
Scheme 7 
Another convenient entry towards 2-(carboxyethyl)aziridines starts from N-Boc-protected glutamate 
42, which is readily reduced to amino alcohol 43 with sodium borohydride. Cyclization of alcohol 43 
under Mitsunobu conditions afforded 2-(carboxyethyl)aziridine 44 in 74% yield (Scheme 8).29 
Subsequent boron(III) fluoride-catalyzed reaction with isoamyl alcohol 45 did not result in the desired 
ring opening product but instead a ring transformation to γ-lactone 46 was observed.  
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Scheme 8 
In another example, Boc-protected glutamic acid δ-methyl ester 47 was reduced with 1M borane in 
THF to amino alcohol 48, which was subsequently tosylated in pyridine and ring closed with NaH in 
DMF to afford aziridine 50 in 60% yield (Scheme 9).30 
 
Scheme 9 
Functionalized alcohol 51, prepared in three steps from 3-(benzyloxy)propylmagnesium chloride and 
fluoroacetonitrile, was oxidized with CrO3/pyridine in the presence of t-butanol/acetic anhydride to 
t-butyl ester 52 and subsequent hydrolysis in refluxing HCl afforded racemic  
α-(fluoromethyl)glutamate 53 in 86% yield (Scheme 10). Finally, aziridino-glutamate 54 was obtained 
upon heating of acid 53 in 1M KOH at 85 °C. The compound proved to be stable when stored in 1M 
KOH, however, lowering the pH resulted in cyclization towards γ-lactone 55. The synthesized 
analogue of glutamic acid 54 acts as an irreversible inhibitor of Lactobacillus glutamate racemase.15 
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Scheme 10 
2.2 Synthesis of 2-(carboxyethyl)aziridines through N1-C2 bond formation 
Another example of the use of natural products from the chiral pool for the synthesis of enantiopure 
2-(carboxyethyl)aziridines is illustrated by the synthesis of Boc-protected aziridines 57 (Scheme 11). 
Starting from Boc-protected L-phenylalanine, a six step synthesis afforded both isomers of alcohol 
56, which was ring closed under Mitsunobu conditions to enantiopure aziridines 57a and 57b in 
excellent yield.31 
 
Scheme 11 
2.3 Synthesis of 2-(carboxyethyl)aziridines via the Gabriel-Cromwell reaction 
Of several existing aziridination strategies, the Gabriel-Cromwell reaction remains one of the most 
convenient and useful. Reaction of dibromoester 58 with primary amines in the precense of DBU 
afforded the corresponding aziridines 59 in 63-80% yield (Scheme 12). The reaction showed to be 
compatible with a nucleoside-derived amine, which suggests a broad scope of applications, for 
example as precursor of cofactor mimics of S-adenosyl-L-methionine.32 
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Scheme 12 
2.4 Synthesis of 2-(carboxyethyl)aziridines by transfer of nitrogen to olefins 
2.4.1 Copper-catalyzed iminoiodinane-mediated aziridination of olefins 
Since its discovery at the end of the 19th century, iodosylbenzene PhI=O is used for the synthesis of 
epoxides via a metal-catalyzed oxygen atom transfer to alkenes. Evans demonstrated that the aza-
analogues, i.e. the iminoiodinanes, also react with olefins to give the corresponding aziridines.33 
However, the troublesome preparation of these nitrene sources hampers a wider application of this 
aziridination process in organic chemistry. A first example describes the aziridination of ethyl sorbate 
60 with PhI=NTs as nitrene source, catalyzed by copper-complex 61 (Scheme 13). The system only 
reacts with the terminal double bond and vinylaziridine (±)-62 was obtained in 55% yield.34 
Treatment of the latter aziridine with a catalytic amount of copper(II) hexafluoroacetylacetonate in 
toluene resulted in the diastereoselective formation of 3-pyrroline (±)-63 in excellent yield.35  
 
Scheme 13 
A one pot process was developed by Dodd and co-workers, allowing a direct copper-catalyzed 
nitrogen transfer onto olefins without isolation of these capricious iminoiodinane reagents, mediated 
by iodosylbenzene itself.36 In the context of the synthesis of novel conformationally constrained 
analogues of arginine 66, one of them being a protected form 66b of the natural amino acid 
enduracididine, aziridination of the (S)-enantiomer of N-phenylfluorenyl (NHPhF) protected 
allylglycine 64 via copper-catalyzed reaction with in situ generated PhI=NSes (Ses: SO2CH2CH2SiMe3) 
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provided an inseparable 7:3 mixture of diastereomers 65 in 28% yield (Scheme 14).37 An additional 
four step synthesis afforded the target compounds. 
 
Scheme 14 
2.4.2 Rhodium-catalyzed aziridination of sulfamate esters 
Chiral sulfamate esters (±)-67 proved to be excellent substrates for a diastereoselective 
intramolecular aziridination reaction, leading to the corresponding bicyclic aziridines (±)-68 (Scheme 
15).38 Generation of the active nitrene species was done in situ by oxidation of the amine reagent 
with PhI(OAc)2 in the presence of a catalytic amount of rhodium. 
 
Scheme 15 
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2.4.3 Aziridination of α,β-unsaturated aldehydes 
A new highly enantioselective organocatalytic aziridination of α,β-unsaturated aldehydes was 
described by Córdova en co-workers, involving the formation of catalytic iminium and enamine 
intermediates (Scheme 16).39 The formation of 2-(carboxyethyl)aziridine 72 is initiated by reaction 
of the chiral amine catalyst, TMS-protected diphenylprolinol 71, with aldehyde 69 to form iminium 
intermediate 73. Reaction with acylated hydroxylamine 70 as “nitrene” equivalent via an aza-Michael 
addition gave the corresponding enamine 74, which is transformed to aziridine 75 via 
enantiocontrolled intramolecular substitution. Finally, the catalyst is regenerated by hydrolysis, 
delivering 2-formylaziridine 72 in 62% yield. 
 
Scheme 16 
2.4.4 Aziridination of nitroalkenes 
Aziridination of E-nitroalkene 76, using ethyl [(4-nitrobenzenesulfonyl)oxy]carbamate as “nitrene” 
equivalent in the presence of a base, resulted in the formation of cis-aziridine (±)-77a as the main 
product (Scheme 17).40 Experimental findings suggest that the aziridination proceeds via an aza-
Michael addition of the NsON–CO2Et anion to the β-position of the nitro group, followed by ring 
closure by expulsion of the good leaving group (NsO–) instead of a direct nitrene formation and 
addition after deprotonation with CaO. 
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Scheme 17 
2.4.5 Aziridination via intramolecular azide-diene cycloaddition 
Starting from protected L-erythrose 78, a three step procedure afforded dienes 79, which were ring 
closed to the corresponding aziridines upon heating in benzene at reflux via intramolecular  
1,3-dipolar cycloaddition (Scheme 18).41 Due to instability of the resulting triazoline intermediates, 
a thermal rearrangement occurs to the corresponding 2-(carboxyethyl)aziridines 80a,b. Further 
elaboration resulted in the synthesis of the pyrrolizidine alkaloid trihydroxyheliotridane as the 
protected acetonide 81. Starting from D- erythrose, the other enantiomer was obtained as well. 
 
Scheme 18 
2.5 Synthesis of 2-(carboxyethyl)aziridines by transfer of carbon to imines 
2.5.1 Sulfur ylide-mediated three component aziridination of imines 
The application of sulfur ylides in a three-component coupling reaction resulted in the formation of 
1-tosyl-2-(carboxyethyl)aziridines (±)-85 (Scheme 19).42 Malonate derivatives 82 were deprotonated 
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with NaH in THF and reacted with diphenylvinylsulfonium triflate 83. Addition of the ylide 86 across 
N-tosylimines 84, followed by intramolecular ring closure, furnished the corresponding N-tosyl-2-
(carboxyethyl)aziridines (±)-85 in high yield and moderate cis-selectivity, which was improved by 
using electron-rich aromatic imines. However, the reaction is limited to nucleophiles bearing only 
one acidic proton. Upon reaction with diethyl malonate (R1 = H), the electrophilic imine was not 
trapped and instead a 1,3-proton transfer occurred in the ylide 86, followed by cyclopropane 
formation. 
 
Scheme 19 
2.5.2 NaI-catalyzed ring opening and aziridination of cyclopropenes with imines 
Based upon previous research involving halide-catalyzed ring opening and coupling reactions of 
cyclopropenes, the group of Hou reported the stereoselective formation of cis-vinylaziridines upon 
NaI-catalyzed reaction of cyclopropenes with imines (Scheme 20).43 Regioselective ring opening of 
cyclopropene 88 by the I– nucleophile leads to the formation of allylic carbanion 90, which reacts 
further with N-tosylimines 84 to give intermediate 91. Subsequent intramolecular nucleophilic 
substitution regenerates I– and leads to the highly stereoselective formation of cis-vinylaziridines  
(±)-89 in 58-77% yield. Based upon 1H NMR analysis of the crude reaction mixtures, formation of the 
trans-isomer was not observed. 
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Scheme 20 
2.6 Hydrolysis of 2-(cyanoethyl)aziridines 
Treatment of 1-arylmethyl-2-(2-cyanoethyl)aziridines 92, prepared from 2-(bromomethyl)aziridines, 
with KOH in EtOH/H2O (3:1) under reflux afforded the corresponding potassium salts 93 in 80-90% 
yield (Scheme 21).20a Subsequent treatment with acetic acid leads to a ring expansion towards  
γ-lactones 94 in high yield. Neutralization of the alkaline medium transforms potassium salts 93 into 
zwitterionic species, which are highly susceptible to ring transformation. 
 
Scheme 21 
2.7 Functional group transformations towards 2-(carboxyethyl)aziridines 
starting from aziridine-2-carboxylates or aziridine-2-carboxaldehydes 
Several studies have shown the potency of aziridine-2-carboxylates and aziridine-2-carboxaldehydes 
as synthetic precursors for the synthesis of 2-(carboxyethyl)aziridines via functional group 
transformations including Wittig or Horner-Wadsworth-Emmons olefination, aldol condensation, 
condensation with dialkyl malonates, Baylis-Hillman reaction, synthesis of bisaziridines and addition 
across aldimines. 
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2.7.1 Synthesis of 2-(carboxyethyl)aziridines via Wittig or Horner-Wadsworth-Emmons 
olefination 
A first series of examples starts from chiral N-methylbenzyl aziridinecarboxylates or the 
corresponding aldehydes, easily prepared from commercially available chiral aziridines or upon 
reaction of 2,3-dibromopropionate with chiral α-methylbenzylamine.44 
In a first example, enantiomerically pure aziridine-2-carboxaldehydes 95 were prepared via oxidation 
of commercially available alcohols. Wittig-reaction of (2R)- and (2S)-aziridinecarboxaldehyde 95 with 
Ph3P=CHCO2R afforded (2R)- and (2S)-Z-alkenylaziridines 96 in excellent yield and E/Z ratio. The 
corresponding E-alkenylaziridines 97 were also obtained upon Horner-Wadsworth-Emmons 
olefination with ethyl and methyl diethyl phosphonoacetate (Scheme 22).45 Selective reduction of 
the carbon-carbon double bond of ethyl E-(2S)-97b was achieved upon reaction with  
o-nitrobenzenesulfonylhydrazide (NBSH) in the presence of Et3N in CH2Cl2. The reduction product 98 
was hydrogenated with Pd(OH)2/C in a next step to the corresponding (5R)-methylpyrrolidin-2-one 
99 in 91% yield via selective hydrogenolysis of the C(3)-N aziridine bond, debenzylation and 
subsequent intramolecular cyclization46. 
 
Scheme 22 
Conjugate addition of benzylamine to methyl E- and Z-acrylate (2R)-97a and 96a showed a big 
difference in reactivity and stereoselectivity between the two substrates. The Z-isomer is much more 
reactive and led to a diastereomeric mixture of 100a1 and 100b1 in a 4:1 ratio while with the  
E-isomer, the reaction is quite sluggish and no diastereoselectivity was observed (Scheme 23). To 
improve the diastereoselectivity, the reactions were also performed with (R)- and (S)-α-
methylbenzylamine. In the case of (R)-α-methylbenzylamine, no improvement was observed in terms 
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of selectivity (3.3:1 ratio). However, in the case of the (S)-isomer, compound 100a3 was obtained as 
the only product. The addition of benzylamine to methyl Z-(2S)-96a resulted in a similar selectivity to 
give addition products in a 2.6:1 ratio. In this case, however, both reactions with (R)- and (S)-α-
methylbenzylamine yielded addition products with poor selectivities of 1.2:1 and 2.1:1, respectively. 
Finally, addition product 100a3 was cyclized to the Boc-protected γ-lactam 101 upon treatment with 
hydrogen in the presence of Pd(OH)2/C, followed by reaction with (Boc)2O. 
 
Scheme 23 
Cis-dihydroxylation of E-enoates (2S)- and (2R)-97b was performed with OsO4 in the presence of 
NMO and afforded an inseparable mixture of diastereomers (2S)-102 and (2R)-102 in 77% and 73% 
yield and diastereomeric ratio of 1:1.7 and 1:1, respectively (Scheme 24).47 Subsequent treatment 
with acetic acid in CH2Cl2 afforded a regioselective aziridine ring opening, followed by lactamization 
at 50 °C in toluene to produce a mixture of (5S)-103a-b and (5R)-103a-b in the same diastereomeric 
ratios. This time both diastereomers were separated by facile crystallization. Having the pure 
diastereomers in hand, they were easily transformed into the corresponding iminosugar 1,4-dideoxy-
1,4-imino-D-arabinitol (5R)-104a and its three stereoisomers in two steps. 
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Scheme 24 
A higher level of diastereoselectivity was achieved when Sharpless asymmetric dihydroxylation 
conditions with either the AD-mix-α or AD-mix-β reagents were used. Recently, the synthesis of  
(+)-polyoxamic acid 105 was described, making use of this stereoselective dihydroxylation step 
(Scheme 25).48 (+)-Polyoxamic acid is a polyhydroxy amino acid which is commonly found in a variety 
of polyoxins, a family of natural peptidyl nucleosidic antibiotics.  
 
Scheme 25 
Chapter 2  Literature Overview 
 
 
23 
 
In a last example, Z-enoate (2S)-96a was subjected to Sharpless asymmetric dihydroxylation using 
AD-mix-β (Scheme 26).49 This time (2S,3S)-2,3-dihydroxy ester 106a was obtained with a high level of 
diastereoselectivity (106a/106b 10:1) and was isolated as a single diastereomer in 70% yield after 
column chromatography. Again, this diol was transformed into the corresponding γ-lactam 107 in 
82% yield. A nine-step synthesis, starting from this lactam afforded the known indolizidine alkaloid  
(-)-8-epi-swainsonine 108. 
 
Scheme 26 
The use of the D-glucose-derived aziridino ester 110, synthesized from aziridinecarboxylate 109 via 
reduction and subsequent two-carbon homologation using Ph3P=CHCO2Et, has also been described 
for the preparation of polyhydroxylated quinolizidine and indolizidine alkaloids (Scheme 27).50 
 
Scheme 27 
A series of benzyl-protected aziridines (±)-113 and (±)-114 was described by Sugiyama and co-
workers (Scheme 28).51 Aldehydes (±)-111a and (±)-111b were treated with Ph3P=CHCO2Et or 
(EtO)2P(O)CH2CO2Et, respectively, to afford esters (±)-(E)- and (±)-(Z)-113a in 67% combined yield and 
(±)-(E)-113b in 52% yield. In a similar manner, Horner-Wadsworth-Emmons reaction of aldehydes  
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(±)-112a and (±)-112b with triethyl phosphonoacetate resulted in the formation of  
2-(carboxyethyl)aziridines (±)-114a and (±)-114b in 26% and 53% yield respectively. 
 
Scheme 28 
Tardella and co-workers reported the synthesis of vinyl aziridines 116 via wittig olefination with high 
E-stereoselectivity (up to 99%), starting from aziridines 115 (Scheme 29).52 
 
Scheme 29 
In a next example, unprotected aziridino aldehydes (±)-117 were used as starting material. Although 
these aziridines exist as dimers (±)-118, the use of 2,2,2-trifluoroethanol (TFE) as a solvent promotes 
partial dissociation of the dimer and vinylic aziridines (±)-119 were obtained in high yield and 
excellent Z-selectivity upon reaction with stabilized Wittig reagents (Scheme 30).53 
Chapter 2  Literature Overview 
 
 
25 
 
 
Scheme 30 
Several studies have reported the use of (2S)-methyl N-tritylaziridine-2-carboxylate 124 and (2S)  
N-tritylaziridine-2-carboxaldehyde (S)-120, readily prepared from L-serine, as suitable substrates for 
the synthesis of 2-(carboxyethyl)aziridines. In a first example, unsaturated esters 122 were prepared 
as an inseparable E/Z mixture of isomers (11:1) through a Horner-Wadsworth-Emmons olefination 
between phosphonate 121 and enantiomerically pure aldehyde (S)-120 (Scheme 31).54 These 
scaffolds were used in an efficient approach to the core skeleton of schizozyganes, a small group of 
hexacyclic indoline alkaloids. 
 
Scheme 31 
Homologation of aldehyde (S)-120 via Wittig olefination with methyl 
(triphenylphosphoranylidene)acetate was also possible to yield alkenylaziridine 123 in 99% yield after 
column chromatography (Scheme 32).55 
 
Scheme 32 
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Another study reports the synthesis of optically active 2-(carboxyethyl)aziridines 127, starting from 
(2S)-methyl N-tritylaziridine-2-carboxylate 124 (Scheme 33).56 Reduction of the ester with 
diisobutylaluminium hydride, followed by a Swern oxidation and aryllithium addition resulted in the 
formation of alcohol 126 in 64% yield as a 1:1 mixture of diastereomers. A second Swern oxidation, 
followed by Horner olefination gave α,β-unsaturated esters 127a-b as a mixture of E/Z isomers, 
separable via column chromatography. 
 
Scheme 33 
N-Tosylaziridine (±)-129 was prepared as a 7:1 E/Z mixture in 95% yield upon Horner olefination of 
aldehyde (±)-128 with trimethyl phosphonoacetate and NaH in THF (Scheme 34).35 The unsaturated 
aziridine (±)-129 was highly diastereoselective rearranged to the corresponding bicyclic 3-pyrroline 
(±)-130 using Cu(hfacac)2 as a catalyst. The same study also described the synthesis and copper-
catalyzed rearrangement of N-phthalimido and N-tosyl protected aziridines 133, obtained via Wittig 
or Horner olefination of the proper starting material 131 or 132, respectively, to 3-pyrrolines 134. 
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Scheme 34 
To conclude, a series of optically pure mesyl, tosyl and 2,4,6-trimethylbenzenesulfonyl protected  
E- and Z-vinylaziridines were synthesized (Scheme 35).57 Aziridine-2-carboxylates 135 and 138 and 2-
vinylaziridines 141,142,149 and 150, prepared from optically active amino acids, amino alcohols or 
2,3-epoxy alcohols, were transformed into the corresponding aldehydes via reduction with DIBAL-H 
or ozonolysis, respectively. Wittig olefination afforded separable mixtures of the desired E- and  
Z-α,β-unsaturated esters 136, 137, 139a,b, 140, 143-148 and 151-156. The sodium salt of trimethyl 
phosphonoacetate was used to obtain E-α,β-enoate 136c as the major product. 
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Scheme 35 
Theoretical calculations on two sets of four stereoisomeric α,β-enoates (136a/c, 137a/c, 139a/c and 
140a/c) predicted the order of decreasing relative thermodynamic stabilities to be as follows: 4,5-cis-
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(2E)-136a/c > 4,5-trans-(2E)-139a/c > 4,5-cis-(2Z)-137a/c > 4,5-trans-(2Z)-140a/c. These findings 
were supported by the Pd(PPh3)4-catalyzed reaction of five sets of four stereoisomeric enoates, 
(136a, 137a,139a or 140a), (136b, 137b, 139a or 140a), (136c, 137c,139c or 140c), (143, 144, 151 or 
152) and (147, 148, 155 of 156) in THF, leading to equilibrated mixtures of the four possible 
stereoisomers in which the cis-(E)-isomers predominated over the others [cis-(E):other isomers = 
85:15−94:6], starting from either isomer (Scheme 36). The stereochemical outcome of these 
isomerizations was rationalized by considering the formation of π-allylpalladium complexes, 
generated by oxidative addition to the Pd(0) complex. 
 
Scheme 36 
2.7.2 Synthesis of 2-(carboxyethyl)aziridines via the aldol condensation 
β-Keto esters 157 were prepared via a Claisen condensation of aziridino ester 124 with the enolate of 
i-propyl and ethyl acetate (Scheme 37).56 The conversion of these β-keto esters 157 to  
α,β-unsaturated esters E-127a, 159b and 160b, bearing an additional aryl or alkynyl substituent cis 
with respect to the ester group, was achieved upon in situ generation of enol triflates 158 followed 
by Pd-catalyzed Stille cross-coupling reactions. 
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Scheme 37 
In another example, enantiomerically pure aziridino ethyl esters 161 were transformed into the 
corresponding β-keto esters 162 upon homologation with the enolate of ethyl acetate, obtained 
after deprotonation with LiHMDS in THF. Reduction of the latter compounds with NaBH4 in the 
presence of NH4Cl, led to a 1:1 and 2:1 diastereomeric mixture of aziridino alcohols (2S)-164a-b and 
(2R)-164a-b respectively, separable via column chromatography (Scheme 38).58 Reaction conditions 
were not further optimized to obtain a higher stereoselectivity. Hydrogenation with Pd(OH)2/C 
resulted in debenzylation and ring transformation to 5-methyl-4-hydroxypyrrolidinones 165a-d. 
These pyrrolidinones were further transformed into the 5-methyl-4-mercapto analogues and used 
for the synthesis of a new series of 1β-methylcarbapenems, showing excellent antibacterial activity. 
In another study, reaction of chiral aziridino ethyl ester (2R)-161 with t-butyl acetate yielded β-keto 
ester (2R)-163 in 88% yield (Scheme 38).59 This time, the reaction conditions were optimized to 
reduce the latter compound with high stereoselectivity. Sodium borohydride in isopropyl alcohol at  
-40 °C provided the best result and diastereomers 166a-b were obtained as a 10:1 mixture in 88% 
yield. 
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Scheme 38 
In a final example, methyl 3-(azidomethyl)aziridine-2-carboxylate 167, synthesized from vinylglycine 
in six steps, was converted to β-keto ester 168 upon reaction with the enolate of ethyl acetate, 
generated with LDA in THF. Reduction of the azide afforded bicyclic aziridine 169 in 76% yield 
(Scheme 39).60 This aziridinopyrrolidine was used as a building block for the synthesis of analogues of 
mitomycin antitumor antibiotics.  
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Scheme 39 
2.7.3 Synthesis of 2-(carboxyethyl)aziridines via condensation with dialkyl malonates 
Racemic aziridines (±)-170 were reduced with DIBAL-H to aldehydes (±)-171, followed by 
condensation with diethyl malonate to afford alkenyl aziridines (±)-172, which were suitable 
substrates for a Michael-initiated ring closure (MIRC) reaction with a series of organometallic 
reagents (Scheme 40).61 A variety of substituents were introduced onto the resulting 
cyclopropanedicarboxylic ester derivatives (±)-173 with highly diastereoselective formation of the cis-
isomer (cis/trans ratios ranged from 1:1 to 91:9). 
 
Scheme 40 
A second example describes the reaction of N-tritylaziridine-2-carboxaldehyde 120 with dimethyl 
malonate to afford diester 174 in 47% yield (Scheme 41).51 
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Scheme 41 
2.7.4 Synthesis of 2-(carboxyethyl)aziridines via the Baylis-Hillman reaction 
N-tritylaziridine-(2S)-carboxaldehyde 120 undergoes facile Baylis-Hillman reaction with activated 
alkenes 175, resulting in a separable 1:1 mixture of the syn- and anti-adducts 176 (Scheme 42).62 The 
synthetic utility of these adducts was further investigated and acetylation of 176a with Ac2O/Et3N 
gave acetate 178 in good yield. However, when Ac2O/pyridine was used instead, the rearranged 
acetate 177 was obtained, the E-isomer being the main product. The thermodynamically more stable 
trisubstituted alkene 177 is obtained via a SN2’ substitution of the allylic acetate 178 by acetate. 
 
Scheme 42 
Treatment of (E)-177 with various nucleophiles resulted in the apparent SN2 substitution products 
179-181 as the sole regioisomers (Scheme 43).  
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Scheme 43 
Remarkably, these compounds were obtained as a mixture of E- and Z-isomers, which is not in 
accordance with a direct SN2 displacement.
62 This result could be explained by the initial formation of 
an ionic intermediate 182, followed by reaction with the nucleophile to give intermediate 183 and 
expulsion of acetate to give a mixture of E- and Z-isomers 184 (Scheme 44). 
 
Scheme 44 
2.7.5 Synthesis of bisaziridines 
Alkylation of aziridine-2-carboxylates has been proven to be difficult due to either degradation or 
self-condensation of the resulting enolate species after deprotonation with LDA. Indeed several 
studies report the formation of bisaziridines as the main condensation product.63 For example, 
aziridino ethyl ester (2S)-185a was deprotonated with LDA in THF at -78 °C and subsequent reaction 
with an electrophile afforded condensation product 186 (Scheme 45).63d The t-butyl ester (2S)-185b, 
however, was deprotonated and reacted with different electrophiles under the same conditions to 
give aziridines 187. When the same reaction conditions were used on aziridino esters (2R)-185, again 
only aziridinyl ketones 188 were isolated. In contrast, in a 5:1 mixture of DME/Et2O, the aziridine 
(2R)-185b was functionalized to aziridines 189 in moderate yields. However, competitive self-
condensation could not be completely avoided. Due to steric reasons, stabilization of the transition 
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state does not occur for diastereomer (2R)-185b, and an intermolecular stabilization by DME is 
required. 
 
Scheme 45 
2.7.6 Synthesis of 2-(carboxyethyl)aziridines via addition across aldimines 
Enantiopure diamine 192 was constructed upon addition of ketene silyl acetal 191 across chiral 
aziridinyl-2-carboxaldimine 190, prepared from the condensation of carboxaldehyde (2R)-95 with  
p-anisidine, in the presence of BF3.OEt2 as a single diastereomer in 87% yield (Scheme 46).
64  
 
Scheme 46 
2.8 Conclusion 
In conclusion, it can be stated that many different approaches towards stereochemically defined  
2-(carboxyethyl)aziridines have been reported in literature with diverse substitution patterns. As 
demonstrated in this overview, the presence of the strained ring system and the functionalized side 
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chain makes these substrates excellent building blocks for a variety of natural products. However, 
only one synthesis has been reported to date (see section 2.4.1) leading to 2-(carboxyethyl)aziridines 
bearing an amino substituent at the α-position of the ester moiety and therefore new approaches 
towards these γ,δ-aziridino α-amino acid derivatives, which is envisioned within this research, might 
be a valuable addition to this class of attractive substrates as synthetic building blocks. 
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3 Results and discussion 
3.1 Introduction 
As has been pointed out within the literature overview, only one synthesis towards 2-
(carboxyethyl)aziridines bearing an amino substituent at the α-position of the ester moiety has been 
reported to date. Therefore a first goal within this thesis was to develop new synthetic routes 
towards γ,δ-aziridino α-amino acid derivatives, via substitution of aziridines bearing a functionalized 
methyl substituent, suitable for nucleophilic substitution, at the 2-position with protected glycine 
derivatives. Having introduced the 2,4-diaminobutanoyl functionality these compounds now could 
serve as scaffolds for the synthesis of new DPP II inhibitors. Furthermore, ring transformation of 
these synthons to 2-(aminomethyl)-1-aminocyclopropanecarboxylic acid derivatives will give access 
to suitable building blocks for the synthesis of 2,3-methano analogues of Dab-Pip and for the 
synthesis of short model peptides to investigate their conformational behavior. Finally, within a last 
part of this thesis, the use of the tert-butanesulfinyl group will be investigated for the asymmetric 
synthesis of chiral 2-aryl-2-vinylaziridines. To that extent, the addition of different alkenylmagnesium 
bromides across aromatic α-halo N-(tert-butanesulfinyl)imines will be evaluated. 
3.2 Synthesis and elaboration of γ,δ-aziridino α-amino acid derivatives 
3.2.1 Synthesis of γ,δ-aziridino α-amino acid derivatives 
1-Benzyl-2-(bromomethyl)aziridine 194 was chosen as starting material, a versatile substrate in 
organic synthesis with sufficient degree of reactivity towards nucleophiles due to the presence of the 
constrained azaheterocycle and the haloalkyl moiety.20 Furthermore, this aziridine is easily prepared 
in high yield and purity via an optimized and frequently used procedure developed in our research 
group.20b,20c,20k The desired α,γ-diamino functionality was introduced by substitution of aziridine 194 
with N-protected glycine esters 193a-b and the synthesis of aziridino esters 195a-b was carefully 
optimized by systematically changing the reaction conditions (Table 1).  
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Table 1. Synthesis of alkyl 3-(N-benzylaziridin-2-yl)-2-aminopropanoates 195a–b 
 
Entry Ester Base x equiv 
y 
equiv Time/Temp Product 
Conversion[a] 
(%) dr
[b] Yield (%)[c] 
1 193a LiHMDS 1.1 1.1 
1 h, -78 °C; 
16 h, Δ 
195a 0 - - 
2 193a LiHMDS 1.5 1.5 
1 h, -78 °C; 
16 h, Δ 
195a 10 1:1 - 
3 193a LiHMDS 2 2 16 h, r.t. 195a 0 - - 
4 193a LiHMDS 2 2 16 h, Δ 195a 30 1:1 - 
5 193a LDA 2 2 16 h, Δ 195a 0 - - 
6 193a LiHMDS 2 2 
1 h, -78 °C; 
16 h, Δ 
195a 100 1:1 89 
7 193b LiHMDS 2 2 
1 h, -78 °C; 
16 h, Δ 
195b 100 1:1 70 
8 193b LiHMDS 1 2 
1 h, -78 °C; 
16 h, Δ 
195b 0 - - 
[a] Determined via 
1
H NMR of the crude reaction mixture. [b] Determined via 
1
H NMR after column chromatography. [c] 
Isolated yield after column chromatograpy 
In a first attempt (entry 1), the substitution of compound 194 was performed with 1.1 equivalents of 
ethyl glycinate 193a. After deprotonation of the ester 193a with LiHMDS in THF at -78 °C, aziridine 
194 was added and the mixture was stirred for one hour at -78 °C, followed by 16 hours at reflux in 
THF. After workup, the 1H NMR of the crude reaction mixture indicated that no reaction had 
occurred. When the reaction was repeated with 1.5 equivalents of the enolate (entry 2), a conversion 
of only 10% was observed. The use of two equivalents of the enolate derived from glycine 193a, 
reacting for 16 hours at room temperature (entry 3) also did not result in the formation of aziridino 
ester 195a. When reflux was applied for two equivalents of the enolate (entry 4), a conversion of 
30% was observed, and when LDA was used as an alternative base (entry 5) again no reaction 
occurred. Finally, the reaction was repeated with two equivalents of LiHMDS (entry 6) and the 
reaction mixture was stirred for one hour at -78 °C before heating under reflux for 16 hours. This 
time, the reaction was successful and the substitution product 195a was isolated in 89% yield after 
purification by column chromatography. The same procedure was repeated with methyl glycinate 
193b (entry 7) and again the desired compound was isolated in 70% yield. Optimal conditions for the 
successful substitution of aziridine 194 thus include an additional hour of reaction time at -78 °C 
before heating under reflux for 16 hours after formation of the enolate derived from glycine esters 
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193 and addition of aziridine 194. The need for the additional hour at -78 °C to get full conversion 
might be explained by the formation of a reactive complex between the enolate and aziridine 194 to 
avoid selfcondensation of the enolate, which occurs when reaction temperature is directly brought 
to reflux after addition of aziridine 194. The substitution products 195a-b were obtained as a 1:1 
mixture of the syn1,3 and anti1,3 diastereomers, which could not be separated by column 
chromatography. In an additional attempt (entry 8), reaction of one equivalent of glycine ester 193b 
with two equivalents of base resulted in degradation of the starting material. 
3.2.2 Attempted synthesis of γ,δ-aziridino-α-amino amide derivatives  
As the previously reported highly selective DPP II inhibitors all contain a  
2,4-diaminobutanoylpiperidine skeleton (see chapter 1), it seemed interesting to perform the 
substitution reaction with glycine amide 196 as well, leading directly to substitution product 197 as a 
potential precursor of new conformationally constrained analogues of Dab-Pip 3 (Scheme 47). Similar 
reaction conditions as for the substitution reaction with N-(diphenylmethylene) glycine esters 193 
were investigated. No reaction was observed after 30 minutes at -78 °C followed by 30 minutes at 
room temperature. However, after 16 hours of reflux, analysis of the crude reaction mixture (LC-MS, 
1H NMR) indicated the formation of a 1:1 mixture of two diastereomers. Comparison with the 1H 
NMR spectrum of aziridine 195b indeed implies the formation of the desired compound. Similar to 
the spectrum of aziridine 195b, two AB-systems are observed in the range of δ = 3.0-3.6 ppm, which 
correspond to the chemical shifts of the benzylic CH2 of both diastereomers. Furthermore, typical 
resonance signals in the range of δ = 4.1-4.5 ppm, corresponding to the CH at the α-position of the 
ester moiety of aziridine 195b, were also observed in the crude spectrum of compound 197. The 
mass spectroscopic data however did not match the expected mass of the desired compound 197 
(LC-MS). A possible explanation for this observation might be a ring transformation into the 
corresponding lactam 198 or lactone 199. As will be shown in section 3.2.3 and 3.2.4 of this thesis, 
these aziridines are highly susceptible towards ring transformation to the corresponding lactams and 
lactones. Unfortunately, all attempts to isolate the resulting diastereomers from the crude reaction 
mixture via column chromatography failed and only decomposition products were isolated.  
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Scheme 47 
3.2.3 Attempted saponification of γ,δ-aziridino α-amino acid derivatives 
In order to synthesize the desired amide 197, another route had to be developed, involving 
saponification of the ester function present in aziridines 195 followed by a coupling reaction with 
piperidine.  
Attempts were made to do the saponification directly on the diphenylmethylidene protected 
aziridine 195b. Unfortunately due to lack of stability of the imino function during acidic aqueous 
workup, saponification of this compound was not possible and other appropriate N-protecting 
groups had to be evaluated in order to allow this saponification. The N-diphenylmethylidene group of 
aziridine 195b (Scheme 48) was cleaved by treatment of the aziridine with five equivalents of 
trifluoroacetic acid in a 2:1 mixture of acetone/water at room temperature for 15 minutes, resulting 
in the free amine 200 in 55% yield after basic workup with an aqueous NH4OH solution. In a next 
experiment, the tert-butoxycarbonyl group was introduced as N-protecting group (Scheme 48) upon 
treatment of amine 200 with di-tert-butyl dicarbonate in the presence of triethylamine and 
compound 201 was isolated in 59% yield as a 1:1 mixture of diastereomers. The benzyloxycarbonyl 
protected amine 202 was also isolated in 39% yield (dr 1:1) upon reaction with Cbz-Cl in 
dioxane/water (1:1). 
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Scheme 48 
Having the N-Boc and N-Cbz protected aziridines 201 and 202 in hand, attempts were made to 
hydrolyse the ester function under basic conditions (Scheme 49). Aziridines 201 and 202 were 
treated with five equivalents of 2M aq. NaOH in a 1:3 mixture of 2M NaOH/MeOH. The progress of 
the reaction was followed by thin layer chromatography and after one hour of stirring at room 
temperature all starting material was consumed. Methanol was evaporated and the residue was 
acidified with aq. 2M HCl before extraction with an organic solvent. Hydrolysis of  
2-(cyanoethyl)aziridines under basic conditions (see section 2.6) showed that the resulting potassium 
carboxylates were isolated but a ring expansion to the corresponding lactones occurred upon 
treatment of these salts with acetic acid. These findings, together with the 1H NMR and LC-MS 
analysis of the reaction mixture, suggest indeed the formation of lactones 203. Unfortunately, all 
attempts to isolate these compounds 203 via column chromatography failed. 
 
Scheme 49 
Since a ring transformation to the corresponding γ-butyrolactones 203 seems unavoidable upon 
acidic workup, the possibility was investigated to isolate the sodium salts instead. The same reaction 
conditions were applied as before but this time the aqueous residue was not treated with HCl before 
extraction. Comparison of LC-MS results with the previously obtained ones indicated that the lactone 
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had already been formed under basic conditions. Again it was impossible to obtain the pure 
compound after column chromatography. 
The same reaction conditions were applied to N-diphenylmethylidene-protected aziridine 195b to 
verify if also in this case ring expansion of carboxylate 204 to the corresponding lactone occurred 
under basic conditions and if so, if the pure compounds could be isolated. Indeed a 1:1 mixture of  
γ-lactones 199 was obtained and both diastereomers were isolated in 69% combined yield (Scheme 
50). Formation of the corresponding δ-lactone was not observed, probably due to a disfavored  
6-endo-tet ring closure according to Baldwin’s rules as compared to a favored 5-exo-tet cyclization. 
Finally, both diastereomers were separated from each other to yield (±)-199a and (±)-199b in 19% 
and 21% yield, respectively, using preparative TLC. 
 
Scheme 50 
Formation of γ-lactam 198 can also be excluded, based upon comparison with experimental data for 
similar γ-lactones from literature20a and γ-lactams 205, (±)-215 and (±)-211a, the synthesis of which is 
described within the next section (see section 3.2.4, experimental section). A first indication is the 
difference in value of the C=O stretching vibration, equal to 1771 and 1772 for isomer (±)-199a and 
(±)-199b, respectively, in the IR-spectra. While similar γ-lactones show a typical value of about 1770 
cm-1, all synthesized γ-lactams show a value around 1680-1690 cm-1. A second indication is the 1H 
NMR-chemical shift of the benzylic CH2. For all synthesized lactams, both protons show an AX-system 
which resonates downfield at δ = 4.0-4.2 ppm and δ = 4.9-5.1 ppm with a difference in δ-value of 
about 1 ppm. For both isomers (±)-199a and (±)-199b however, an AB-system which resonates 
around 3.7-3.9 ppm with a smaller difference in δ-value (0.04 ppm) is visible, which is in accordance 
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with data from similar γ-lactones. Finally, a difference in chemical shift is observed for Ha (Figure 7 
and 9) of the resulting lactones and lactams, respectively. The proton Ha resonates between δ = 3.5-
4.0 ppm for all synthesized lactams, while Ha of isomers (±)-199a and (±)-199b resonates at δ = 4.5-
5.0 ppm. 
The relative stereochemistry of both diastereomers was assigned via a combined analysis of 
observed coupling constants and 1D-NOESY experiments (Figure 7). Only in the case of isomer  
(±)-199a, both methylene protons Hb and Hc are resolved in the 
1H NMR spectrum and therefore only 
coupling constants of this isomer can be compared. Ha (multiplet) and Hd (dxd) can be unambiguously 
assigned from the 1H NMR spectrum based on their multiplicity. Hd (dxd, 4.43 ppm) of isomer  
(±)-199a exhibits two vicinal coupling constants, Jcd = 8.2 Hz and Jbd = 5.7 Hz. The assignment of Hb 
and Hc was made, assuming that a cis-relationship would give the largest coupling constant. The 
signal of Hc (dxdxd, 2.18 ppm) shows a geminal coupling constant of Jbc = 13.0 Hz and two vicinal 
ones, being Jcd = 8.2 Hz and Jac = 5.5 Hz, which confirms the cis-relationship of Hc and Hd and suggests 
a trans-coupling between Hc and Ha. Hb (dxdxd, 2.50 ppm) again exhibits a geminal coupling constant 
of Jbc = 13.0 Hz and two vicinal ones of Jab = 7.6 Hz and Jbd = 5.7 Hz, which now confirms the trans-
relationship of Hb and Hd and cis-relationship of Hb and Ha. Based on these findings it can be 
concluded that the two substituents of isomer (±)-199a should be trans opposed to each other.  
However, no firm assignments of stereochemistry can be made based on the size of coupling 
constants alone, and therefore 1D transient NOESY experiments were performed on both 
diastereomers (Figure 7, experimental section). The traditional steady-state 1D NOE experiment 
involves saturation at the resonance frequency of one peak in the 1H NMR spectrum with low power 
radio frequency. Then a 90° pulse is applied and an FID is recorded to measure the amount of 
perturbation on the nearby nuclei. Since the enhancement of signals is quite small, it is necessary to 
record a control spectrum and to subtract the control spectrum from the NOE spectrum (NOE 
difference). With shaped (selective) pulses a 180° pulse can be applied specifically to a single peak in 
the spectrum. After a short time this perturbation propagates to nearby nuclei and a 90° pulse will 
"read" the effect on the other nuclei in the form of a spectrum with enhanced peak areas. In 
principle, a NOE spectrum similar to a NOE difference spectrum is obtained but the transient NOE 
does not involve the subtraction of spectra and therefore practically no artifacts are observed.65 
When Ha of isomer (±)-199a was irradiated, a negligible increase in the signal of Hd (0.3%) was 
observed while a substantial NOE of 5.6% for Hb (2.50 ppm) and a very small NOE of 0.3% for Hc (2.18 
ppm) was observed. These results now indeed suggest a trans-relationship of Ha and Hd in isomer  
(±)-199a and indicate a cis-relationship between Ha and Hb and thus confirm the hypothesis made 
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based upon the size of the coupling constants. To unambiguously prove the trans-relationship of 
both substituents in lactone (±)-199a, Ha of isomer (±)-199b was also irradiated. In this case, a 
significant increase in the signal of Hd of 3.2% was observed. Furthermore, a substantial NOE of 5.2% 
for the signal of Hb and Hc (m, 2.37-2.44 ppm) was observed. Since both protons are not resolved in 
the 1H NMR spectrum no further conclusions about the relative position of Hb and Hc towards Ha can 
be drawn. From these results, in can be concluded that the relative stereochemistry of lactones (±)-
199a and (±)-199b can be assigned as (±)-trans-199a and (±)-cis-199b. 
 
Figure 7. Determination of the trans- and cis-stereochemistry of lactones (±)-199 
3.2.4 Ring transformation of γ,δ-aziridino-α-amino acid derivatives into  
5-(bromomethyl)pyrrolidinones 
Having the desired conformationally constrained γ,δ-aziridino α-amino ester 195b in hand, its 
application as synthetic building block was investigated. Treatment of aziridine 195b with 2 
equivalents of a 33% HBr solution in glacial acetic acid resulted in the formation of a 1:1 
diastereomeric mixture of 5-(bromomethyl)pyrrolidinones 205 (Scheme 51). This time, regioselective 
ring opening occurred at the unsubstituted aziridine carbon atom of the intermediate aziridinium salt 
206, which is in accordance with previously observed results concerning the ring opening of  
2-(cyanomethyl)aziridines with HBr.66 Intramolecular ring closure of the resulting α,γ-diamino ester 
207 resulted in the formation of pyrrolidinones 205. 
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Scheme 51 
One of the diastereomers spontaneously precipitated from the crude reaction mixture upon addition 
of Et2O and was easily isolated in 41% yield, while column chromatography afforded the other isomer 
as a pure compound in 23% yield. 
To assign the relative cis/trans stereochemistry of both diastereomers, 1H NMR spectroscopic data of 
both diastereomers was compared with literature data for similar substituted pyrrolidinones. 
Momose and co-workers reported the synthesis of related 3,5-disubstituted pyrrolidin-2-ones  
(±)-208-(±)-213 by iodolactamization via homoallylic asymmetric induction (Figure 8).67 Assignment 
of the trans- or cis-relationship between the C-3 substituent and the iodomethyl group was achieved 
by the characteristic 1H NMR chemical shift data of the methylene protons Hb and Hc at C-4 (Figure 8). 
In the case of the cis-isomers, the signals for Hb and Hc are split into two sets of signals, usually 
separated by 0.5-1.1 ppm, while for the trans-isomers the methylene signals usually overlap or the 
difference in chemical shift is smaller. Furthermore, the trans-relationship of the substituents in 
pyrrolidinone (±)-211a was confirmed by X-ray diffraction analysis. 
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Figure 8. Lactams synthesized by Momose and co-workers
67
  
Comparison of these findings with the experimental data of the synthesized pyrrolidinones (±)-205a 
and (±)-205b (Figure 9), could suggest a cis-relationship of the bromomethyl and 
diphenylmethylideneamino substituents of compound (±)-205a. The methylene signals of isomer  
(±)-205a are clearly split into two resolved signals while those for isomer (±)-205b overlap to form a 
multiplet.  
 
Figure 9. Spectroscopic data of γ-lactams (±)-205 
A more detailed look into literature showed the same pattern in a series of N-Boc-protected  
3,5-disubstituted pyrrolidin-2-ones 214 (Figure 10). Furthermore, it was observed that Ha signals are 
deshielded in the trans-isomers in comparison with the corresponding cis-isomers and for all trans 
compounds, the coupling constants Jab and Jac are very different from each other while those for the 
cis-isomers are similar.68 
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Figure 10. N-Boc-protected 3,5-disubstituted pyrrolidin-2-ones
68
 
These additional findings now suggested a trans-relationship in compound (±)-205a. Indeed, Ha of 
isomer (±)-205b (m, 3.54-3.66 ppm) resonates at a lower delta value of as compared to Ha of isomer 
(±)-205a (m, 3.90-3.97 ppm). In the case of isomer (±)-205a, Hd (dxd, 4.45 ppm) exhibits two vicinal 
coupling constants, Jcd = 8.3 Hz and Jbd = 6.1 Hz. Ha (multiplet) and Hd (dxd) can be unambiguously 
assigned from the 1H NMR spectrum based on their multiplicity, the assignment of Hb and Hc was 
made, assuming that a cis-relationship would give the largest coupling constant. The signal of Hc 
(dxdxd, 2.14 ppm) shows a geminal coupling constant of Jbc = 13.2 Hz and two vicinal ones, being  
Jcd = 8.3 Hz and Jac = 3.9 Hz, which confirms the cis-relationship of Hc and Hd and suggests a trans-
coupling between Hc and Ha. Hb (dxdxd, 2.38 ppm) again exhibits a geminal coupling constant of  
Jbc = 13.2 Hz and two vicinal ones of Jab = 8.3 Hz and Jbd = 6.1 Hz, which now confirms the  
trans-relationship of Hb and Hd and cis-relationship of Hb and Ha. Based on these findings, which 
should be interpreted with some precaution, it can be concluded that the two substituents of isomer 
(±)-205a should be trans opposed to each other.  
Interestingly, isomer (±)-205a was easily transformed into the known compound (±)-211a for 
comparison of its spectroscopic data (Scheme 52).67 Deprotection using 5 equivalents of TFA in a 2:1 
mixture of acetone/water gave the free amine, which was used without further purification in the 
next step. Reaction with benzyl chloroformate afforded Cbz-protected pyrrolidinone (±)-215 in 58% 
overall yield. Exchange of halogen atoms via Finkelstein reaction subsequently afforded  
5-(iodomethyl)pyrrolidinone (±)-211a in 71% yield. Comparison of 1H NMR spectra with literature 
data for (±)-trans-211a,67 showed both compounds to be identical, thus supporting the  
trans-substitution in pyrrolidinone(±)-205a. 
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Scheme 52 
The stereochemistry of isomer (±)-205a was finally unambiguously assigned as (±)-trans-205a by  
X-ray diffraction analysis (in collaboration with Prof. K. Van Hecke, Inorganic and Physical Chemistry, 
Ghent University, Belgium) (Figure 11). 
  
Figure 11. X-ray diffraction analysis of trans-pyrrolidinone (±)-trans-205a 
3.2.5 Stereoselective ring transformation of γ,δ-aziridino-α-amino acid derivatives into 
2-(aminomethyl)-1-aminocyclopropanecarboxylic acid derivatives 
The first synthesis of the naturally-occurring 2-aminomethyl-substituted ACC derivative carnosadine 
11, involved a cyclopropanation of a functionalized α,β-dehydroamino acid, followed by a resolution 
step which allowed assignment of the absolute configuration.16 A key step towards the first 
asymmetric synthesis of carnosadine was the synthesis of chiral 2-hydroxymethyl-ACC  
(2,3-methanohomoserine) via double alkylation of a chiral aminonitrile synthon with epibromohydrin 
after which the primary hydroxyl group can easily be transformed into a variety of other functional 
groups.69 All known syntheses towards 2-aminomethyl-substituted ACC derivatives proceed via this 
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key intermediate. Entries towards this intermediate involve double alkylation of a chiral glycine 
equivalent with enantiopure epichlorohydrins as bifunctional electrophiles,70 or diastereoselective 
cyclopropanation of a homochiral dehydroamino acid derivative, obtained from D-mannitol.71 Finally, 
the asymmetric synthesis of all stereoisomers of carnosadine was performed via reaction of cyclic 
sulfates with malonate diesters.72  
Aziridines have already demonstrated their utility as valuable substrates for ring transformation to 
cyclopropanes.21 In order to prepare a ring transformation towards 2-(aminomethyl)-
cyclopropanecarboxylic acid derivatives, thus avoiding the intermediacy of 2-hydroxymethyl-ACC 
derivatives, the introduction of a potential leaving group in γ-position of the α-amino ester moiety 
via ring opening of aziridine 195b was investigated.  
As previously reported for the ring opening of related aziridines,21a aziridine 195b was treated with 
benzyl bromide in acetonitrile under reflux which resulted in degradation of the starting material 
however. The reaction was repeated at room temperature but this time no reaction occurred and 
starting material was recovered. Finally, treatment of aziridine 195b with benzyl bromide at room 
temperature in acetonitrile in the presence of two equivalents of NaI afforded β-bromo amine 217 as 
a single regioisomeric product in 82% yield in a 1:1 diastereomeric ratio (Scheme 53). Benzyl bromide 
is responsible for both the activation of the aziridine ring leading to the aziridinium salt 216 and for 
the delivery of the nucleophilic bromide anion which induces ring opening of the aziridinium ion at 
the more-hindered aziridine carbon atom, which is in accordance with previously observed reactivity 
of related aziridines.73 Formation of the β-iodo amine was not observed and previous research has 
shown that substitution of bromine for iodine in the ring opening product of related aziridines 
proceeds via the aziridinium salt intermediate.74 To complete this substitution, three hours at reflux 
and 20 equivalents of NaI were necessary. When 15 equivalents were used, a longer reaction time of 
five hours was required. This clearly indicates the lower reactivity of the iodide ion and thus explains 
why no formation of the iodo derivative is observed under the conditions used here. 
Deprotonation at the α-position of the ester moiety, assisted by the iminated α-amino function,75 
and bromide expulsion through intramolecular nucleophilic displacement gave a ring closure toward 
cyclopropane (±)-cis-218 with excellent diastereoselectivity (dr 98:2). Both KHMDS and DBU were 
used as a base for this cyclopropane formation, and in each case the cyclopropane (±)-cis-218 was 
isolated, after column chromatography followed by recrystallization from ethanol, as a single 
diastereomer (dr > 99:1) in 67-70% yield (Scheme 53). The stereochemistry was unambiguously 
assigned as cis-cyclopropane (±)-cis-218 by X-ray diffraction analysis (in collaboration with Prof. K. 
Törnroos, Department of Chemistry, University of Bergen, Norway) (Figure 12).76  
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Scheme 53 
 
Figure 12. X-ray diffraction analysis of cis-cyclopropane (±)-cis-218 
The cis-stereoselectivity obtained in the cyclization of the isomeric mixture of γ-bromo-α,δ-diamino 
esters 217 can be rationalized by steric effects and implicates a preferred conformation as present in 
the proposed transition state TS-A (Figure 13).77 Transition state TS-B, leading to the trans-
cyclopropane is disfavored due to steric interactions between the dibenzylaminomethyl moiety and 
the ‘enolate’ group, which appear to be greater than those between the dibenzylaminomethyl 
moiety and the ‘diphenylmethylidenamino’ group. In contrast to the smaller ester group of the final 
cyclopropanes 218, the effective steric bulk of the ‘enolate’ group (involving the counterion M+) is 
larger than that of the ‘diphenylmethylidenamino’ group. Furthermore, TS-A might be stabilized via 
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-  interactions between the aromatic rings. The observed cis-stereoselectivity is in accordance with 
previously reported results concerning the ring closure of similar substrates.78 
 
 
Figure 13. Proposed transition-state model for the synthesis of cis-cyclopropane (±)-cis-218 
In conclusion, new conformationally constrained α,γ-diamino acid derivatives 195a-b were 
synthesized via substitution of 1-benzyl-2-(bromomethyl)aziridine 194 with different protected 
glycine esters 193. Substitution with protected glycine amide 196 to synthesize the conformationally 
constrained analogue 197 of Dab-Pip 3 failed however and other synthetic routes towards this 
compound should be investigated. The use of methyl 3-(aziridin-2-yl)-2-aminopropanoate 195b as 
building block for other organic molecules was subsequently investigated. Saponification of the latter 
compound resulted in the formation of a diastereomeric mixture of γ-lactones 199. Both isomers 
were separated via column chromatography and the relative stereochemistry of both diastereomers 
was assigned using NOE-experiments. Treatment of aziridine 195b with HBr led to a 1:1 
diastereomeric separable mixture of γ-lactams 205, whose relative stereochemistry was 
unambiguously assigned via X-ray diffraction analysis. Finally, aziridine 195b proved to be an 
excellent substrate for ring transformation into the corresponding stereochemically defined cis-2-
(aminomethyl)-1-aminocyclopropanecarboxylic acid derivative (±)-cis-218, the structure of which was 
also confirmed by X-ray diffraction analysis.  
3.3 Synthesis of 2,3-methano analogues of (S)-2,4-diaminobutanoylpiperidine 
Dab-Pip 
The previously synthesized 2-aminomethyl-substituted 1-aminocyclopropane-1-carboxylic acid (ACC) 
derivative (±)-cis-218 now could serve as building block for the 2,3-methano analogue (±)-219 of Dab-
Pip 3 as a potential conformationally constrained inhibitor of dipeptidyl peptidases (Scheme 54).79 
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Scheme 54 
A route was developed to introduce the amide functionality, involving saponification of the ester 
function present in cyclopropane (±)-cis-218 followed by a coupling reaction with piperidine. This 
transformation proved to be difficult. Attempts were made to perform the saponification directly on 
the N-diphenylmethylidene-protected cyclopropane (±)-cis-218, but unfortunately, due to lack of 
stability of the imino function during aqueous workup, a selective saponification of this compound 
was not possible and again other appropriate N-protecting groups had to be introduced in order to 
achieve this saponification. 
The N-diphenylmethylidene group of cyclopropane (±)-cis-218 was hydrolysed by treatment with five 
equivalents of trifluoroacetic acid in a 2:1 mixture of acetone/water at room temperature for 15 
minutes, resulting in the free amine (±)-220 in 48% yield after basic workup with aqueous NH4OH 
(Scheme 55). Subsequently, the benzyloxycarbonyl group was introduced as N-protecting group upon 
treatment of amine (±)-220 with 1.01 equivalents of Cbz-Cl in saturated aqueous NaHCO3/Et2O (1:1) 
providing N-Cbz protected α-aminocyclopropanecarboxylic ester (±)-221 in 69% yield. Reaction of 
amine (±)-220 with 1.2 equivalents of Boc2O resulted in the formation of N-Boc protected 
cyclopropanecarboxylic ester (±)-222 in 53% yield. 
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Scheme 55 
Saponification with 1M aqueous NaOH/MeOH (1:3), followed by acidic workup with aqueous HCl 
afforded carboxylic acids (±)-223 and (±)-224 in 81% and 63% yield respectively (Scheme 56). 
Subsequent reaction of cyclopropanecarboxylic acid (±)-223 with piperidine at room temperature for 
16 hours in the presence of EDC.HCl as coupling reagent led to amide (±)-225 in 73% yield.  
 
Scheme 56 
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Complete deprotection of the latter compound would then lead to the desired 2,3-methano-
analogue (±)-219 of (S)-2,4-diaminobutanoylpiperidine 3 (Table 2). In a first experiment, deprotection 
was tried with palladium on carbon (20%) in methanol under reflux in the presence of five 
equivalents of ammonium formate as hydrogen source, resulting in complete deprotection of 
cyclopropane (±)-225 (Entry 1). Upon standing however, a white precipitate was formed within the 
reaction mixture. A possible explanation for this observation could be the reaction of completely 
deprotected cyclopropane (±)-219 with carbon dioxide, resulting in the formation of ammonium 
carbamate (±)-227, which is in accordance with the observed mass in LC-MS. Indeed, aliphatic amines 
are known to react promptly with CO2 to afford the corresponding ammonium carbamate.
80 The use 
of palladium hydroxide on carbon in methanol under H2 atmosphere (5 bar) resulted in a mixture of 
the completely deprotected cyclopropane (±)-219 and the monodebenzylated cyclopropane (±)-226 
after 20 hours at room temperature (Entry 2). The catalyst was switched to palladium on carbon but 
after reacting for four hours under H2 atmosphere of 5 bar, decomposition of the starting material 
was observed, resulting in a complex reaction mixture (Entry 3). In a next experiment a milder 
pressure of 2 bar was applied which resulted in the formation of a mixture of completely 
deprotected and monodebenzylated cyclopropanes (±)-219 and (±)-226 after 30 minutes or two 
hours of reaction time (Entry 4-5). Finally, after four hours, reaction was complete and the 
deprotected cyclopropane (±)-219 was isolated in 91% yield (Entry 6). 
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Table 2. Deprotection of cyclopropane (±)-225 
 
Entry Reaction conditions Result 
1 
5 equiv NH4HCO2, 20% Pd/C 
MeOH, Δ, 30 min 
Complete deprotection 
Mixture of (±)-219 and (±)-227 
2 20% Pd(OH)2/C, H2 (5 bar), MeOH, rt, 20 h Mixture of (±)-219 and (±)-226 
3 20% Pd/C, H2 (5 bar), MeOH, rt, 4 h Complex reaction mixture 
4 20% Pd/C, H2 (2 bar), MeOH, rt, 30 min Mixture of (±)-219 and (±)-226 
5 20% Pd/C, H2 (1.8 bar), MeOH, rt, 2 h Mixture of (±)-219 and (±)-226 
6 20% Pd/C, H2 (1.8 bar), MeOH, rt, 4 h 
Complete deprotection 
(±)-219, 91% 
 
In conclusion, cyclopropane (±)-cis-218 could serve as building block for the synthesis of 2,3-methano 
analogue (±)-219 of Dab-Pip 3. Coupling with piperidine and subsequent deprotection of the amino 
functions led to the new conformationally constrained 2,4-diaminobutanoylpiperidine derivative  
(±)-219. An asymmetric synthesis of these 2-aminomethyl-ACC derivatives and the corresponding  
N-(α,γ-diaminoacyl)pyrrolidine and -piperidine derivatives from cyclopropanecarboxylic acids (±)-223 
and (±)-224 should be prepared in future research. Biological evaluation of these molecules will help 
fill the gaps in the knowledge of SAR of dibasic inhibitors of DPP II and other catalytically active 
dipeptidyl peptidases such as DPP IV, DPP8 and DPP9. Furthermore, for the latter targets, several 
structurally related dibasic compounds have been reported as highly potent inhibitors.81 
3.4 Synthesis of model peptides containing 2-(aminomethyl)-1-
aminocyclopropanecarboxylic acid derivatives 
In a next part, the previously synthesized conformationally constrained Cα-tetrasubstituted  
α,γ-diamino acid residues R2-AMAc3c-OR
1 (±)-220, (±)-223 and (±)-224 were used to carry out the 
synthesis of selected model peptides to study the conformational bias they impart to a peptide 
chain. The use of Cα-tetrasubstituted α-amino acids to restrict backbone conformations of peptides 
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and to inhibit biodegradation has already been demonstrated,82 making these amino acids 
interesting building blocks for the design of peptidomimetic drugs. The conformational preferences 
of peptides containing a cycloaliphatic residue Acnc (n = 3–8) have already been investigated 
thoroughly,83 but the influence of an extra substituent on this cycloaliphatic moiety has not been 
fully studied so far. Furthermore, previous research has shown that the oxygen atoms of the 1,3-
dioxane system of residue 228 may act as H-bond acceptors for amide NHs (Figure 14).84 These main-
chain to side-chain intramolecular H-bonds destabilize the 310-helical structures, typically adopted by 
the related homopeptides containing the Ac6c residue 229. Similarly, the nitrogen present in the 
azetidine ring of residue 230 also forms a main-chain to side-chain intramolecular H-bond when 
incorporated into small peptides.85 
 
Figure 14 
Based on this similarity, it was intended to assess whether the presence of the aminomethyl 
substituent affects the β-turn/helix induction tendency of the parent Ac3c residue. To this aim, the 
tripeptides Cbz-AMAc3c-Ala-Ala-OMe 231 and Cbz-Ala-AMAc3c-Ala-OMe 232 were synthesized by 
classical methods of peptide synthesis in solution. 
The syntheses of model peptides described within this paragraph were performed at the University 
of Padova (Italy) during a research stay under the supervision of Prof. F. Formaggio. 
3.4.1 Synthesis of Cbz-AMAc3c-Ala-Ala-OMe tripeptide 
In the first step Boc protected alanine 233 was coupled with alanine methyl ester hydrochloride 234 
by using the HOAt/EDC activation method to afford Boc-(Ala)2-OMe 235 in 82% yield (Scheme 57). 
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Scheme 57 
The N-t-butoxycarbonyl protecting group of dipeptide 235 was subsequently removed by reaction 
with trifluoroacetic acid in dichloromethane and the obtained TFA salt 236 was used without further 
purification in a final HOAt/EDC-mediated coupling reaction with N-benzyloxycarbonyl-protected 
carboxylic acid (±)-223 to give the desired tripeptide Cbz-AMAc3c-Ala-Ala-OMe 231 in 80% yield as a 
1:1 mixture of diastereomers (Scheme 58). Both diastereomers were separated by column 
chromatography to give the enantiomerically pure compounds 231a and 231b in 18% and 26% yield, 
respectively. Unfortunately, the absolute configuration of both diastereomers has not been 
determined yet. 
 
Scheme 58 
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3.4.2 Synthesis of Cbz-Ala-AMAc3c-Ala-OMe tripeptide 
Cbz-AMAc3c-OH (±)-223 was coupled with alanine methyl ester hydrochloride 234 to afford Cbz-
AMAc3c-Ala-OMe 237 in 83% yield as a 1:1 mixture of diastereomers which could not be separated 
via column chromatography (Scheme 59). Since both diastereomers of the previously synthesized 
tripeptide 231 were separable via column chromatography, it was believed that also in this case, the 
introduction of an extra alanine fragment would lead to the formation of separable diasteromers and 
the mixture of dipeptides 237 was used in a next coupling reaction. Subsequent removal of the  
N-benzyloxycarbonyl protecting group to yield dipeptide 240 by catalytic hydrogenation failed 
however, leading to a complex reaction mixture in which debenzylation of dipeptide 237 also 
occured according to LC-MS and 1H NMR results. The strategy was changed and this time, Boc-
protected dipeptide Boc-AMAc3c-Ala-OMe 238 was prepared in 83% yield. Again a 1:1 mixture of 
diastereomers, not separable via column chromatography, was obtained.  
 
Scheme 59 
The N-Boc protecting group was removed by treatment with TFA in CH2Cl2 and the obtained salt 239 
was coupled with Cbz-protected alanine 241 to afford the desired tripeptide Cbz-Ala-AMAc3c-Ala-
OMe 232 in 59% combined yield and 1:1 diastereomeric ratio (Scheme 60). Both diastereomers again 
were separated via column chromatography to give the optically active compounds 232a and 232b, 
of which the absolute configuration still needs to be determined, in 26% and 21% yield, respectively. 
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Scheme 60 
3.4.3 Synthesis of tripeptides containing glycine and α-aminoisobutyric acid (Aib) 
Since the incorporated cyclopropane residue is a racemic mixture of enantiomers, coupling with 
chiral amino acids leads to the formation of diastereomers, which have to be separable from each 
other. To avoid this problem, tripeptides containing the achiral amino acids glycine and Aib were also 
synthesized since the obtained mixtures of enantiomers would still give valuable information about 
the conformational preferences of the peptides. Furthermore, the strong tendency of Aib peptides to 
give single crystals would allow a detailed X-ray diffraction analysis of the obtained peptides.83 
In a first step, Boc-AMAc3c-OH (±)-224 was coupled with glycine ethyl ester hydrochloride 242a to 
provide Boc-AMAc3c-Gly-OEt (±)-243a in 85% yield after column chromatography, coupling of Boc-
AMAc3c-OH (±)-224 with 2-aminoisobutyric acid methyl ester hydrochloride H-Aib-OMe.HCl 242b 
provided Boc-AMAc3c-Aib-OMe (±)-243b in 81% yield (Scheme 61). TFA-mediated deprotection in 
CH2Cl2 of the N-Boc protecting group gave TFA-salts (±)-244, which were used without further 
purification in the next coupling step. 
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Scheme 61 
The desired tripeptides Cbz-Gly-AMAc3c-Gly-OEt (±)-246a and Cbz-Aib-AMAc3c-Aib-OMe (±)-246b 
were obtained in 63% and 38% yield, respectively, via HOAt/EDC coupling of the obtained TFA-salts 
(±)-244 with Cbz-protected glycine 245a or Aib 245b followed by purification via column 
chromatography (Scheme 62). 
 
Scheme 62 
Coupling of Boc-protected glycine 247 and glycine ethyl ester hydrochloride 242a via the HOAt/EDC 
activation method afforded the corresponding dipeptide Boc-(Gly)2-OEt 248 in 71% yield (Scheme 
63).  
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Scheme 63 
Again, TFA-mediated deprotection in CH2Cl2 of the N-Boc protecting group, present in dipeptide 248, 
followed by HOAt/EDC coupling of the obtained TFA salt 249 with Cbz-AMAc3c-OH (±)-223 led to the 
tripeptide Cbz-AMAc3c-(Gly)2-OEt (±)-250 in 78% yield after column chromatography (Scheme 64). 
 
Scheme 64 
The N-protecting benzyloxycarbonyl group of dipeptide Cbz-(Aib)2-OMe 251, available at the host 
institution, was quantitatively removed by catalytic hydrogenation, using an atmospheric pressure of 
hydrogen gas in the presence of Pd/C in methanol (Scheme 65).  
 
Scheme 65 
Having both fragments in hand, a final HOAt/EDC coupling of Cbz-AMAc3c-OH (±)-223 with 
deprotected dipeptide H-(Aib)2-OMe 252 afforded Cbz-AMAc3c-(Aib)2-OMe (±)-253 in 50% yield 
(Scheme 66). 
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Scheme 66 
3.4.4 Attempted synthesis of Cbz-(AMAc3c)n-OMe homopeptides 
As the homopeptide sequences would be the most suited for a clear assignment of the 
conformational preferences of the 2-(aminomethyl)-1-aminocyclopropanecarboxylic acid derivatives, 
attempts were made to synthesize Cbz-(AMAc3c)n-OMe homopeptides (n = 3-5). 
Boc-AMAc3c-OH (±)-224 was successfully coupled with H-AMAc3c-OMe (±)-220 using the HOAt/EDC 
activation method to give the homodipeptide Boc-(AMAc3c)2-OMe 254 in 58% yield as a 1:1 mixture 
of the diastereomers which were not separable via column chromatography (Scheme 67). 
 
Scheme 67 
Coupling with another fragment at this stage would be useless since this would lead to a complex 
mixture of eight stereoisomers, which would be inseparable for sure. Therefore, the need of 
enantiomericaly pure starting materials to synthesize these homopeptides is unavoidable and 
different attempts were undertaken to obtain the enantiopure AMAc3c starting material via chiral 
resolution. 
3.4.5 Chiral resolution of 2-(aminomethyl)-1-aminocyclopropanecarboxylic acid 
derivatives 
Derivatization of racemic mixtures is possible via reaction with optically active reagents, forming 
pairs of diastereomers that are separable by conventional techniques, such as column 
chromatography. However, after separation of the diastereomers, it should be possible to obtain the 
optically pure cyclopropane for further elaboration, thus implying that the coupled optically active 
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reagents should be readily removable. A first strategy was to couple Cbz-AMAc3c-OH (±)-223 with a 
chiral alcohol, separate the obtained diastereomers and finally obtain the enantiopure carboxylic 
acid 223 after basic hydrolysis of the ester bond. In a first attempt, Cbz-AMAc3c-OH (±)-223 was 
coupled with (-)-menthol but unfortunately an inseparable 1:1 mixture of diastereomers 255 was 
obtained in 67% yield (Scheme 68). 
 
Scheme 68 
Since the tripeptides 231 and 232, containing two extra chiral centra, were separable via column 
chromatography, it was tried to mimic these tripeptides via coupling of Cbz-AMAc3c-OH  
(±)-223 with the side-chain hydroxyl function of the serine residue in dipeptide Cbz-Ser-Ala-OMe 256, 
prepared via the HOAt/EDC activation method described above, without success (Scheme 69).  
 
Scheme 69 
In a final attempt, Cbz-AMAc3c-OH (±)-223 was coupled with amino alcohol 258 but again an 
inseparable mixture of diastereomers 259 was obtained (Scheme 70). 
 
Scheme 70 
Since the N-diphenylmethylidene protecting group in cyclopropane (±)-218 needs to be replaced by 
another more appropriate one for further elaboration of the compound, the idea arose to introduce 
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a chiral protecting group on nitrogen. Indeed, examples exist in literature were diastereomers,  
N-protected with (1R,2S,5R)-(-)-menthyl chloroformate, were separated from each other.86 
Cyclopropane (±)-218 was deprotected in a first step via reaction with TFA and subsequently coupled 
with (1R,2S,5R)-(-)-menthyl chloroformate to the corresponding carbamate 260 as a 1:1 mixture of 
diastereomers. Unfortunately again, both diastereomers were not separable via column 
chromatography (Scheme 71). 
Scheme 71 
The first synthesis of carnosadine 11, described by Shiba et al.,16 involved a resolution step in which 
two diastereomers 266, separable by column chromatography, were obtained via coupling of a 
racemic 2-aminomethyl-1-aminocyclopropanecarboxylic acid derivative with chiral (R)-(+)-α-
methylbenzylamine. In a next step, the amide bond was hydrolyzed again with 6M HCl. Starting from 
the racemic cyclopropane (±)-222, the described compound should be easily accessible and this way 
it would be possible to resolve both enantiomers. 
 
In a first step, debenzylation of the aminomethyl substituent of cyclopropane (±)-222 was 
investigated (Table 3). In a first experiment, conditions that were successful for the deprotection of 
compound (±)-225 were applied, however, a mixture of monodebenzylated cyclopropane (±)-262 and 
completely deprotected cyclopropane (±)-261 was obtained (Entry 1). Prolonged reaction time of 16 
hours (Entry 2) or application of a higher hydrogen pressure (Entry 3) also did not result in complete 
deprotection of compound (±)-222. Finally, ammonium formate was used as hydrogen source under 
reflux in methanol in the presence of Pd/C, and this time the deprotected compound (±)-261 was 
obtained in 96% yield (Entry 4). 
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Table 3. Debenzylation of cyclopropane (±)-222 
 
Entry Reaction conditions Result 
1 20% Pd/C, H2 (2 bar), MeOH, rt, 4 h Mixture of (±)-261 and (±)-262 
2 20% Pd/C, H2 (2 bar), MeOH, rt, 16 h Mixture of (±)-261 and (±)-262 
3 20% Pd/C, H2, (4.5 bar), MeOH, rt, 5 h Mixture of (±)-261 and (±)-262 
4 
5 equiv NH4HCO2, 20% Pd/C 
MeOH, Δ, 30 min 
complete deprotection 
(±)-261, 96% 
 
In the following step, the free amine (±)-261 was protected again upon reaction with benzyl 
chloroformate in a 1:1 mixture of Et2O/aq. NaHCO3 (sat.) for 15 minutes at 0 °C to give N-Cbz 
protected cyclopropane (±)-263 in 57% yield (Scheme 72). Subsequent saponification of the latter 
compound under alkaline conditions to carboxylic acid (±)-264, followed by coupling via the 
HOAt/EDC activation method with (R)-(+)-α-methylbenzylamine 265 afforded the same amide  
266 as reported by Shiba et al. as a 1:1 mixture of diastereomers.16  
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Scheme 72 
Indeed both diastereomers were separable via column chromatography, unfortunately the 
compounds were lost during an accident in the lab before they could be analysed.  
A closer look at the literature described by Shiba et al. revealed however that no data of the resulting 
diastereomers 266 was available for comparison and so direct determination of the absolute 
configuration of the obtained compounds 266 would not be possible.16 Therefore, the previously 
described synthetic route was abandoned and it was investigated if coupling of cyclopropane (±)-223 
with (R)-(+)-α-methylbenzylamine 265 would also lead to a mixture of diastereomers, separable by 
column chromatography. Indeed, HOAt/EDC-mediated coupling led to a 1:1 mixture of diastereomers 
267 in 69% combined yield after a first attempted separation by preparative TLC. Finally, both 
diastereomers were obtained as enantiopure compounds in 22% and 23% yield, respectively, after 
additional preparative TLC (Scheme 73). One of the diastereomers was obtained as an amorphous 
solid and at this moment attempts are made to obtain single crystals, suitable for X-ray diffraction 
analysis to determine the absolute configuration of the compounds. 
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Scheme 73 
Currently, the conformational preferences of the synthesized tripeptides are being investigated at 
the host institution. Attempts to grow single crystals are being made and crystal-state (X-ray 
diffraction) analyses and solution (1H-NMR and infrared) investigations will be performed to reveal 
the conformational preferences induced by the Cα-tetrasubstituted amino acid residues .  
However, preliminary results obtained from an IR absorption investigation, indicate that the 
trisubstituted nitrogen of the aminomethyl substituent may in fact act as a hydrogen-bond acceptor. 
The IR absorption study was performed in CDCl3 and the frequency interval of 3550-3200 cm
-1 
(Amide A band), related to the stretching vibrations of the N-H bonds belonging to the urethane and 
amide groups, was analyzed. It is generally assumed that in CDCl3 solvated NH groups (the so-called 
free NHs) resonate at wave numbers higher than 3400 cm-1, whereas H-bonded NH groups resonate 
at lower wavelengths.87 The spectrum of the synthesized dipeptide Cbz-AMAc3c-Ala-OMe 237 (Figure 
15), shows an absorption band at 3428 and a smaller one at 3378. As the dipeptides cannot form a  
-turn, it must be assumed that a non-classical, weak H-bond is present. To exclude the possibility 
whether the band of the H-bonded NH is due to intermolecular interactions, the effect of dilution 
was studied and Figure 16 shows the spectra of Cbz-AMAc3c-Ala-OMe 237 at two concentrations (the 
10-fold dilution is counterbalanced by a 10-fold increase of the cuvette pathlength). As only 
moderate dilution effects were observed, the H-bond is likewise intramolecular. The same behaviour 
was observed for all other dipeptides. 
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Figure 15. IR absorption spectrum of dipeptide 237 in 
CDCl3 solution at 1mM peptide concentration, the 
bottom line is the inverted second derivative 
 
Figure 16. IR absorption spectra of dipeptide 237 in 
CDCl3 solution at 0.1mM (A) and 1mM (B) peptide 
concentration
In conclusion, 2-aminomethyl-substituted 1-aminocyclopropane-1-carboxylic acid derivatives were 
used for the synthesis of model peptides in good yield, using classical methods of peptide synthesis 
in solution. However, since the incorporated cyclopropane residue is a racemic mixture of 
enantiomers, the synthesis of stereochemically pure homopeptides was not possible. Coupling of this 
cyclopropane with a chiral amine afforded separable diastereomers 267 of which the absolute 
stereochemistry still needs to be determined. Having both diastereomers in hand, hydrolysis of the 
amide function should be investigated to obtain the enantiopure cyclopropane residue 223. 
Subsequently, these enantiopure cyclopropanes can be used for the synthesis of optically active 
homopeptides. Elucidation of the preferred secondary structure of peptides containing this 
conformationally constrained cyclopropane residue could make this Cα-tetrasubstituted α,γ-diamino 
acid a usefull scaffold for the design of peptidomimetic drugs. 
3.5 Synthesis of 3-aryl-3-pyrrolines and 3-arylpyrroles via spontaneous 
rearrangement of N-sulfinyl 2-aryl-2-vinylaziridines 
Functionalized aziridines are versatile intermediates in the synthesis of acyclic nitrogen-containing 
compounds and azaheterocycles via cleavage of the carbon–nitrogen or carbon–carbon bond and via 
elaboration of functionalized substituents.88 As such, a strong interest exists to obtain a better 
understanding of the reactivity of aziridines which depends strongly on the substitution pattern of 
the aziridines and the reaction conditions.89 The further development of aziridine-mediated synthesis 
of functionalized heterocycles, especially nitrogen-containing five-membered heterocycles,90 relies 
on the availability of highly substituted chiral aziridines and the ability to control their further 
transformations in the desired way.91 Vinylaziridines are mostly synthesized by addition of a nitrene 
to a diene, addition of an allylic ylid to an imine or cyclization of unsaturated amino alcohols,92 and 
are increasingly being utilized as reactive building blocks in organic synthesis,24,88e via nucleophilic 
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ring opening,93 and via rearrangements toward different azaheterocycles.94 The rearrangement of  
2-vinylaziridines to pyrrolines typically requires thermal (180 °C), nucleophilic (HBr), or metal-
promoted conditions.92 The rearrangement usually yields 3-pyrrolines via C–N bond fission,35,94g,94l,95 
but ring expansion to 2-pyrrolines via C–C bond cleavage of specifically substituted 2-vinylaziridines is 
known as well.94m,96 More specifically, 3-aryl-3-pyrrolines are of significant biological interest as 
mechanism-based inactivators or substrates of amine oxidases.97 Moreover, the corresponding  
3-arylpyrroles act as reversible competitive inhibitors of monoamine oxidase B.98 Besides the 
aforementioned HBr promoted rearrangement of 2-aryl-2-vinylaziridines,95b ring-closing metathesis 
(RCM),99 Suzuki coupling reactions,100 ring contraction of 4-aryl-1,2,5,6-tetrahydropyridines,101 and 
dehydration of 3-aryl-3-pyrrolidinols,97d,102 have also been reported as alternative methods for the 
preparation of 3-aryl-3-pyrrolines. 
Inspired by the work of Davis103 and Ellman,22a,104 on the use of N-sulfinyl imines for the synthesis of a 
variety of nitrogen containing compounds,22b,105 our group and others have established the 
importance of α-halogenated N-tert-butanesulfinyl imines in the synthesis of chiral aziridines, 
including vinylaziridines.25b,69b,106 Addition of various ylids across enantiopure N-sulfinyl imines, 
provided optically active 2(,2)-(di)substituted 3-vinylaziridines as well.107 Noteworthy, none of the 
reported chiral N-sulfinyl vinylaziridines have a second substituent on the carbon atom bearing the 
vinyl group. Recently, however, a synthesis of chiral N-sulfinyl 2-alkyl- and 2-allyl-2-arylaziridines via 
Grignard addition across aromatic α-chloroketimines was developed by our research group.106i 
Therefore, it was envisaged that, using the latter method, unreported chiral N-sulfinyl 2-aryl-2-
vinylaziridines should become accessible as well and would represent suitably substituted activated 
vinylaziridines for rearrangement to 3-aryl-3-pyrrolines under mild conditions. 
3.5.1 Addition of alkenylmagnesium bromides across aromatic N-sulfinyl α-halo 
ketimines 
Previous research in our research group has shown that reaction of aromatic α-halo N-(tert-
butanesulfinyl)imines (RS)-268, synthesized in 75-90% yield via condensation of α-halo ketones with 
(RS)-tert-butanesulfinamide and Ti(OEt)4 in tetrahydrofuran,
25b with two equivalents of 
vinylmagnesium bromide in CH2Cl2 at -78 °C for two hours, followed by four hours at –40 °C, led to 
reaction mixtures of which analysis of the 1H NMR spectrum (300 MHz, CDCl3) allowed the 
identification of 11–24% of dehalogenated imines (RS)-269,
108 5–19% of 2-aryl-2-vinylaziridines  
(RS)-270, and 10–12% of 3-aryl-3-pyrrolines (RS)-271 together with a large amount (59-60%) of an 
unidentified condensation product (RS)-272 (Scheme 74). However, purification by chromatography 
on silica gel afforded 3-aryl-3-pyrrolines (RS)-271 in 15–27% yield, which led to the assumption that 
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the chiral N-sulfinyl 2-aryl-2-vinylaziridines (RS)-270 rearranged, with loss of the resulting stereogenic 
center, to the 3-aryl-3-pyrrolines (RS)-271 during the purification step. 
 
Scheme 74 
In order to resolve the structure of the unknown compound (RS)-272, obtained in 59-60% yield, 
several attempts were made to isolate it from the crude reaction mixtures. The reaction was 
repeated with (SS)-α-bromoketimine (SS)-268a and again the unidentified compound (SS)-272 was 
formed in 30% yield, next to 40% of the dehalogenated imine (SS)-269a, 11% of 2-aryl-2-vinylaziridine 
(SS)-270a and 19% of 3-aryl-3-pyrroline (SS)-271a (based upon 
1H NMR analysis of the crude reaction 
mixture). After column chromatography, followed by recrystallization from Et2O, the unknown 
condensation product (SS)-272 was isolated in a disappointing yield of only 5%, next to the 
deprotected 3-aryl-3-pyrroline 273 in 11% yield (Scheme 75). 
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Scheme 75 
The structure of the unknown condensation product was proven to be 3-pyrroline (SS)-272 via X-ray 
diffraction analysis (in collaboration with Prof. K. Van Hecke, Inorganic and Physical Chemistry, Ghent 
University, Belgium) (Figure 17). 
  
Figure 17. X-ray diffraction analysis of 3-pyrroline (SS)-272 
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As can be seen from figure 17 and 18, water is contained within the crystal structure, connecting the 
different molecules via hydrogen bonding. 
 
Figure 18. Hydrogen bonding with water in the crystal structure of 3-pyrroline (SS)-272 
The formation of 3-pyrroline (SS)-272, can be rationalized via initial formation of the dehalogenated 
imine (SS)-269a. The reduction of imine (SS)-268a can be explained through β-hydride transfer from 
the Grignard reagent, in competition with a halogen-metal exchange reaction, which converts the  
α-halo imine to the corresponding Grignard reagent. Protonation of the reaction mixture then gives 
the dehalogenated product.109 Subsequent deprotonation, followed by Mannich-type addition across 
the starting material (SS)-268a results in the formation of aziridine 275, which is then ring expanded 
to the corresponding 3-pyrroline upon second deprotonation, aziridine ring opening and cyclization 
with exclusive formation of the (2R)-isomer (SS)-272 (Scheme 76). 
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Scheme 76 
Upon storage in the freezer for a longer period however, compound (SS)-272 spontaneously 
underwent 1,4-elimination of tert-butanesulfinamide with formation of the corresponding pyrrole 
278, of which the structure was also confirmed by X-ray diffraction analysis (Figure 19). 
 
Figure 19. X-ray diffraction analysis of pyrrole 278 
In an attempt to isolate the resulting 3-pyrroline (SS)-272 in higher yield, p-phenylphenyl-substituted 
N-sulfinyl ketimine (SS)-268c was synthesized via the previously reported procedure in 39% yield. 
Chapter 3  Results and Discussion 
 
 
74 
 
Reaction of the latter compound was performed with vinylmagnesium bromide under the same 
conditions (Scheme 75), hoping the desired product would be easily crystallized from the crude 
mixture due to the presence of the extra phenyl substituent. Investigation of the crude reaction 
mixture (1H NMR), however, indicated that the condensation product was not formed, and only  
3-pyrroline (SS)-271c was isolated in 28% yield after recrystallization from Et2O. 
To verify the proposed mechanism for the formation of 3-pyrroline (SS)-272, imine (SS)-269a was 
synthesized in 73% yield following a literature procedure (Scheme 77).110 The compound was 
deprotonated with LiHMDS in THF at -78 °C for one hour and subsequently reacted with  
α-bromoketimine (SS)-268a for one hour at -78 °C. Comparison of the 
1H NMR spectra of the crude 
reaction mixture with those of the starting materials and the desired product (SS)-272 indicated that, 
next to unreacted starting materials, a significant amount of condensation product (SS)-272 was 
formed. Unfortunately all attempts to isolate it in pure form from the crude reaction mixture failed. 
 
Scheme 77 
On the other hand, when two equivalents of vinylmagnesium bromide were added to  
α-chloroketimines (RS)-281 under the same reaction conditions, only three products were observed 
in the crude reaction mixtures (Scheme 78). The 1H NMR spectrum indicated the presence of 9–35% 
of dehalogenated imines (RS)-269, accompanied by 33–61% of 2-aryl-2-vinylaziridines (RS)-270 and 
19–45% of 3-aryl-3-pyrrolines (RS)-271, before purification. After recrystallization of the reaction 
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mixtures from diethyl ether no 2-aryl-2-vinylaziridines were obtained, but 3-aryl-3-pyrrolines (RS)-271 
were isolated in 65–91% yield. 
 
Scheme 78 
To extend the scope of the Grignard addition reaction across aromatic ketimines 281, the addition of 
other alkenylmagnesium bromides was evaluated. The outcome of the reaction proved to depend 
highly on the substitution pattern of the Grignard reagent.  
In a first experiment, ketimine (RS)-281a reacted with two equivalents of isopropenylmagnesium 
bromide in CH2Cl2 for two hours at -78 °C, followed by four hours at -40 °C (Scheme 79). This time,  
2-aryl-2-isopropenylaziridine 282 was isolated as a stable compound in moderate yield, together with 
the nonconjugated aminodiene 283 in 17% yield. The formation of the latter product can be 
rationalized by SN2’ ring opening of aziridine 282 with the excess of isopropenylmagnesium bromide 
and demonstrates the tendency of 2-alkenyl-2-arylaziridines to react via C–N bond cleavage. In an 
attempt to prevent the formation of diene 283 and to improve the yield of aziridine 282, only a small 
excess of 1.2 equivalents of isopropenylmagnesium bromide was used in a second experiment. This 
time, reaction of ketimine (RS)-281a with isopropenylmagnesium bromide afforded 2-phenyl-2-
isopropenylaziridine 282 as a single stereoisomer in 69% yield while formation of the aminodinene 
283 was not observed. 
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Scheme 79 
The stereochemistry of aziridine 282 is assumed to be in analogy with the stereochemistry obtained 
during the synthesis of similar aziridines from chiral α-chloroaldimines25b,106a,106c and is opposite to 
the one that is predicted via the chelation-controlled transition state, which is the general 
intermediate proposed for non-functionalized N-sulfinyl imines.103-104,111 The reversal of 
stereochemical outcome of the reaction is attributed to the α-coordinating ability of the chlorine 
atom and is analogous to the results obtained with other N-sulfinylimines containing an α-
coordinating group, such as a nitrogen or oxygen atom.111a,112 
Several attempts were performed to rearrange aziridine 282 to the corresponding pyrroline 284 
upon stirring in several solvents (Table 4). Neither reaction at room temperature in Et2O (Entry 1) nor 
reaction under reflux (Entry 2-3) and addition of KI (entry 4) resulted in the formation of the desired 
3-pyrroline 284.  
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Table 4. Attempted synthesis of pyrroline 284 
 
Entry Solvent Reaction conditions Result 
1 Et2O rt, 1 h Recovery of starting material 
2 Et2O Δ, 1 h Recovery of starting material 
3 THF Δ, 3 h Recovery of starting material 
4 Toluene Δ, 1 h Recovery of starting material 
5 Et2O Δ, 1 h, 0.2 equiv KI Recovery of starting material 
 
These results indicate that the rate of rearrangement of 2-alkenylaziridines is influenced by subtle 
steric effects exerted by the substituents on the double bond. This substitution effect is further 
demonstrated by the sluggish reaction of (SS)-N-(tert-butanesulfinyl)imine (SS)-281a with 2 
equivalents of 1-propenylmagnesium bromide, which resulted in a crude mixture of aziridine 285 as 
the major product together with pyrroline 286, dechlorinated imine (SS)-269a, and unreacted imine 
(SS)-281a (Scheme 80). Purification of this reaction mixture by column chromatography on silica gel 
proved to be difficult and only the pyrroline 286 (dr = 86:14) was isolated in low yield (13%), while 
the aziridine 285 was not isolated in pure form. 
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Scheme 80 
Upon rearrangement of 2-alkenyl-2-arylaziridines, the formation of 2-aryl-2-pyrrolines 289 via C-C 
bond cleavage should be considered as well (Scheme 81). However, the structural identity of 3-aryl-
3-pyrrolines 271 and 286, was confirmed through comparison of their 1H NMR spectroscopic data 
with literature data for similar 3-aryl-3-pyrrolines. For the 3-pyrrolines 271, typical resonance signals 
in the range of δ = 3.33-4.45 ppm were observed for the two nitrogen-substituted methylene units. 
The chemical shifts of these methylene units correspond to the reported shifts of related 3-aryl-3-
pyrrolines,94m,97b-d,99c but differ significantly from the chemical shifts (δ = 2.0–2.6 ppm) of the 
methylene unit connected to the double bond of the corresponding 2-aryl-2-pyrrolines.113 This clearly 
indicated that a CH2NCH2 unit is present in the rearranged compounds 271. Similarly, the 
1H NMR 
spectroscopic data of 3-pyrroline 286 also indicated the presence of a CH2NCH unit (δ = 3.5–4.2 
ppm),114 and not the NCH2CH unit that would be present in 2-pyrroline 289 (R
2 = Me). Moreover, the 
chemical shift of the olefinic methine proton of 3-aryl-3-pyrrolines 271 at around δ = 6 ppm is also in 
good correspondence with reported values of related 3-aryl-3-pyrrolines,94m,97b-d,99c and differs 
significantly with the reported shifts (δ = 5.2–5.5 ppm) of the enamine proton of the corresponding 
2-aryl-2-pyrrolines.113 
The ready formation of 3-aryl-3-pyrrolines 271 can be explained due to the specific substitution 
pattern of 2-aryl-2-vinylaziridines 270. Cleavage of the C–N bond of 2-aryl-N-(tert-butanesulfinyl)-2-
vinylaziridines 270, due to the high ring strain and the activating electron-withdrawing group on 
nitrogen, results in a conjugated benzylic carbenium ion 287 (Scheme 81). This zwitterionic 
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intermediate 287, in which both the positive and negative charge are stabilized, can ring close via an 
intramolecular nucleophilic attack at the less hindered electrophilic position to the corresponding 3-
aryl-N-(tert-butanesulfinyl)-3-pyrrolines 271. For the substituted 2-vinylaziridines 282 and 285, the 
rearrangement occurs less easily due to steric effects, resulting in either a stable aziridine, for 
example, compound 282, or inefficient conversion to the 3-pyrroline, for example, pyrroline 286. 
Cleavage of the C–C bond of the aziridines to less stabilized 1,3-dipolar intermediates 288, which 
would subsequently result in the formation of 2-pyrrolines 289, does not occur. 
 
Scheme 81 
The structural identity of pyrrolines (RS)-271 was further ascertained through exploration of their 
chemical reactivity.  
3.5.2 Attempted hydrogenation of 3-aryl-3-pyrrolines 
Different 2- and 3-arylpyrrolidines are know in literature. For example, enantiopure 2-aryl-1-(tert-
butanesulfinyl)pyrrolidines have been synthesized in high yield via stereoselective reduction of  
γ-chloro N-sulfinylketimines with lithium triethylborohydride.115 To be able to compare spectroscopic 
data, attempts were made to transform 3-pyrroline (RS)-271a to the corresponding pyrrolidine 290 
via hydrogenation of the double bond (Scheme 82). Both palladium and palladium hydroxide on 
carbon were used, however, each time the starting material was recovered. 
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Scheme 82 
3.5.3 Oxidation of 3-aryl-3-pyrrolines to 3-arylpyrroles 
In another experiment, pyrrolines (RS)-271 were oxidized with 0.9 equivalents of 2,3-dichloro-5,6-
dicyanobenzoquinone (DDQ) in 1,4-dioxane at room temperature for 16 hours to the corresponding 
3-arylpyrroles 291 in 69–87% yield (Scheme 83). The resemblance of 1H NMR spectroscopic data of 3-
arylpyrroles 291 with data reported in the literature for similar 3-arylpyrroles,116 and significant 
differences with data reported in the literature for related 2-arylpyrroles,117 further confirmed the 
structural identity of pyrrolines 271. Both protons of the CHNCH unit, present in 3-arylpyrroles 291 
resonate in the range of δ = 7.44-7.79 ppm, while the chemical shift of the other olefinic methine 
proton is around δ = 5.9 ppm, which is in good correspondence with reported data of related  
3-arylpyrroles. Indeed, methine protons of the CHNCH unit present in N-tosyl-3-phenylpyrrole also 
resonate above δ = 7 ppm, while CHCHN resonates below 7 ppm (δ = 6.61 ppm). For N-tosyl-2-
phenylpyrrole, typical resonance signals were observed below δ = 7 ppm (δ = 6.13 ppm and 6.28 
ppm) for the the methine protons of the CHCH unit, while the nitrogen-substituted methine unit 
resonates above δ = 7 ppm. 
 
Scheme 83 
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3.5.4 Bromination of 3-phenyl-3-pyrroline 
Finally, bromination of 3-phenyl-3-pyrroline (RS)-271 afforded the corresponding 3,4-
dibromopyrrolidine 292 in moderate yield with spontaneous cleavage of the protective group at 
nitrogen (Scheme 84).118  
 
Scheme 84 
A relative trans-stereochemistry for the 3,4-dibromopyrrolidine 292, resulting from a stereospecific 
anti-addition of bromine across the double bond, was assigned.119 Bromination of related  
N-phosphorylated 3-methyl-3-pyrrolines 293 resulted in the formation of the trans-3,4-
dibromopyrrolidine hydrochlorides 294 (Scheme 85). The corresponding cis-3,4-dibromopyrrolidine 
hydrochlorides, of which the structure was confirmed by X-ray diffraction analysis were also 
prepared. 
 
Scheme 85 
In conclusion, addition of vinylmagnesium bromide across aromatic N-sulfinyl α-chloroketimines 
afforded N-sulfinyl 2-aryl-2-vinylaziridines, which spontaneously rearranged via C–N bond cleavage 
into biologically interesting 3-aryl-3-pyrrolines 271, underlining the excellent utility of highly 
substituted activated aziridines in azaheterocyclic synthesis. Reaction with 1-propenylmagnesium 
bromide proved to be quite sluggish and the corresponding 3-pyrroline 286 was only obtained in low 
yield. When isopropenylmagnesium bromide was used, N-sulfinyl 2-aryl-2-vinylaziridine 282 was 
isolated as a stable compound. The structural identity of 3-pyrrolines 271 was further ascertained via 
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oxidation to the corresponding pyrroles 291 and bromination of the double bond present in  
3-pyrroline (RS)-271a. 
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4 Perspectives 
Within this PhD-thesis, the efficient synthesis of γ,δ-aziridino α-amino acid derivative 195b was 
demonstrated. This compound proved to be a useful building block for the synthesis of different 
carbocyclic and heterocyclic compounds, including functionalized cyclopropanes, γ-lactams and γ-
lactones. In view of the broad applicability of these synthons, the possibilities for further elaboration 
towards new heterocyclic compounds should be further exploited. For example, aziridine 195b might 
be transformed into the corresponding oxazolidin-2-one 295 upon reaction with methyl 
chloroformate, as has been reported in literature for related aziridines (Scheme 86).120 Recently, a 
new class of foldamers containing a 4-carboxyoxazolidin-2-one moiety was reported as new 
supramolecular materials.121 In analogy, compound 295 might be incorporated in peptides to create 
new materials with interesting opportunities. 
 
Scheme 86 
Treatment of aziridine 195b with HBr resulted in the formation of the desired α,γ-diamino acid 
derivative 207, which underwent ring closure to the corresponding lactams 205. The observed ring 
closure might form a common problem with respect to the formation of the desired ring opening 
products and therefore it should be further investigated if this cyclization reaction can be avoided. 
Indeed, the presence of the bromine atom in amino acid derivative 207 makes it an interesting 
intermediate for further functionalization towards ring opening products with potentially interesting 
activities. Because of steric reasons, the introduction of a benzyl or tert-butyl ester instead of the 
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methyl ester might be a solution to avoid this cyclization. If not the case, it should be investigated if 
the resulting lactams are susceptible towards ring opening, which again would result in the formation 
of the desired α,γ-diamino acid derivatives. Indeed, related lactams have been successfully ring 
opened using LiOH and the same conditions could be used in an attempt to open lactam 205 to the 
corresponding α,γ-diamino acid 298 (Scheme 87).45 
 
Scheme 87 
As mentioned before, reaction with benzyl bromide resulted in ring opening at the more substituted 
carbon atom of aziridine 195b and β-bromo amine 217 could be isolated as a pure compound. 
Further functionalisation of this compound might also be investigated. For example, treatment with 
NaN3, followed by reduction of the azide functionality would lead to α,γ,δ-triamino acid derivatives 
299 as an interesting class of compounds (Scheme 88). 
 
Scheme 88 
Due to the increasing interest in the development of new chiral amino acid derivatives, the 
asymmetric synthesis of the obtained γ-δ aziridino α-amino acid derivatives would be a valuable 
addition. Starting from the commercially available chiral aziridino alcohol 300, it should be 
Chapter 4  Perspectives 
 
 
85 
 
investigated if transformation of the alcohol function into a good leaving group, followed by 
substitution with protected glycine derivatives 193 would lead to 2-(carboxyethyl)aziridines 302 as a 
mixture of diastereomers of which the separability should be further investigated (Scheme 89). If 
separation is not possible, the stereoselective ring transformation described in section 3.1.5 would 
still lead to the corresponding enantiomerically pure cyclopropanes. 
 
Scheme 89 
A second goal of this thesis was to synthesize chiral N-(tert-butanesulfinyl)-2-alkenylaziridines via 
addition of alkenylmagnesium bromides across aromatic N-sulfinyl α-chloroketimines. In the case of 
vinylmagnesium bromide, the resulting aziridines spontaneously rearranged to the corresponding 3-
pyrrolines. When isopropenylmagnesium bromide was used however, 2-isopropenylaziridine 282 
was isolated as a stable compound. Having this functionalized aziridine in hand, the potential of this 
compound as synthetic building block should be further evaluated (Scheme 90). Indeed, 
vinylaziridines were shown to be versatile intermediates for the synthesis of a variety of nitrogen-
containing molecules via a range of transformations, including stereoselective nucleophilic ring 
opening reactions, as well as rearrangement and cycloaddition reactions.24  
 
 
Scheme 90
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5 Experimental part 
5.1 General methods 
Flame-dried glassware was used for all non-aqueous reactions. Commercially available solvents and 
reagents were purchased from common chemical suppliers and used without further purification, 
unless stated otherwise. The enantiopure reagents (RS)- and (SS)-tert-butanesulfinamide were 
commercially available (ee > 98%). 
Tetrahydrofuran (THF) and diethyl ether (Et2O) were freshly distilled under a nitrogen atmosphere 
from sodium and sodium/benzophenone ketyl prior to use, whereas dichloromethane (CH2Cl2) was 
distilled from calcium hydride. Petroleum ether refers to the 40-60 °C boiling fraction. 
The purification of the reaction mixtures was performed by column chromatography with silica gel 
(Acros, particle size 0.035-0.070 mm, pore diameter ca. 6 nm). Thin layer chromatography (TLC) was 
performed on glass plates coated with silica gel (Merck, Kieselgel 60 F254, precoated 0.25 mm) using 
standard visualization techniques or agents: UV fluorescence (254 nm and 366 nm), coloring with 
iodine vapors or with potassium permanganate solution. 
High resolution 1H NMR (200 MHz, 300 MHz or 400 MHz), 13C NMR (50 MHz, 75 MHz or 100 MHz) 
spectra were recorded with a Bruker AC 200 spectrometer, a Jeol Eclipse FT 300 NMR spectrometer 
or a Bruker Avance III Nanobay 400 MHz at room temperature unless specified otherwise. Peak 
assignments were obtained with the aid of DEPT, COSY and/or HSQC spectra. The compounds were 
diluted in deuterated solvents, quoted in parts per million (ppm) with tetramethylsilane (TMS, δ= 0 
ppm) as internal standard unless specified otherwise. 
Infrared spectra were recorded on a Perkin Elmer Spectrum BX FT-IR Spectrometer. All compounds 
were analyzed in neat form with an ATR (Attenuated Total Reflectance) accessory. Only selected 
absorbances (νmax/cm
-1) were reported. 
LC-MS analysis was performed with Agilent 1100 series SL (ES, 4000 V) equipment, preceded by a 
reverse phase LC-column (Eclipse plus C18 column). The LC column has dimensions of 50 x 4.6 mm 
and has a particle size of 3.5 μm. Gradient elution was used (30% acetonitrile in water to 100% 
acetonitrile over 6 minutes) and the MS analysis was performed via electron-spray ionization at 4 kV 
(positive mode) or 3.5 kV (negative mode) and fragmentation at 70 eV, with only molecular ions (M + 
H+) and major peaks being reported with intensities quoted as percentage of the base peak, using 
either an LC-MS coupling or a direct inlet system. 
Chapter 5   Experimental part 
 
 
88 
 
High resolution mass spectra were obtained using an Agilent 1100 series HPLC coupled to an Agilent 
6210 TOF-Mass Spectrometer, equipped with ESI/APCI-multimode source. 
Elementary analyses were obtained by means of a Perkin Elmer series II CHNS/O elementary analyzer 
2400. 
Melting points of crystalline compounds were determined using a Büchi B-540 apparatus or a Kofler 
bench, type WME Heizbank of Wagner & Munz. 
Optical rotations were determined using a JASCO P-2000 Series Polarimeter at a wavelength of 589 
nm. 
5.2 Synthesis of alkyl 3-(1-benzylaziridin-2-yl)-2-(diphenylmethyleneamino)-
propanoates 195  
The synthesis of ethyl 3-(1-benzylaziridin-2-yl)-2-(diphenylmethyleneamino)propanoate 195a is 
representative. In a flame-dried round-bottomed flask, N-(diphenylmethylene)glycine ethyl ester 
193a (2.0 equiv, 2.00 mmol, 0.53 g) was dissolved in dry THF (5 mL) under nitrogen atmosphere. The 
solution was cooled to -78 °C, after which a 1M solution of LiHMDS (2.0 equiv, 2.00 mL, 2.00 mmol) in 
THF was added slowly and the mixture was allowed to stir for 1 hour. After this enolate formation, a 
solution of 1-benzyl-2-(bromomethyl)aziridine 194 (1.0 equiv, 1.00 mmol, 0.23 g) in dry THF (5 mL) 
was added dropwise. The reaction mixture was stirred for another hour at -78 °C, followed by 16 
hours at reflux. The reaction mixture was brought to room temperature, a saturated solution of 
aqueous NH4Cl (5 mL) was added and the reaction mixture was extracted with EtOAc (3 x 10 mL). The 
combined organic phases were dried (MgSO4), filtered, and evaporated in vacuo. The crude product 
was purified by column chromatography to yield 0.34 g (0.89 mmol) of ethyl 3-(1-benzylaziridin-2-yl)-
2-(diphenylmethyleneamino)propanoate 195a as a 1:1 mixture of diastereomers.  
Ethyl 3-(1-benzylaziridin-2-yl)-2-(diphenylmethyleneamino)propanoate 195a. 
Spectral data were obtained from a mixture of two diastereomers in a 1:1 ratio. 
Rf = 0.24 (petroleum ether/ethyl acetate 65:35). Brown oil, yield 89%, dr 1:1. IR (cm
-1): νmax 695, 731, 
1622, 1733. 1H NMR (300 MHz, CDCl3): δ 1.21 (3H, t, J = 7.2 Hz, CH3CH2Oisomer 1), 
1.23 (3H, t, J = 7.2 Hz, CH3CH2Oisomer 2), 1.31 (1H, d, J = 6.1 Hz, CH(H)azir, isomer 1), 1.35 
(1H, d, J = 6.1 Hz, CH(H)azir, isomer 2), 1.53 (1H, d, J = 3.3 Hz, CH(H)azir, isomer 1), 1.56-
1.66 (3H, m, CH(H)azir, isomer 2 and 2 x CHazir, isomer 1 and 2), 1.87-2.00 (2H, m, 2 x 
CHCH(H)isomer 1 and 2), 2.07-2.24 (2H, m, 2 x CHCH(H)isomer 1 and 2), 3.09 (1H, d, J = 13.8 
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Hz, NCH(H)Phisomer 1), 3.30 (1H, d, J = 13.2 Hz, NCH(H)Phisomer 2), 3.42 (1H, d, J = 13.2 Hz, NCH(H)Phisomer 
2), 3.54 (1H, d, J = 13.8 Hz, NCH(H)Phisomer 1), 4.06-4.21 (5H, m, 2 x CH3CH2Oisomer 1 and 2 and CHCO2Etisomer 
1), 4.32 (1H, dxd, J = 8.0 Hz, 4.7 Hz, CHCO2Etisomer 2), 7.14-7.69 (30H, m, 30 x CHarom, isomer 1 and 2). 
13C 
NMR (75 MHz, CDCl3): δ 14.2 (2 x CH3CH2Oisomer 1 and 2), 34.0 and 34.3 (2 x CH2, azir, isomer 1 and 2), 36.7 and 
36.8 (2 x CHazir, isomer 1 and 2), 37.4 (2 x CHCH2, isomer 1 and 2), 60.9 and 61.0 (2 x CH3CH2Oisomer 1 and 2), 64.17 
and 64.24 (2 x CHCO2Etisomer 1 and 2), 64.65 and 64.73 (2 x NCH2Phisomer 1 and 2), 126.96, 127.04, 127.9, 
128.0, 128.08, 128.14, 128.35, 128.40, 128.6, 128.7, 128.8, 128.9 and 130.4 (30 x CHarom, isomer 1 and 2), 
136.5, 139.3, 139.65 and 139.70 (6 x Carom, isomer 1 and 2), 170.4 and 170.7 (2 x C=Nisomer 1 and 2), 171.9, 
172.1 (2 x C=Oisomer 1 and 2). MS (ES, pos. mode) m/z (%): 413 (M + H
+, 100). HRMS (ES) calcd for 
C27H29N2O2
+: 413.2224 MH+; found: 413.2219.  
Methyl 3-(1-benzylaziridin-2-yl)-2-(diphenylmethyleneamino)propanoate 195b. 
Spectral data were obtained from a mixture of two diastereomers in a 1:1 ratio. 
Rf = 0.31 (petroleum ether/ethyl acetate 65:35). Brown oil, yield 70%, dr 1:1. IR (cm
-1): νmax 695, 732, 
1622, 1737. 1H NMR (300 MHz, CDCl3): δ 1.31 (1H, d, J = 6.6 Hz, CH(H)azir, isomer 
1), 1.33 (1H, d, J = 6.6 Hz, CH(H)azir, isomer 2), 1.51 (1H, d, J = 3.3 Hz, CH(H)azir, isomer 
1), 1.53-1.67 (3H, m, CH(H)azir, isomer 2 and 2 x CHazir, isomer 1 and 2), 1.88-2.24 (4H, m, 
2 x CHCH2, isomer 1 and 2), 3.05 (1H, d, J = 13.2 Hz, NCH(H)Phisomer 1), 3.27 (1H, d, J = 
13.2 Hz, NCH(H)Phisomer 2), 3.42 (1H, d, J = 13.2 Hz, NCH(H)Phisomer 2), 3.53 (1H, d, 
J = 13.2 Hz, NCH(H)Phisomer 1), 3.63 and 3.67 (2 x 3H, 2 x s, 2 x CH3Oisomer 1 and 2), 
4.18 (1H, dxd, J = 6.3 Hz, 6.3 Hz, CHCO2Meisomer 1), 4.30 (1H, dxd, J = 8.0 Hz, 4.7 Hz, CHCO2Meisomer 2), 
7.14-7.48 (26H, m, 26 x CHarom, isomer 1 and 2), 7.63-7.67 (4H, m, 4 x CHarom, isomer 1 and 2). 
13C NMR (75 MHz, 
CDCl3): δ 33.8 and 34.0 (2 x CH2, azir, isomer 1 and 2), 36.4 and 36.6 (2 x CHazir, isomer 1 and 2), 37.37 and 37.40 (2 
x CHCH2, isomer 1 and 2), 51.95 and 52.04 (2 x CH3Oisomer 1 and 2), 64.0 (2 x CHCO2Meisomer 1 and 2), 64.5 and 
64.6 (2 x NCH2Phisomer 1 and 2), 126.8, 126.9, 127.7, 127.8, 127.91, 127.97, 128.05, 128.2, 128.3, 128.6, 
128.7, 128.8 and 130.4 (30 x CHarom, isomer 1 and 2), 136.2, 139.2, 139.4 and 139.5 (6 x Carom, isomer 1 and 2), 
170.3 and 170.6 (2 x C=Nisomer 1 and 2), 172.3 and 172.4 (2 x C=Oisomer 1 and 2). MS (ES, pos. mode) m/z (%): 
399 (M + H+, 100). HRMS (ES) calcd for C26H27N2O2
+: 399.2067 MH+; found: 399.2075.  
5.3 Synthesis of methyl 2-amino-3-(1-benzylaziridin-2-yl)propanoate 200 
Methyl 3-(1-benzylaziridin-2-yl)-2-(diphenylmethyleneamino)propanoate 195b (0.38 g, 0.95 mmol) 
was dissolved in a 2:1 mixture of acetone/water (6 mL), and trifluoroacetic acid (5 equiv, 4.77 mmol, 
0.37 mL) was added dropwise at room temperature. The reaction mixture was stirred for 15 minutes 
at room temperature after which an aqueous solution of NH4OH was added until a pH = 10 of the 
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solution was obtained. Acetone was evaporated in vacuo and the aqueous phase was extracted with 
CH2Cl2 (3 x 10 mL). The combined organic phases were dried (MgSO4), filtered, and evaporated in 
vacuo. The crude product was purified by column chromatography to yield 0.12 g (0.51 mmol) of 
methyl 2-amino-3-(1-benzylaziridin-2-yl)propanoate 200 as a 1:1 mixture of diastereomers.  
Methyl 2-amino-3-(1-benzylaziridin-2-yl)propanoate 200. 
Spectral data were obtained from a mixture of two diastereomers in a 1:1 ratio. 
Rf = 0.25 (CH2Cl2/ MeOH 97:3). Yellow oil, yield 55%, dr 1:1. IR (cm
-1): νmax 698, 734, 1170, 1201, 1733, 
3366 (weak). 1H NMR (300 MHz, CDCl3): δ 1.43 (1H, d, J = 5.5 Hz, CH(H)azir, isomer 1), 1.46-1.51 (1H, m, 
CH(H)azir, isomer 2), 1.59-1.88 (8H, m, 2 x CH(H)azir, isomer 1 and 2, 2 x CHazir, isomer 1 and 2 and 
2 x CHCH2, isomer 1 and 2), 1.89-1.95 (4H, br s, 2 x NH2, isomer 1 and 2), 3.29 (1H, d, J = 
13.2 Hz, NCH(H)Phisomer 1), 3.32 (1H, d, J = 13.2 Hz, NCH(H)Phisomer 2), 3.49 (1H, d, 
J = 13.2 Hz, NCH(H)Phisomer 2), 3.52 (1H, d, J = 13.2 Hz, NCH(H)Phisomer 1), 3.39-3.56 
(2H, m, 2 x CHCO2Meisomer 1 and 2), 3.68 and 3.69 (2 x 3H, 2 x s, 2 x CH3Oisomer 1 and 2), 
7.22-7.38 (10H, m, 10 x CHarom, isomer 1 and 2). 
13C NMR (75 MHz, CDCl3): δ 33.6 and 34.1 (2 x CH2, azir, isomer 1 
and 2), 36.0 and 36.4 (2 x CHazir, isomer 1 and 2), 37.7 and 38.1 (2 x CHCH2, isomer 1 and 2), 51.9 (2 x CH3Oisomer 1 and 
2), 53.2 and 53.4 (2 x CHCO2Meisomer 1 and 2), 64.6 and 64.7 (2 x NCH2Phisomer 1 and 2), 127.15, 127.24, 
128.2, 128.36 and 128.40 (10 x CHarom, isomer 1 and 2), 139.0 and 139.1 (2 x Carom, isomer 1 and 2), 175.9 and 
176.0 (2 x C=Oisomer 1 and 2). MS (ES, pos. mode) m/z (%): 235 (M + H
+, 100). HRMS (ES) calcd for 
C13H19N2O2
+: 235.1441 MH+; found: 235.1448. 
5.4 Synthesis of methyl 3-(1-benzylaziridin-2-yl)-2-tert-butoxycarbonylamino-
propanoate 201 
To a solution of methyl 2-amino-3-(1-benzylaziridin-2-yl)propanoate 200 (0.1 g, 0.43 mmol) in THF (5 
mL) was added Et3N (1.5 equiv, 0.65 mmol, 65 mg) and Boc2O (1.5 equiv, 0.65 mmol, 140 mg). The 
reaction mixture was stirred for 16 hours at room temperature, water (5 mL) was added and the 
aqueous phase was extracted with EtOAc (3 x 10 mL). The combined organic phases were dried 
(MgSO4), filtered, and evaporated in vacuo. The crude product was purified by column 
chromatography to yield 85 mg (0.25 mmol) of methyl 3-(1-benzylaziridin-2-yl)-2-tert-
butoxycarbonylaminopropanoate 201 as a 1:1 mixture of diastereomers.  
Methyl 3-(1-benzylaziridin-2-yl)-2-tert-butoxycarbonylaminopropanoate 201. 
Spectral data were obtained from a mixture of two diastereomers in a 1:1 ratio. 
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Rf = 0.22 (petroleum ether/ethyl acetate 6:4). Yellow oil, yield 59%, dr 1:1. IR 
(cm-1): νmax 733, 1160, 1710, 1743, 3358 (weak). 
1H NMR (300 MHz, CDCl3): δ 
1.38-1.42 (2H, m, 2 x CH(H)azir, isomer 1 and 2), 1.45 (2 x 9H, s, 2 x t-Buisomer 1 and 2), 
1.52-1.74 (6H, m, 2 x CH(H)azir, isomer 1 and 2, 2 x CHazir, isomer 1 and 2 and 2 x 
CHCH(H)isomer 1 and 2), 1.90-2.13 (2H, m, 2 x CHCH(H)isomer 1 and 2), 2.98 (1H, d, J = 
13.2 Hz, NCH(H)Phisomer 1), 3.11 (1H, d, J = 13.2 Hz, NCH(H)Phisomer 2), 3.65-3.81 
(2H, m, 2 x NCH(H)isomer 1 and 2), 3.71 and 3.72 (2x 3H, 2 x s, 2 x CH3Oisomer 1 and 2), 
4.32-4.44 (2H, m, 2 x CHCO2Meisomer 1 and 2), 5.61 (1H, br d, J = 7.2 Hz, NHisomer 1), 5.71 (1H, br d, J = 7.7 
Hz, NHisomer 2), 7.21-7.38 (10H, m, 10 x CHarom, isomer 1 and 2). 
13C NMR (75 MHz, CDCl3): δ 28.3 (2 x 
(CH3)3Cisomer 1 and 2), 33.3 and 33.6 (2 x CH2, azir, isomer 1 and 2), 34.9 and 35.3 (2 x CHazir, isomer 1 and 2), 35.6 and 
35.8 (2 x CHCH2, isomer 1 and 2), 52.17 and 52.25 (2 x CH3Oisomer 1 and 2), 52.8 (2 x CHCO2Meisomer 1 and 2), 64.3 
and 64.4 (2 x NCH2Phisomer 1 and 2), 79.6 and 79.7 (2 x (CH3)3Cisomer 1 and 2), 127.1, 127.2, 128.1, 128.3, 
128.37 and 128.43 (10 x CHarom, isomer 1 and 2), 138.8 and 138.9 (2 x Carom, isomer 1 and 2), 155.4 (2 x 
NHC=Oisomer 1 and 2), 172.8 and 172.9 (2 x C=Oisomer 1 and 2). MS (ES, pos. mode) m/z (%): 335 (M + H
+, 15), 
279 (M + H+ - isobutene, 100). HRMS (ES) calcd for C18H27N2O4
+: 335.1965 MH+; found: 335.1959 
(15%), 279.1343 (100%).  
5.5 Synthesis of methyl 3-(1-benzylaziridin-2-yl)-2-benzyloxycarbonylamino-
propanoate 202  
To a solution of methyl 2-amino-3-(1-benzylaziridin-2-yl)propanoate 200 (0.18 g, 0.77 mmol) 
dissolved in a 1:1 mixture of dioxane/H2O (5 mL) was added Et3N (5 equiv, 3.85 mmol, 0.39 g). The 
solution was cooled to 0 °C and a solution of benzyl chloroformate (1.1 equiv, 0.85 mmol, 0.12 mL) in 
dioxane (2 mL) was added dropwise. After completion of the reaction (3 hours), the solvent was 
evaporated. Water was added and the aqueous phase was extracted with EtOAc (3 x 5 mL). The 
combined organic phases were dried (MgSO4), filtered, and evaporated in vacuo. The crude product 
was purified by column chromatography to yield 0.11 g (0.30 mmol) of methyl 3-(1-benzylaziridin-2-
yl)-2-benzyloxycarbonylaminopropanoate 202 as a 1:1 mixture of two diastereomers.  
Methyl 3-(1-benzylaziridin-2-yl)-2-benzyloxycarbonylaminopropanoate 202. 
Spectral data were obtained from a mixture of two diastereomers in a 1:1 ratio. 
Rf = 0.22 (petroleum ether/ethyl acetate 4:6). Yellow oil, yield 39%, dr 1:1. IR (cm
-1): νmax 697, 729, 
1212, 1717, 3332 (weak). 1H NMR (300 MHz, CDCl3): δ 1.38 (1H, d, J = 3.3 Hz, CH(H)azir, isomer 1), 1.40 
(1H, d, J = 3.3 Hz, CH(H)azir, isomer 2), 1.52-1.73 (6H, m, 2 x CH(H)azir, isomer 1 and 2, 2 x CHazir, isomer 1 and 2 and 2 x 
CHCH(H)isomer 1 and 2), 2.03-2.19 (2H, m, 2 x CHCH(H)isomer 1 and 2), 2.99 (1H, d, J = 13.2 Hz, NCH(H)isomer 1), 
Chapter 5   Experimental part 
 
 
92 
 
3.11 (1H, d, J = 13.2 Hz, NCH(H)isomer 2), 3.59-3.81 (2H, m, 2 x NCH(H)isomer 1 and 2), 
3.72 and 3.73 (2x 3H, 2 x s, 2 x CH3Oisomer 1 and 2), 4.39-4.48 (2H, m, 2 x 
CHCO2Meisomer 1 and 2), 5.08-5.13 (4H, m, 2 x CH2Oisomer 1 and 2), 5.86 (1H, br d, J = 
6.6 Hz, NHisomer 1), 5.99 (1H, br d, J = 8.3 Hz, NHisomer 2), 7.20-7.39 (20H, m, 20 x 
CHarom, isomer 1 and 2). 
13C NMR (75 MHz, CDCl3): δ 33.3 and 33.6 (2 x CH2, azir, isomer 1 
and 2), 34.6 and 35.1 (2 x CHazir, isomer 1 and 2), 35.4 and 35.7(2 x CHCH2, isomer 1 and 2), 
52.3 and 52.4 (2 x CH3Oisomer 1 and 2), 53.2 and 53.3 (2 x CHCO2Meisomer 1 and 2), 
64.4 (2 x CH2Nisomer 1 and 2), 66.8 and 66.9 (2 x CH2Oisomer 1 and 2), 127.1, 127.2, 128.07, 128.13, 128.3, 
128.4 and 128.5 (20 x CHarom, isomer 1 and 2), 136.3, 136.5, 138.6 and 138.8 (4 x Carom, isomer 1 and 2), 155.8 and 
155.9 (2 x NHC=Oisomer 1 and 2), 172.5 and 172.6 (2 x C=Oisomer 1 and 2). MS (ES, pos. mode) m/z (%): 369 (M 
+ H+, 100). HRMS (ES) calcd for C21H25N2O4
+: 369.1809 MH+; found: 369.1813.  
5.6 Synthesis of cis- and trans-4-[(benzylamino)methyl]-2-(diphenylmethylene-
amino)butyrolactone (±)-199a and (±)-199b 
Methyl 3-(1-benzylaziridin-2-yl)-2-(diphenylmethyleneamino)propanoate 195b (110 mg, 0.28 mmol) 
was treated with 1M aqueous NaOH (5 equiv, 1.4 mmol, 1.4 mL) in a 3:1 mixture of MeOH/1M NaOH 
and the reaction mixture was allowed to stir for one hour at room temperature. The organic fraction 
was evaporated and ethyl acetate was added to the residue. The organic phase was dried (MgSO4), 
filtered, and evaporated in vacuo. The crude product was purified by column chromatography to 
yield 74 mg (0.19 mmol) of 4-[(benzylamino)methyl]-2-(diphenylmethyleneamino)butyrolactone 199 
as a 1:1 mixture of two diastereomers. Both diastereomers were separated from each other via 
preparative TLC to give trans- and cis-4-[(benzylamino)methyl]-2-(diphenylmethyleneamino)-
butyrolactones (±)-199a and (±)-199b in 19% and 21% yield respectively.  
Trans-4-[(benzylamino)methyl]-2-(diphenylmethyleneamino)butyrolactone (±)-199a. Rf = 0.2 
(petroleum ether/EtOAc 1:1). Yellow oil, yield 19%. IR (cm-1): νmax 694, 1177, 1619, 1771. 
1H NMR 
(300 MHz, CDCl3): δ 2.18 (1H, dxdxd, J = 13.0 Hz, 8.2 Hz, 5.5 Hz, CH(H)CHN), 
2.50 (1H, dxdxd, J = 13.0 Hz, 7.6 Hz, 5.7 Hz, CH(H)CHN), 2.70 (1H, dxd, J = 
13.0 Hz, 6.5 Hz, NHCH(H)CH), 2.91 (1H, dxd, J = 13.0 Hz, 3.5 Hz, 
NHCH(H)CH), 3.76 (1H, d, J = 13.3 Hz, NHCH(H)Ph), 3.80 (1H, d, J = 13.3 Hz, 
NHCH(H)Ph), 4.43 (1H, dxd, J = 8.2 Hz, 5.7 Hz, CHN), 4.95-5.02 (1H, m, 
CHO), 7.19-7.64 (15H, 15 x CHarom). 
13C NMR (75 MHz, CDCl3): δ 34.7 (CH2CHN), 52.6 (NHCH2CH), 53.8 
(NHCH2Ph), 61.1 (CHN), 78.5 (CHO), 127.1, 128.1, 128.4, 128.5, 128.6, 129.0, 129.1 and 130.6 (15 x 
CHarom), 135.6, 139.1 and 139.6 (3 x Carom), 172.0 (C=N), 175.5 (C=O). MS (ES, pos. mode) m/z (%): 385 
(M + H+,100). HRMS (ES) calcd for C25H25N2O2
+: 385.1911 MH+; found: 385.1929. 
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1D-NOESY of (±)-199a: 
 
Cis-4-[(benzylamino)methyl]-2-(diphenylmethyleneamino)butyrolactone (±)-199b. Rf = 0.11 
(petroleum ether/EtOAc 1:1). Yellow oil, yield 21%. IR (cm-1): νmax 694, 1178, 1772. 
1H NMR (300 MHz, 
CDCl3): δ 2.37-2.44 (2H, m, CH2CHN), 2.89-3.02 (2H, m, NHCH2CH), 3.83 
(1H, d, J = 13.3 Hz, NHCH(H)Ph), 3.88 (1H, d, J = 13.3 Hz, NHCH(H)Ph), 
4.36 (1H, dxd, J = 9.4 Hz, 9.4 Hz, CHN), 4.49-4.57 (1H, m, CHO), 7.23-7.64 
(15H, m, 15 x CHarom). 
13C NMR (75 MHz, CDCl3): δ 35.0 (CH2CHN), 53.0 
(NHCH2CH), 53.7 (NHCH2Ph), 61.5 (CHN), 78.5 (CHO), 127.1, 128.09, 
128.13, 128.5, 128.6, 129.0, 129.1 and 130.7 (15 x CHarom), 135.7, 139.0 and 139.6 (3 x Carom), 172.9 
(C=N), 174.8 (C=O). MS (ES, pos. mode) m/z (%): 385 (M + H+,100). HRMS (ES) calcd for C25H25N2O2
+: 
385.1911 MH+; found: 385.1912. 
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1D-NOESY of (±)-199b: 
 
5.7 Synthesis of cis- and trans-1-benzyl-5-(bromomethyl)-3-(diphenyl-
methyleneamino)pyrrolidin-2-one (±)-205a and (±)-205b 
To a solution of methyl 3-(1-benzylaziridin-2-yl)-2-(diphenylmethyleneamino)propanoate 195b (1.5 g, 
3.76 mmol) in CH3CN (10 mL) was added a 33% hydrobromic acid solution in glacial acetic acid (2 
equiv, 0.43 mL, 7.53 mmol) and the resulting mixture was stirred for 16 hours at room temperature. 
A saturated solution of NaHCO3 (5 mL) was added and the reaction mixture was extracted with EtOAc 
(3 x 10 mL). The combined organic phases were dried (MgSO4), filtered, and evaporated in vacuo. The 
crude mixture was dissolved in Et2O and the obtained precipitate was filtered off to yield 0.69 g (1.54 
mmol) of trans-1-benzyl-5-(bromomethyl)-3-(diphenylmethyleneamino)pyrrolidin-2-one (±)-205a, 
recrystallization of which from MeOH afforded crystals suitable for X-ray diffraction analysis. The 
filtrate was evaporated in vacuo and purified by column chromatography to yield 0.39 g (0.87 mmol) 
of cis-1-benzyl-5-(bromomethyl)-3-(diphenylmethyleneamino)pyrrolidin-2-one (±)-205b. 
Trans-1-benzyl-5-(bromomethyl)-3-(diphenylmethyleneamino)pyrrolidin-2-one (±)-205a. White 
crystals, yield 41%. Mp 150 ± 0.5 °C. IR (cm-1): νmax 699, 1249, 1429, 1682. 
1H NMR (300 MHz, CDCl3): 
δ 2.14 (1H, dxdxd, J = 13.2 Hz, 8.3 Hz, 3.9 Hz, CHCH(H)CHN), 2.38 (1H, dxdxd, J = 13.2 Hz, 8.3 Hz, 6.1 
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Hz, CHCH(H)CHN), 3.33-3.36 (2H, m, CH2Br), 3.90-3.97 (1H, m, CHCH2Br), 4.04 
(1H, d, J = 15.4 Hz, NCH(H)Ph), 4.45 (1H, dxd, J = 8.3 Hz, 6.1 Hz, CHC=O), 5.03 
(1H, d, J = 15.4 Hz, NCH(H)Ph), 7.25-7.50 (13H, m, CHarom), 7.59-7.66 (2H, m, 
CHarom). 
13C NMR (100 MHz, CDCl3): δ 33.0 (CHCH2CHN), 34.7 (CH2Br), 44.8 
(NCH2Ph), 55.0 (CHCH2Br), 61.9 (CHC=O), 127.8, 127.9, 128.1, 128.4, 128.6, 
128.8, 128.9 and 130.2 (15 x CHarom), 135.7, 135.9 and 139.6 (3 x Carom), 171.3 
and 173.4 (C=N and C=O). MS (ES+): m/z (%) = 447/449 (M + H+, 100). HRMS (ES): calcd. for 
C25H24
79BrN2O
+: 447.1067 MH+; found 447.1077. 
Cis-1-benzyl-5-(bromomethyl)-3-(diphenylmethyleneamino)pyrrolidin-2-one (±)-205b. Rf = 0.31 
(petroleum ether/ethyl acetate 8:2). Yellow oil, yield 23%. IR (cm-1): νmax 695, 1414, 1692. 
1H NMR 
(300 MHz, CDCl3): δ 2.15-2.33 (2H, m, CHCH2CHN), 3.54-3.66 (3H, m, CH2Br and 
CHCH2Br), 4.18 (1H, d, J = 14.9 Hz, NCH(H)Ph), 4.26 (1H, dxd, J = 8.3 Hz, 5.5 Hz, 
CHC=O), 4.94 (1H, d, J = 14.9 Hz, NCH(H)Ph), 7.14-7.49 (13H, m, CHarom), 7.58-
7.65 (2H, m, CHarom). 
13C NMR (75 MHz, CDCl3): δ 33.2 (CHCH2CHN), 34.3 
(CH2Br), 45.0 (NCH2Ph), 56.0 (CHCH2Br), 62.3 (CHC=O), 127.7, 127.9, 128.0, 
128.4, 128.6, 128.8, 128.9 and 130.3 (15 x CHarom), 135.8, 136.2 and 139.4 (3 x 
Carom), 170.9 and 173.3 (C=N and C=O). MS (ES
+): m/z (%) = 447/449 (M + H+, 100). HRMS (ES): calcd. 
for C25H24
79BrN2O
+: 447.1067 MH+; found 447.1068. 
5.8 Synthesis of trans-benzyl [1-benzyl-5-(bromomethyl)-2-oxopyrrolidin-3-
yl]carbamate (±)-215 
Trans-1-benzyl-5-(bromomethyl)-3-(diphenylmethyleneamino)pyrrolidin-2-one (±)-205a (44 mg, 0.98 
mmol) was dissolved in a 2:1 mixture of acetone/water (6 mL) and trifluoroacetic acid (5 equiv, 4.88 
mmol, 0.38 mL) was added dropwise at room temperature. The reaction mixture was stirred for 15 
minutes at room temperature after which an aqueous solution of NH4OH (28-30% NH3) was added 
until pH = 10 of the solution was obtained. Acetone was evaporated in vacuo and the aqueous phase 
was extracted with CH2Cl2 (3 x 10 mL). The combined organic phases were dried (MgSO4), filtered, 
and evaporated in vacuo. The crude reaction mixture was used without any purification and 
dissolved in a 1:1 mixture of an aqueous saturated NaHCO3 solution and Et2O. The solution was 
cooled to 0 °C and benzyl chloroformate (1.01 equiv, 0.99 mmol, 0.14 mL) was added dropwise. The 
reaction mixture was allowed to stir for 15 minutes at 0 °C. The aqueous phase was extracted with 
Et2O and the combined organic phases were dried (MgSO4), filtered, and evaporated in vacuo. The 
crude product was purified by column chromatography to yield 240 mg (0.58 mmol) of trans-benzyl 
[1-benzyl-5-(bromomethyl)-2-oxopyrrolidin-3-yl]carbamate (±)-215.  
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The intermediate deprotected compound trans-3-amino-1-benzyl-5-(bromomethyl)pyrrolidin-2-one 
was purified once via column chromatography to allow full characterization of the compound. 
Trans-3-amino-1-benzyl-5-(bromomethyl)pyrrolidin-2-one. Rf = 0.19 (CH2Cl2/MeOH 95:5). Yellow oil, 
yield 40%. IR (cm-1): νmax 702, 727, 1682, 3364. 
1H NMR (300 MHz, CDCl3): δ 1.83-1.96 (1H, m, 
CH(H)CHNH2), 2.04-2.16 (2H, br s, NH2), 2.40 (1H, dxdxd, J = 13.2 Hz, 8.8 Hz, 1.7 
Hz, CH(H)CHNH2), 3.34-3.45 (2H, m, CH2Br), 3.70-3.79 (1H, m, CHCH2Br), 3.89 
(1H, dxd, J = 8.5 Hz, 8.5 Hz, CH2CHNH2), 4.04 (1H, d, J = 15.2 Hz, NCH(H)Ph), 4.96 
(1H, d, J = 15.2 Hz, NCH(H)Ph), 7.22-7.39 (5H, m, CHarom). 
13C NMR (75 MHz, 
CDCl3): δ 33.6 (CH2CHNH2), 34.3 (CH2Br), 44.9 (NCH2Ph), 51.5 (CH2CHNH2), 54.5 (CHCH2Br), 128.0 
(CHarom), 128.1 (2 x CHarom), 128.9 (2 x CHarom), 135.6 (Carom), 176.1 (C=O). MS (ES
+): m/z (%) = 283/285 
(M + H+, 100). HRMS (ES): calcd. for C12H16
79BrN2O3
+: 283.0441 MH+; found 283.0450. 
Trans-benzyl [1-benzyl-5-(bromomethyl)-2-oxopyrrolidin-3-yl]carbamate (±)-215. Rf = 0.21 
(petroleum ether/ethyl acetate 7:3). White crystals, yield 58%. Mp 98 ± 0.5 °C. IR (cm-1): νmax 697, 
1246, 1684, 3304. 1H NMR (400 MHz, CDCl3): δ 2.07-2.18 (1H, m, CH(H)CHNH), 
2.51-2.62 (1H, m, CH(H)CHNH), 3.34-3.45 (2H, m, CH2Br), 3.75-3.82 (1H, m, 
CHCH2Br), 4.05 (1H, d, J = 15.2 Hz, NCH(H)Ph), 4.48 (1H, dxt, J = 9.2 Hz, 5.6 Hz, 
CH2CHNH), 5.01 (1H, d, J = 15.2 Hz, NCH(H)Ph), 5.12 (2H, s, OCH2Ph), 5.47 (1H, 
br s, NH), 7.24-7.38 (10H, m, CHarom). 
13C NMR (100 MHz, CDCl3): δ 31.6 
(CH2CHNH), 34.4 (CH2Br), 44.9 (NCH2Ph), 51.4 (CH2CHNH), 54.6 (CHCH2Br), 
66.8 (OCH2Ph), 127.9, 127.97, 128.01, 128.4 and 128.8 (10 x CHarom), 135.2 
and 136.3 (2 x Carom), 156.2 (NHC=O), 172.6 (C=O). MS (ES
+): m/z (%) = 417/419 (M + H+, 100). HRMS 
(ES): calcd. for C20H22
79BrN2O3
+: 417.0808 MH+; found 417.0828. 
5.9 Synthesis of methyl 4-bromo-5-(dibenzylamino)-2-(diphenylmethylene-
amino)pentanoate 217 
To a solution of methyl 3-(1-benzylaziridin-2-yl)-2-(diphenylmethyleneamino)propanoate 195b (0.3 g, 
0.75 mmol) in CH3CN (5 mL) was added benzyl bromide (2 equiv, 1.5 mmol, 0.26 g) and NaI (2 equiv, 
1.5 mmol, 0.23 g). The reaction mixture was stirred for 3 hours at room temperature. After 
completion, the solids were filtered off and the solvent was evaporated in vacuo. The crude product 
was purified by column chromatography to yield 0.30 g (0.53 mmol) of methyl 4-bromo-5-
(dibenzylamino)-2-(diphenylmethyleneamino)pentanoate 217 as a 1:1 mixture of diastereomers.  
Methyl 4-bromo-5-(dibenzylamino)-2-(diphenylmethyleneamino)pentanoate 217. 
Spectral data were obtained from a mixture of two diastereomers in a 1:1 ratio. 
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Rf = 0.27 (petroleum ether/ethyl acetate 9:1). Yellow oil, yield 82%, dr 1:1. IR (cm
-1): νmax 695, 733, 
1737. 1H NMR (300 MHz, CDCl3): δ 1.79 (1H, dxdxd, J = 14.7 Hz, 10.4 Hz, 
4.4 Hz, CH(H)CHCO2Meisomer 1), 2.05 (1H, dxdxd, J = 14.5 Hz, J = 9.5 Hz, J = 
2.5 Hz, CH(H)CHCO2Meisomer 2), 2.69-3.09 (6H, m, 2 x CH(H)CHCO2Meisomer 1 
and 2 and 2 x NCH2CHisomer 1 and 2), 3.49 (2H, d, J = 13.2 Hz, 2 x NCH(H)Phisomer 
1 and 2), 3.51 (2H, d, J = 13.5 Hz, 2 x NCH(H)Phisomer 1 and 2), 3.64 (2H, d, J = 
13.2 Hz, 2 x NCH(H)Phisomer 1 and 2), 3.67 (6H, s, 2 x CH3Oisomer 1 and 2), 3.72 (2H, d, J = 13.5 Hz, 2 x 
NCH(H)Phisomer 1 and 2), 3.86-3.98 (1H, m, CHBrisomer 1), 4.20-4.30 (1H, m, CHBrisomer 2), 4.35 (1H, dxd, J = 
10.4 Hz, 2.5 Hz, CHCO2Meisomer1), 4.42 (1H, dxd, J = 9.5 Hz, 4.4 Hz, CHCO2Meisomer2), 7.10-7.67 (40H, m, 
40 x CHarom, isomer 1 and 2). 
13C NMR (75 MHz, CDCl3): δ 40.5 (2 x CH2CHCO2Meisomer 1 and 2), 50.3 (CHBrisomer 
1), 51.0 (CHBrisomer 2), 52.2 (2 x CH3Oisomer 1 and 2), 58.5 (2 x NCH2Phisomer 1 and 2), 58.9 (2 x NCH2Phisomer 1 and 
2), 61.1 (NCH2CHisomer 1), 61.2 (NCH2CHisomer 2), 62.9 (CHCO2Meisomer1), 63.9 (CHCO2Meisomer2), 127.06, 
127.10, 127.3, 128.0, 128.1, 128.2, 128.3, 128.5, 128.72, 128.77, 128.86, 128.90, 129.1, 130.46 and 
130.51 (40 x CHarom, isomer 1 and 2), 135.9, 136.1, 138.8, 139.3 and 139.4 (8 x Carom, isomer 1 and 2), 171.0, 172.2 
and 172.4 (2 x C=Nisomer 1 and 2 and 2 x C=Oisomer 1 and 2). MS (ES, pos. mode) m/z (%): 569/571 (M + H
+, 
25), 489 (M + H+ - HBr, 100), 507 (M + H+ - Br + OH, 9). HRMS (ES): calcd. for C33H34
79BrN2O2
+: 
569.1798 MH+; found 507.2646 (M + H+ - Br + OH). 
5.10 Synthesis of cis-methyl 2-[(dibenzylamino)methyl]-1-(diphenylmethylene-
amino)cyclopropane-1-carboxylate (±)-cis-218  
Procedure A: In a flame-dried round-bottomed flask, methyl 4-bromo-5-N,N-dibenzylamino-2-
(diphenylmethyleneamino)pentanoate 217 (0.28 g, 0.49 mmol) was dissolved in dry THF (5 mL) under 
nitrogen atmosphere and the solution was cooled to -78 °C, after which a 1M solution of KHMDS (1.2 
equiv, 0.59 mL, 0.59 mmol) in THF was added slowly and the mixture was allowed to stir for 2 hours 
at -78 °C. To the reaction mixture was added a saturated aqueous solution of NH4Cl (5 mL) and the 
mixture was extracted with EtOAc (3 x 10 mL). The combined organic phases were dried (MgSO4), 
filtered, and evaporated in vacuo. The crude product was purified by flash chromatography, followed 
by recrystallization from ethanol to yield 0.17 g (0.35 mmol) of cis-methyl 2-[(dibenzylamino)methyl]-
1-(diphenylmethyleneamino)cyclopropane-1-carboxylate (±)-cis-218. 
Procedure B: A flame-dried round-bottomed flask was charged with methyl 4-bromo-5-N,N-
dibenzylamino-2-(diphenylmethyleneamino)pentanoate 217 (0.25 g, 0.44 mmol) in dry CH2Cl2 (5 mL) 
under nitrogen atmosphere. The solution was cooled to 0 °C and DBU (1.2 equiv, 0.53 mmol, 0.08 g) 
was added. The mixture was stirred at room temperature for 1 hour. Water (5 mL) was added and 
the aqueous phase was extracted with EtOAc (3 x 10 mL). The combined organic phases were dried 
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(MgSO4), filtered, and evaporated in vacuo. The crude product was purified by flash chromatography, 
followed by recrystallization from ethanol to yield 0.14 g (0.29 mmol) of cis-methyl 2-
[(dibenzylamino)methyl]-1-(diphenylmethyleneamino)cyclopropane-1-carboxylate (±)-cis-218. 
Cis-methyl 2-[(dibenzylamino)methyl]-1-(diphenylmethyleneamino)cyclopropane-1-carboxylate 
(±)-cis-218. Rf = 0.22 (petroleum ether/ethyl acetate 9:1). White crystals, yield 70% (Procedure A), 
67% (Procedure B). Mp 98.5 ± 0.5 °C. IR (cm-1): νmax 696, 963, 1253, 1717. 
1H 
NMR (300 MHz, CDCl3): δ 0.55 (1H, dxd, J = 7.2 Hz, 5.0 Hz, CH(H)cycl), 1.56 
(1H, dxd, J = 9.4 Hz, 5.0 Hz, CH(H)cycl), 1.83-1.94 (1H, m, CHcycl), 2.55 (1H, dxd, 
J = 13.2 Hz, 6.6 Hz, CHCH(H)N), 2.97 (1H, dxd, J = 13.2 Hz, 6.1 Hz, CHCH(H)N), 
3.48 (3H, s, OCH3), 3.57 (2H, d, J = 13.8 Hz, 2 x NCH(H)Ph), 3.81 (2H, d, J = 
13.8 Hz, 2 x NCH(H)Ph), 7.06-7.52 (20H, m, 20 x CHarom). 
13C NMR (75 MHz, 
CDCl3): δ 23.1 (CH2, cycl), 28.5 (CHcycl), 48.0 (Cq, cycl), 50.9 (CHCH2N), 51.7 
(OCH3), 58.0 (2 x NCH2Ph), 126.6, 127.8, 127.9, 128.0, 128.6, 128.7 and 130.3 (20 x CHarom), 137.7, 
139.78 and 139.83 (4 x Carom), 172.7 and 173.9 (C=N and C=O). MS (ES, pos. mode) m/z (%): 489 (M + 
H+, 100). HRMS (ES) calcd for C33H33N2O2
+: 489.2537 MH+; found: 489.2539. 
5.11 Synthesis of cis-methyl 1-amino-2-[(dibenzylamino)methyl]cyclopropane-1-
carboxylate (±)-220 
Cis-methyl 2-[(dibenzylamino)methyl]-1-(diphenylmethyleneamino)cyclopropane-1-carboxylate  
(±)-cis-218 (0.22 g, 0.45 mmol) was dissolved in a 2:1 mixture of acetone/water (6 mL), and 
trifluoroacetic acid (5 equiv, 2.25 mmol, 0.17 mL) was added dropwise at room temperature. The 
reaction mixture was stirred for 15 minutes at room temperature after which an aqueous solution of 
NH4OH (28-30% NH3) was added until pH = 10 of the solution was obtained. Acetone was evaporated 
in vacuo and the aqueous phase was extracted with CH2Cl2 (3 x 10 mL). The combined organic phases 
were dried (MgSO4), filtered, and evaporated in vacuo. The crude product was purified by column 
chromatography to yield 0.07 g (0.22 mmol) of cis-methyl 1-amino-2-[(dibenzylamino)methyl]-
cyclopropane-1-carboxylate (±)-220. 
Cis-methyl 1-amino-2-[(dibenzylamino)methyl]cyclopropane-1-carboxylate (±)-220. Rf = 0.18 
(petroleum ether/ethyl acetate 7:3). Yellow oil, yield 48%. IR (cm-1): νmax 698, 
732, 1148, 1719, 3381 (weak). 1H NMR (300 MHz, CDCl3): δ 0.66 (1H, dxd, J = 
7.2 Hz, 3.9 Hz, CH(H)cycl), 1.43 (1H, dxd, J = 9.4 Hz, 3.9 Hz, CH(H)cycl), 1.61-
1.72 (3H, m, CHcycl and NH2), 2.67 (1H, dxd, J = 13.2 Hz, 5.5 Hz, CHCH(H)N), 
2.75 (1H, dxd, J = 13.2 Hz, 7.2 Hz, CHCH(H)N), 3.55 (2H, d, J = 13.8 Hz, 2 x 
NCH(H)Ph), 3.63 (3H, s, OCH3), 3.68 (2H, d, J = 13.8 Hz, 2 x NCH(H)Ph), 7.18-7.39 (10H, m, 10 x CHarom). 
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13C NMR (75 MHz, CDCl3): δ 23.0 (CH2, cycl), 26.2 (CHcycl), 38.9 (Cq, cycl), 52.2 (OCH3), 52.5 (CHCH2N), 58.6 
(2 x NCH2Ph), 126.9, 128.2 and 128.8 (10 x CHarom), 139.8 (2 x Carom), 176.7 (C=O). MS (ES, pos. mode) 
m/z (%): 325 (M + H+, 100). HRMS (ES) calcd for C20H25N2O2
+: 325.1911 MH+; found: 325.1918. 
5.12 Synthesis of cis-methyl 1-(benzyloxycarbonylamino)-2-[(dibenzylamino)-
methyl]cyclopropane-1-carboxylate (±)-221 
Cis-methyl 1-amino-2-[(dibenzylamino)methyl]cyclopropane-1-carboxylate (±)-220 (0.28 g, 0.86 
mmol) was dissolved in a 1:1 mixture of an aqueous saturated NaHCO3 solution and Et2O. The 
solution was cooled to 0 °C and benzyl chloroformate (1.01 equiv, 0.87 mmol, 0.12 mL) was added 
dropwise. The reaction mixture was allowed to stir for 15 minutes at 0 °C. The aqueous phase was 
extracted with Et2O and the combined organic phases were dried (MgSO4), filtered, and evaporated 
in vacuo. The crude product was purified by column chromatography to yield 0.27 g (0.59 mmol) of 
cis-methyl 1-(benzyloxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropane-1-carboxylate  
(±)-221. 
Cis-methyl 1-(benzyloxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropane-1-carboxylate  
(±)-221. Rf = 0.14 (petroleum ether/ethyl acetate 4:1). Yellow oil, yield 69%. IR (cm
-1): νmax 698, 728, 
1722, 3378 (weak). 1H NMR (300 MHz, CDCl3, 50 °C): δ 0.85-0.99 (1H, m, 
CH(H)cycl), 1.73-1.87 (2H, m, CH(H)cycl and CHcycl), 2.39-2.52 (1H, m, 
CHCH(H)N), 2.70 (1H, dxd, J = 13.5 Hz, 5.2 Hz, CHCH(H)N), 3.36 (2H, d, J = 
13.2 Hz, 2 x NCH(H)Ph), 3.61 (3H, s, OCH3), 3.78 (2H, d, J = 13.2 Hz, 2 x 
NCH(H)Ph), 5.02 (1H, d, J = 12.4 Hz, OCH(H)Ph), 5.09 (1H, d, J = 12.4 Hz, 
OCH(H)Ph), 5.87 (1H, br s, NH), 7.12-7.39 (15H, m, 15 x CHarom). 
13C NMR (75 
MHz, CDCl3): δ 23.9 (CH2, cycl), 25.3 (CHcycl), 37.8 (Cq, cycl), 52.4 (OCH3), 53.9 
(CHCH2N), 58.9 (2 x NCH2Ph), 66.6 (OCH2Ph), 127.2, 128.0, 128.1, 128.3, 128.4 and 128.8 (15 x 
CHarom), 136.5 and 138.6 (3 x Carom), 156.8 (NHC=O), 172.9 (C=O). MS (ES, pos. mode) m/z (%): 459 (M 
+ H+, 100). HRMS (ES) calcd for C28H31N2O4
+: 459.2278 MH+; found: 459.2283. 
5.13 Synthesis of cis-methyl 1-(tert-butoxycarbonylamino)-2-[(dibenzylamino)-
methyl]cyclopropane-1-carboxylate (±)-222 
To a solution of cis-methyl 1-amino-2-[(dibenzylamino)methyl]cyclopropane-1-carboxylate (±)-220 
(0.2 g, 0.62 mmol) in THF (5 mL) was added Boc2O (1.2 equiv, 0.74 mmol, 162 mg) and Et3N (1.2 
equiv, 0.74 mmol, 75 mg). The reaction mixture was stirred for 16 hours at room temperature, water 
(5 mL) was added and the aqueous phase was extracted with EtOAc (3 x 10 mL). The combined 
organic phases were dried (MgSO4), filtered, and evaporated in vacuo. The crude product was 
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purified by column chromatography to yield 0.14 g (0.33 mmol) of cis-methyl 1-(tert-
butoxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropane-1-carboxylate (±)-222. 
 Cis-methyl 1-(tert-butoxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropane-1-carboxylate 
(±)-222. Rf = 0.18 (petroleum ether/ethyl acetate 4:1). Yellow oil, yield 53%. IR (cm
-1): νmax 698, 734, 
1159, 1720, 3358. 1H NMR (300 MHz, CDCl3): δ 1.23-1.28 (1H, m, CH(H)cycl), 
1.43 (9H, s, t-Bu), 1.33-1.85 (2H, m, CH(H)cycl and CHcycl), 2.41-2.53 (1H, m, 
CHCH(H)N), 2.66 (1H, d, J = 12.1 Hz, CHCH(H)N), 3.37 (2H, d, J = 12.9 Hz, 2 x 
NCH(H)Ph), 3.63 (3H, s, OCH3), 3.76 (2H, d, J = 12.9 Hz, 2 x NCH(H)Ph), 5.64 
(1H, br s, NH), 7.17-7.39 (10H, m, 10 x CHarom). 
13C NMR (75 MHz, CDCl3): δ 
23.6 (CH2, cycl), 25.2 (CHcycl), 28.3 (C(CH3)3), 37.8 (Cq, cycl), 52.3 (OCH3), 53.9 
(CHCH2N), 59.0 (2 x NCH2Ph), 79.5 (C(CH3)3) , 127.1, 128.4 and 128.9 (10 x 
CHarom), 138.9 (2 x Carom), 156.3 (NHC=O), 173.2 (C=O). MS (ES, pos. mode) m/z (%): 425 (M + H
+, 100). 
HRMS (ES) calcd for C25H33N2O4
+: 425.2435 MH+; found: 425.2440. 
5.14 Synthesis of cis-1-(benzyloxycarbonylamino)-2-[(dibenzylamino)methyl]-
cyclopropane-1-carboxylic acid (±)-223  
Cis-methyl 1-(benzyloxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropane-1-carboxylate  
(±)-221 (0.20 g, 0.44 mmol) was treated with 1M aq. NaOH (5 equiv, 2.2 mmol, 2.2 mL) in a 1:3 
mixture of 1M NaOH/MeOH. The reaction mixture was stirred for 1 hour at reflux, after which MeOH 
was evaporated in vacuo. The aqueous phase was brought to pH = 4 with 1M aq. HCl and extracted 
with EtOAc (3 x 10 mL). The combined organic phases were dried (MgSO4), filtered and evaporated in 
vacuo. Precipitation in diethyl ether afforded 0.16 g (0.36 mmol) of cis-1-(benzyloxycarbonylamino)-
2-[(dibenzylamino)methyl]cyclopropane-1-carboxylic acid (±)-223. 
Cis-1-(benzyloxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropane-1-carboxylic acid (±)-223. 
White amorphous solid, yield 81%. Mp 169.5 ± 0.5 °C. IR (cm-1): νmax 697, 740, 1236, 1726, 3218 
(weak). 1H NMR (300 MHz, CD3OD): δ 0.98 (1H, dxd, J = 7.2 Hz, 5.5 Hz, 
CH(H)cycl), 1.60 (1H, dxd, J = 9.4 Hz, 5.5 Hz, CH(H)cycl), 2.13-2.26 (1H, m, CHcycl), 
3.12 (1H, dxd, J = 13.8 Hz, 8.8 Hz, CHCH(H)N), 3.36 (1H, dxd, J = 13.8 Hz, 6.1 
Hz, CHCH(H)N), 4.19 (2H, d, J = 13.2 Hz, 2 x NCH(H)Ph), 4.29-4.47 (2H, m, 2 x 
NCH(H)Ph), 4.94 (1H, d, J = 12.7 Hz, OCH(H)Ph), 5.08 (1H, d, J = 12.7 Hz, 
OCH(H)Ph), 7.12-7.49 (15H, m, 15 x CHarom). 
13C NMR (75 MHz, CD3OD): δ 19.9 
(CH2, cycl), 21.6 (CHcycl), 38.5 (Cq, cycl), 53.4 (CHCH2N), 57.7 (2 x NCH2Ph), 67.2 
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(OCH2Ph), 127.4, 127.9, 128.3, 129.3, 129.5, 130.0 and 130.8 (15 x CHarom), 136.3 (3 x Carom), 160.1 
(NHC=O), 172.7 (C=O). MS (ES, pos. mode) m/z (%): 445 (M + H+, 100). HRMS (ES) calcd for 
C27H29N2O4
+: 445.2122 MH+; found: 445.2120. 
5.15 Synthesis of cis-1-(tert-butoxycarbonylamino)-2-[(dibenzylamino)methyl]-
cyclopropane-1-carboxylic acid (±)-224 
Cis-methyl 1-(tert-butoxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropane-1-carboxylate  
(±)-222 (0.17 g, 0.40 mmol) was treated with 1M aq. NaOH (5 equiv, 2 mmol, 2 mL) in a 1:3 mixture 
of 1M NaOH/MeOH. The reaction mixture was stirred for 1 hour at room temperature, after which 
MeOH was evaporated in vacuo. The aqueous phase was brought to pH = 4 with 2M aq. HCl and 
extracted with EtOAc (3 x 10 mL). The combined organic phases were dried (MgSO4), filtered and 
evaporated in vacuo. Precipitation in diethyl ether afforded 0.10 g (0.24 mmol) of cis-1-(tert-
butoxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropane-1-carboxylic acid (±)-224. 
Cis-1-(tert-butoxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropane-1-carboxylic acid (±)-
224. White amorphous solid, yield 81%. Mp 135 ± 0.5 °C. IR (cm-1): νmax 698, 753, 1161, 1717, 1737, 
3261 (weak). 1H NMR (300 MHz, CD3OD): δ 0.97 (1H, dxd, J = 6.6 Hz, 5.5 Hz, 
CH(H)cycl), 1.37 (9H, s, t-Bu), 1.58 (1H, dxd, J = 8.8 Hz, 5.5 Hz, CH(H)cycl), 2.03-
2.15 (1H, m, CHcycl), 3.15 (1H, dxd, J = 14.0 Hz, 7.2 Hz, CHCH(H)N), 3.28 (1H, 
dxd, J = 14.0 Hz, 7.7 Hz, CHCH(H)N), 4.25 (2H, d, J = 13.2 Hz, 2 x NCH(H)Ph), 
4.38 (2H, d, J = 13.2 Hz, 2 x NCH(H)Ph), 7.34-7.49 (10H, m, 10 x CHarom). 
13C 
NMR (75 MHz, CD3OD): δ 20.4 (CH2, cycl), 21.5 (CHcycl), 27.4 (t-Bu), 53.4 (Cq, cycl), 
57.5 (CHCH2N), 65.6 (2 x NCH2Ph), 80.6 (C(CH3)3), 129.2, 129.7, 129.9 and 
130.7 (10 x CHarom), 135.6 (3 x Carom), 159.1 (NHC=O), 173.1 (C=O). MS (ES, pos. mode) m/z (%): 411 
(M + H+, 100). HRMS (ES) calcd for C24H31N2O4
+: 411.2278 MH+; found: 411.2296. 
5.16 Synthesis of cis-benzyl {2-[(dibenzylamino)methyl]-1-(piperidine-1-
carbonyl)cyclopropyl}carbamate (±)-225  
A flame-dried round-bottomed flask was charged with cis-1-(benzyloxycarbonylamino)-2-
[(dibenzylamino)methyl]cyclopropane-1-carboxylic acid (±)-223 (300 mg, 0.67 mmol) in anhydrous 
CH2Cl2 (10 mL) under a nitrogen atmosphere. To the solution was added HOAt (1 equiv, 0.67 mmol, 
93 mg) and EDC·HCl (1 equiv, 0.67 mmol, 128 mg) and the solution was stirred for 5 minutes at room 
temperature, after which piperidine (2 equiv, 1.34 mmol, 115 mg) and Et3N (to pH 8) were added. 
The reaction mixture was stirred for 16 hours, the solvent was evaporated, and the crude product 
was purified by column chromatography to give 250 mg (0.49 mmol) of cis-benzyl {2-
[(dibenzylamino)methyl]-1-(piperidine-1-carbonyl)cyclopropyl}carbamate (±)-225. 
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 Cis-benzyl {2-[(dibenzylamino)methyl]-1-(piperidine-1-carbonyl)cyclopropyl}carbamate (±)-225. Rf 
= 0.17 (petroleum ether/ethyl acetate 3:2). Yellow oil, yield 73%. IR (cm-1): νmax 697, 730, 1234, 1451, 
1624, 1720, 3265 (weak). 1H NMR (300 MHz, CDCl3, 50 °C): δ 0.70-0.89 (1H, 
m, CH(H)cycl), 1.36-1.77 (8H, m, CH(H)cycl, CHcycl and 3 x CH2), 2.42 (1H, dxd, J 
= 13.2 Hz, 8.8 Hz, CHCH(H)N), 2.67 (1H, dxd, J = 13.2 Hz, 5.5 Hz, 
CHCH(H)N), 3.32 (2H, d, J = 13.2 Hz, 2 x NCH(H)Ph), 3.44-3.62 (4H, m, 2 x 
NCH2), 3.95 (2H, d, J = 13.2 Hz, 2 x NCH(H)Ph), 4.89-5.01 (1H, m, 
OCH(H)Ph), 5.06 (1H, d, J = 12.1 Hz, OCH(H)Ph), 5.77 (1H, br s, NH), 7.13-
7.38 (15H, m, 15 x CHarom). 
13C NMR (75 MHz, CDCl3): δ 20.0 (CH2, cycl), 21.4 
(CHcycl), 24.6 and 25.9 (3 x CH2), 39.3 (Cq, cycl), 45.6 (2 x NCH2), 53.2 (CHCH2N), 58.3 (2 x NCH2Ph), 66.6 
(OCH2Ph), 127.2, 128.1, 128.4, 128.5 and 128.9 (15 x CHarom), 136.5 and 138.5 (3 x Carom), 156.0 
(NHC=O), 169.3 (C=O). MS (ES, pos. mode) m/z (%): 512 (M + H+, 100). HRMS (ES) calcd for 
C32H38N3O3
+: 512.2908 MH+; found: 512.2909. 
5.17 Synthesis of cis-[1-amino-2-(aminomethyl)cyclopropyl](piperidin-1-yl)-
methanone (±)-219 
To a solution of cis-benzyl {2-[(dibenzylamino)methyl]-1-(piperidine-1-carbonyl)cyclopropyl}-
carbamate (±)-225 (50 mg, 0.1 mmol) in MeOH (5 mL) was added Pd/C (20% mass fraction, 10 mg). 
The reaction mixture was stirred for four hours at room temperature under a H2 atmosphere (1.8 
bar) and subsequently filtered through a syringe filter. The organic phase was evaporated in vacuo to 
yield 18 mg (0.09 mmol) of cis-[1-amino-2-(aminomethyl)cyclopropyl](piperidin-1-yl)methanone  
(±)-219 as a colorless oil.  
Cis-[1-amino-2-(aminomethyl)cyclopropyl](piperidin-1-yl)methanone (±)-219. Colorless oil, 91% 
yield. IR (cm-1): νmax = 1133, 1252, 1280, 1363, 1441, 1468, 1606, 2855, 2933, 3359. 
1H NMR (400 
MHz, CDCl3): δ = 0.59 (1H, dxd, J = 6.6 Hz, 5.1 Hz, CH(H)cycl), 1.16 (1H, dxd, 
J = 9.5 Hz, 5.1 Hz, CH(H)cycl), 1.25–1.33 (1H, m, CHcycl), 1.50–1.71 (6H, m, 3 
x CH2), 1.85-2.13 (4H, br s, 2 x NH2), 2.91 (1H, dxd, J = 13.1 Hz, 7.5 Hz, 
CH(H)NH2), 2.99 (1H, dxd, J = 13.1 Hz, 6.0 Hz, CH(H)NH2), 3.52–3.65 (4H, 
m, 2 x NCH2) ppm. 
13C NMR (100 MHz, CDCl3): δ = 17.7 (CH2, cycl), 24.6 (CH2), 25.8 (CHcycl), 25.9 (2 x 
NCH2CH2), 40.2 (CH2NH2), 40.3 (Cq, cycl), 44.9 (2 x NCH2), 171.9 (C=O). MS (ES
+): m/z (%) = 198 (M + H+, 
100). HRMS (ES): calcd. for C10H20N3O
+: 198.1601 MH+; found 198.1602. 
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5.18 Synthesis of dipeptides 237, 238, (±)-243a, (±)-243b and 254 
The synthesis of (S)-methyl 2-{1-(tert-butoxycarbonylamino)-2-[(dibenzylamino)methyl]-
cyclopropanecarboxamido}propanoate 238 is representative. To a solution of cis-1-(tert-
butoxycarbonyl amino)-2-[(dibenzylamino)methyl]cyclopropane-1-carboxylic acid (±)-224 (50 mg, 
0.12 mmol) in dry CH2Cl2 (5mL) was added HOAt (1 equiv, 0.12 mmol, 16 mg) and the resulting 
mixture was allowed to stir for five minutes at room temperature, after which EDC.HCl (1 equiv, 0.12 
mmol, 23 mg) was added in one portion. Again the reaction mixture was stirred for five minutes, 
followed by the addition of (S)-alanine methyl ester hydrochloride 234 (2 equiv, 0.24 mmol, 34 mg) 
and Et3N until a pH ≈ 8 of the solution was obtained. The reaction mixture was allowed to stir for 16 
hours at room temperature and the solvent was evaporated in vacuo. The crude product was purified 
by column chromatography to yield 50 mg (0.10 mmol) of (S)-methyl 2-{1-(tert-
butoxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropanecarboxamido}propanoate 238. 
(S)-Methyl 2-{1-(tert-butoxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropanecarbox-
amido}propanoate 238. 
Spectral data were obtained from a mixture of two diastereomers in a 1:1 ratio. 
Rf = 0.23 (petroleum ether/ethyl acetate 6:4). Colorless oil, yield 83%. IR (cm
-1): νmax 699, 737, 1164, 
1366, 1451, 1513, 1667, 1722, 1740, 3330. 1H NMR (200 MHz, 
CDCl3): δ 0.81-0.96 (2H, m, 2 x CH(H)cycl, isomer 1 and 2), 1.38 (6H, d, J = 
7.1 Hz, 2 x CH3CHisomer 1 and 2), 1.44 (18H, s, 2 x t-Buisomer 1 and 2), 1.74-
2.07 (4H, m, 2 x CH(H)cycl, isomer 1 and 2 and 2 x CHcycl, isomer 1 and 2), 2.40-
2.62 (2H, m, 2 x CHCH(H)Nisomer 1 and 2), 2.70-2.94 (2H, m, 2 x 
CHCH(H)Nisomer 1 and 2), 3.32-3.58 (4H, m, 4 x NCH(H)Phisomer 1 and 2), 3.68 (3H, s, OCH3, isomer 1), 3.74 (3H, s, 
OCH3, isomer 2), 3.89-4.18 (4H, m, 4 x NCH(H)Phisomer 1 and 2), 4.55 (2H, quintet, J = 7.1 Hz, 2 x CHCH3, isomer 1 
and 2), 6.38 (2H, br s, 2 x NHisomer 1 and 2), 6.93-7.15 (2H, m, 2 x NHisomer 1 and 2), 7.20-7.52 (20H, m, 20 x 
CHarom, isomer 1 and 2). 
13C NMR (50 MHz, CDCl3): δ 18.3 and 18.5 (2 x CH3CHisomer 1 and 2), 23.1 (2 x CHcycl, 
isomer 1 and 2 and 2 x CH2, cycl, isomer 1 and 2), 28.2 (2 x C(CH3)3, isomer 1 and 2), 39.3 (2 x Cq, cycl, isomer 1 and 2), 48.4 (2 x 
CH3CHisomer 1 and 2), 52.2 and 52.3 (2 x OCH3, isomer 1 and 2), 53.0 (2 x CHCH2Nisomer 1 and 2), 57.9 (4 x 
NCH2Phisomer 1 and 2), 80.2 and 80.3 (2 x C(CH3)3, isomer 1 and 2), 127.0, 127.8, 128.2, 128.6, 129.5 (20 x 
CHarom, isomer 1 and 2), 139.2 (4 x Carom, isomer 1 and 2), 155.9 (2 x NHC=OOisomer 1 and 2), 171.4 (2 x C=Oisomer 1 and 2), 
173.1 and 173.2 (2 x C=Oisomer 1 and 2). MS (ES, pos. mode) m/z (%): 496 (M + H
+, 100). HRMS (ES) calcd 
for C28H38N3O5
+: 496.2806 MH+; found: 496.2808. 
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(S)-methyl 2-{1-(benzyloxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropanecarboxamido}- 
propanoate 237. 
Spectral data were obtained from a mixture of two diastereomers in a 1:1 ratio. 
Rf = 0.27 (petroleum ether/ethyl acetate 6:4). Colorless oil, yield 83%. IR (cm
-1): νmax 697, 737, 1220, 
1451, 1495, 1514, 1665, 1736, 3335. 1H NMR (200 MHz, CDCl3): 
δ 0.81-0.95 (2H, m, 2 x CH(H)cycl, isomer 1 and 2), 1.36 (6H, d, J = 7.1 
Hz, 2 x CH3CHisomer 1 and 2), 1.83-2.04 (4H, m, 2 x CH(H)cycl, isomer 1 
and 2 and 2 x CHcycl, isomer 1 and 2), 2.26-2.44 (2H, m, 2 x 
CHCH(H)Nisomer 1 and 2), 2.73-2.90 (2H, m, 2 x CHCH(H)Nisomer 1 and 
2), 3.10 (4H, d, J = 13.1 Hz, 4 x NCH(H)Phisomer 1 and 2), 3.65 (3H, s, OCH3, isomer 1), 3.73 (3H, s, OCH3, isomer 2), 
3.94 (2H, d, J = 13.1 Hz, 2 x NCH(H)Phisomer 1 and 2), 3.95 (2H, d, J = 13.1 Hz, 2 x NCH(H)Phisomer 1 and 2), 
4.46-4.63 (2H, m, 2 x CHCH3, isomer 1 and 2), 4.95-5.22 (4H, m, 2 x OCH2, isomer 1 and 2), 6.56 and 6.69 (2 x 1H, 
2 x br s, 2 x NHisomer 1 and 2), 6.92 and 6.96 (2 x 1H, 2 x s, 2 x NHisomer 1 and 2), 7.20-7.52 (30H, m, 30 x 
CHarom, isomer 1 and 2). MS (ES, pos. mode) m/z (%): 530 (M + H
+, 100). HRMS (ES) calcd for C31H36N3O5
+: 
530.2649 MH+; found: 530.2648. 
Ethyl 2-{1-(tert-butoxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropanecarboxamido}-
acetate (±)-243a. Rf = 0.30 (petroleum ether/ethyl acetate 6:4). Colorless oil, yield 85%. IR (cm
-1): νmax 
698, 743, 1165, 1367, 1521, 1666, 1721, 3339. 1H NMR (200 MHz, 
CDCl3): δ 0.77-0.90 (1H, m, CH(H)cycl), 1.25 (3H, t, J = 7.1 Hz, 
OCH2CH3), 1.43 (9H, s, t-Bu), 1.76-2.01 (2H, m, CH(H)cycl and CHcycl), 
2.42 (1H, dxd, J = 12.8 Hz, 9.1 Hz, CHCH(H)N), 2.78 (1H, dxd, J = 
12.8 Hz, 5.3 Hz, CHCH(H)N), 3.33 (2H, d, J = 13.4 Hz, 2 x 
NCH(H)Ph), 3.84 (2H, d, J = 13.4 Hz, 2 x NCH(H)Ph), 3.98 (1H, d, J = 4.5 Hz, CH(H)CO2Et), 4.01 (1H, d, J 
= 4.5 Hz, CH(H)CO2Et), 4.19 (2H, q, J = 7.1 Hz, OCH2CH3), 6.20 and 6.96 (2 x 1H, 2 x br s, 2 x NH), 7.15-
7.45 (10H, m, 10 x CHarom). 
13C NMR (50 MHz, CDCl3): δ 14.1 (OCH2CH3), 23.9 and 24.3 (CHcycl and 
CH2,cycl), 28.3 (C(CH3)3), 39.1 (Cq, cycl), 41.9 (NHCH2), 54.3 (CHCH2N), 58.4 (2 x NCH2Ph), 61.4 (OCH2CH3), 
80.4 (C(CH3)3), 127.2, 128.5, 129.1 (10 x CHarom), 138.4 (2 x Carom), 156.0 (NHC=OO), 169.8 and 172.2 (2 
x C=O). MS (ES, pos. mode) m/z (%): 496 (M + H+, 100). HRMS (ES) calcd for C28H38N3O5
+: 496.2806 
MH+; found: 496.2808. 
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Methyl 2-{1-(tert-butoxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropanecarboxamido}-2-
methylpropanoate (±)-243b. Rf = 0.28 (petroleum ether/ethyl acetate 7:3). White amorphous solid, 
yield 81%. Mp 39 ± 1 °C. IR (cm-1): νmax 698, 738, 1159, 1365, 
1453, 1513, 1670, 1724, 3335. 1H NMR (200 MHz, CDCl3): δ 0.73-
0.83 (1H, m, CH(H)cycl), 1.46 (9H, s, t-Bu), 1.51 (3H, s, CH3CNH), 
1.54 (3H, s, CH3CNH) 1.74-2.03 (2H, m, CH(H)cycl and CHcycl), 2.39 
(1H, dxd, J = 12.1 Hz, 9.1 Hz, CHCH(H)N), 2.77 (1H, dxd, J = 12.1 
Hz, 4.5 Hz, CHCH(H)N), 3.25 (2H, d, J = 13.1 Hz, 2 x NCH(H)Ph), 3.64 (3H, s, OCH3), 3.94 (2H, d, J = 13.1 
Hz, 2 x NCH(H)Ph), 6.33 and 7.12 (2 x 1H, 2 x br s, 2 x NH), 7.22-7.42 (10H, m, 10 x CHarom). 
13C NMR 
(50 MHz, CDCl3): δ 23.2 and 23.5 (CHcycl and CH2, cycl), 24.5 and 25.1 ((CH3)2C), 28.3 (C(CH3)3), 39.1 (Cq, 
cycl), 52.3 (OCH3), 53.8 (CHCH2N), 56.4 (CH3)2C), 58.0 (2 x NCH2Ph), 80.2 (C(CH3)3), 127.2, 128.4, 129.1 
(10 x CHarom), 138.3 (2 x Carom), 155.9 (NHC=OO), 171.4 and 174.8 (2 x C=O). MS (ES, pos. mode) m/z 
(%): 510 (M + H+, 100). HRMS (ES) calcd for C29H40N3O5
+: 510.2962 MH+; found: 510.2971. 
Methyl 1-{1-(tert-butoxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropanecarboxamido}-2-
[(dibenzylamino)methyl]cyclopropanecarboxylate 254. 
Spectral data were obtained from a mixture of two diastereomers in a 1:1 ratio. 
Rf = 0.29 (petroleum ether/ethyl acetate 6:4). White amorphous solid, yield 81%. Mp 60 ± 1 °C. IR 
(cm-1): νmax 697, 744, 1160, 1452, 1492, 1682, 1724, 3387. 
1H 
NMR (200 MHz, CDCl3): δ 0.78-0.97 (4H, m, 2 x 
CH(H)CCO2Meisomer 1 and 2 and 2 x CH(H)CNHBocisomer 1 and 2), 1.35 
(9H, s, t-Buisomer 1), 1.41 (9H, s, t-Buisomer 2), 1.71-2.09 (8H, m, 2 
x CH(H)CCO2Meisomer 1 and 2, 2 x CH(H)CNHBocisomer 1 and 2, 2 x 
CHCCO2Meisomer 1 and 2 and 2 x CHCNHBocisomer 1 and 2), 2.30-2.92 
(8H, m, 4 x CHCH2Nisomer 1 and 2), 3.19-4.12 (16H, m, 8 x 
NCH2Phisomer 1 and 2), 3.68 (6H, s, OCH3, isomer 1 and 2), 6.02 (2H, br s, 2 x NHisomer 1 and 2), 6.50 (2H, m, 2 x 
NHisomer 1 and 2), 7.06-7.49 (40H, m, 40 x CHarom, isomer 1 and 2). MS (ES, pos. mode) m/z (%): 717 (M + H
+, 
100). HRMS (ES) calcd for C44H53N4O5
+: 717.4010 MH+; found: 717.4044. 
5.19 Synthesis of tripeptides 232, (±)-246a and (±)-246b 
The synthesis of (S)-methyl 2-{(1S,2S)-1-[(S)-2-(benzyloxycarbonylamino)propanamido]-2-
[(dibenzylamino)methyl]cyclopropanecarboxamido}propanoate and (S)-methyl 2-{(1R,2R)-1-[(S)-2-
(benzyloxycarbonylamino)propanamido]-2-[(dibenzylamino)methyl]cyclopropanecarboxamido}-
propanoate 232a and 232b is representative. (S)-Methyl 2-{1-(tert-butoxycarbonylamino)-2-
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[(dibenzylamino)methyl]cyclopropanecarboxamido}propanoate 238 (100 mg, 0.202 mmol) was 
dissolved in a 1:1 mixture of TFA/CH2Cl2 and the resulting mixture was stirred for one hour at room 
temperature. The solvent was evaporated in vacuo and the obtained TFA-salt 239 was used without 
further purification in the next step. To a solution of (S)-(benzyloxycarbonyl)alanine 241 (2 equiv, 
0.404 mmol, 90 mg) in dry CH2Cl2 (5 mL) was added HOAt (2 equiv, 0.404 mmol, 55 mg) and the 
resulting mixture was allowed to stir for five minutes at room temperature, after which EDC.HCl (2 
equiv, 0.404 mmol, 77 mg) was added in one portion. Again the reaction mixture was stirred for five 
minutes, followed by the addition of TFA-salt 239 (0.202 mmol) and Et3N until a pH ≈ 8 of the 
solution was obtained. The reaction mixture was allowed to stir for 16 hours at room temperature 
and the solvent was evaporated in vacuo. The crude product was purified by column 
chromatography to yield 32 mg (0.053 mmol) and 26 mg (0.043 mmol) of (S)-methyl 2-{(1S,2S)-1-[(S)-
2-(benzyloxycarbonylamino)propanamido]-2-[(dibenzylamino)methyl]cyclopropanecarboxamido}-
propanoate and (S)-methyl 2-{(1R,2R)-1-[(S)-2-(benzyloxycarbonylamino)propanamido]-2-
[(dibenzylamino)methyl]cyclopropanecarboxamido}propanoate 232a and 232b or vice versa. 
(S)-methyl 2-{(1S,2S)-1-[(S)-2-(benzyloxycarbonylamino)propanamido]-2-[(dibenzylamino)methyl]-
cyclopropanecarboxamido}propanoate or (S)-methyl 2-{(1R,2R)-1-[(S)-2-(benzyloxycarbonyl-
amino)propanamido]-2-[(dibenzylamino)methyl]cyclopropanecarboxamido}propanoate 232a or 
232b. Rf = 0.24 (CH2Cl2/MeOH 10:0.2). White amorphous solid, yield 26%. Mp 60 ± 1.0 °C. [α]D +11.1 
(c 0.2, MeOH). IR (cm-1): νmax 698, 737, 1255, 1529, 
1668, 1700, 1739, 3344. 1H NMR (200 MHz, CDCl3): δ 
0.73 (1H, dxd, J = 5.6 Hz, 4.5 Hz, CH(H)cycl), 0.82 (3H, d, 
J = 6.6 Hz, CH3CH), 1.37 (3H, d, J = 7.1 Hz, CH3CH), 1.87-
2.10 (2H, m, CH(H)cycl and CHcycl), 2.36 (1H, dxd, J = 12.9 
Hz, 9.6 Hz, CHCH(H)N), 2.84 (1H, dxd, J = 12.9 Hz, 5.1 
Hz, CHCH(H)N), 3.18 (2H, d, J = 13.1 Hz, 2 x NCH(H)Ph), 
3.51 (3H, s, OCH3), 4.00 (2H, d, J = 13.1 Hz, 2 x 
NCH(H)Ph), 4.52 (1H, quintet, J = 7.1 Hz, CH3CH), 5.05 
(1H, d, J = 12.4 Hz, OCH(H)Ph), 5.17 (1H, d, J = 12.4 Hz, 
OCH(H)Ph), 5.04-5.18 (1H, m, CH3CH), 7.23-7.40 (15H, 
m, 15 x CHarom). 
13C NMR (50 MHz, CDCl3): δ 17.0 and 
17.4 (2 x CHCH3), 23.0 and 23.2 (CH2, cycl and CHcycl), 38.1 (Cq, cycl), 48.6 and 51.1 (2 x CHCH3), 51.9 
(OCH3), 53.5 (CHCH2N), 58.3 (2 x NCH2Ph), 67.1 (OCH2Ph), 127.4, 128.0, 128.3, 128.6 and 129.5 (15 x 
CHarom), 136.0 and 138.7 (3 x Carom), 156.3 (NHC=OO), 170.7, 173.2, 173.9 (3 x C=O). MS (ES, pos. 
mode) m/z (%): 601 (M + H+, 100). HRMS (ES) calcd for C34H41N4O6
+: 601.3021 MH+; found: 601.3049. 
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(S)-methyl 2-{(1S,2S)-1-[(S)-2-(benzyloxycarbonylamino)propanamido]-2-[(dibenzylamino)methyl]-
cyclopropanecarboxamido}propanoate or (S)-methyl 2-{(1R,2R)-1-[(S)-2-(benzyloxycarbonyl-
amino)propanamido]-2-[(dibenzylamino)methyl]cyclopropanecarboxamido}propanoate 232a or 
232b. Rf = 0.16 (CH2Cl2/MeOH 10:0.2). White 
amorphous solid, yield 21%. Mp 111 ± 1.0 °C. [α]D -
100.9 (c 0.2, MeOH). IR (cm-1): νmax 697, 740, 1203, 
1239, 1253, 1530, 1665, 1701, 1733, 3339. 1H NMR 
(200 MHz, CDCl3): δ 0.76-0.90 (1H, m, CH(H)cycl), 1.17 
(3H, d, J = 6.6 Hz, CH3CH), 1.37 (3H, d, J = 7.1 Hz, 
CH3CH), 1.87 (1H, dxd, J = 9.1 Hz, 4.5 Hz, CH(H)cycl), 
1.95-2.14 (1H, m, CHcycl), 2.46 (1H, dxd, J = 12.9 Hz, 8.3 
Hz, CHCH(H)N), 2.73 (1H, dxd, J = 12.9 Hz, 5.8 Hz, 
CHCH(H)N), 3.28 (2H, d, J = 13.4 Hz, 2 x NCH(H)Ph), 
3.71 (3H, s, OCH3), 3.87 (2H, d, J = 13.4 Hz, 2 x 
NCH(H)Ph), 4.48 (1H, quintet, J = 7.1 Hz, CH3CH), 5.04 
(1H, d, J = 12.4 Hz, OCH(H)Ph), 5.18 (1H, d, J = 12.4 Hz, OCH(H)Ph), 5.03-5.18 (1H, m, CH3CH), 7.16-
7.39 (15H, m, 15 x CHarom). 
13C NMR (50 MHz, CDCl3): δ 18.1 and 18.4 (2 x CHCH3), 23.0 and 23.5 (CH2, 
cycl and CHcycl), 38.1 (Cq, cycl), 48.5 and 50.8 (2 x CHCH3), 52.3 (OCH3), 53.4 (CHCH2N), 58.2 (2 x NCH2Ph), 
67.0 (OCH2Ph), 127.5, 128.0, 128.3, 128.5 and 129.3 (15 x CHarom), 136.1 and 138.6 (3 x Carom), 155.9 
(NHC=OO), 170.6, 173.2, 173.7 (3 x C=O). MS (ES, pos. mode) m/z (%): 601 (M + H+, 100). HRMS (ES) 
calcd for C34H41N4O6
+: 601.3021 MH+; found: 601.3040. 
Ethyl 2-{1-[2-(benzyloxycarbonylamino)acetamido]-2-[(dibenzylamino)methyl]cyclopropane-
carboxamido}acetate (±)-246a. Rf = 0.25 (petroleum ether/ethyl acetate 2:8). White amorphous 
solid, yield 63%. Mp 47 ± 1.0 °C. IR (cm-1): νmax 697, 
748, 1193, 1260, 1522, 1668, 1699, 3314. 1H NMR 
(200 MHz, CDCl3): δ 0.81-0.94 (1H, m, CH(H)cycl), 1.22 
(3H, t, J = 7.1 Hz, OCH2CH3), 1.88 (1H, dxd, J = 9.1 Hz, 
4.5 Hz, CH(H)cycl), 1.99-2.14 (1H, m, CHcycl), 2.26-2.50 
(1H, m, CHCH(H)N), 2.82 (1H, dxd, J = 13.1 Hz, 5.1 Hz, CHCH(H)N), 3.26 (2H, d, J = 12.6 Hz, 2 x 
NCH(H)Ph), 3.95 (2H, d, J = 12.6 Hz, 2 x NCH(H)Ph), 3.11-4.08 (4H, m, 2 x NHCH2) 4.14 (2H, q, J = 7.6 
Hz, OCH2CH3), 5.09 (1H, d, J = 12.4 Hz, OCH(H)Ph), 5.16 (1H, d, J = 12.4 Hz, OCH(H)Ph), 7.25-7.40 
(15H, m, 15 x CHarom). 
13C NMR (50 MHz, CDCl3): δ 14.1 (OCH2CH3), 15.2 and 21.3 (CHcycl and CH2,cycl), 
38.7 (Cq, cycl), 41.8 and 45.1 (2 x NHCH2), 52.8 (CHCH2N), 57.1 (2 x NCH2Ph), 61.1 (OCH2CH3), 67.0 
(OCH2Ph), 127.9, 128.0, 128.4, 129.1 and 130.6 (15 x CHarom), 136.4 (3 x Carom), 157.3 (NHC=OO), 169.8 
Chapter 5   Experimental part 
 
 
108 
 
and 170.6 (3 x C=O). MS (ES, pos. mode) m/z (%): 587 (M + H+, 100). HRMS (ES) calcd for C33H39N4O6
+: 
587.2864 MH+; found: 587.2869. 
methyl 2-{1-(2-(benzyloxycarbonylamino)-2-methylpropanamido)-2-[(dibenzylamino)methyl]-
cyclopropanecarboxamido}-2-methylpropanoate (±)-246b. Rf = 0.2 (petroleum ether/ethyl acetate 
7:3). White amorphous solid, yield 38%. Mp1 100 ± 1.0 
°C and MP2 134 ± 1.0 °C. IR (cm
-1): νmax 698, 737, 1152, 
1265, 1530, 1663, 1705, 1738, 3345. 1H NMR (200 
MHz, CDCl3): δ 0.46 (1H, dxd, J = 6.6 Hz, 4.0 Hz, 
CH(H)cycl), 0.73-1.77 (12H, m, 2 x (CH3)2C), 1.80-2.06 
(2H, m, CH(H)cycl and CHcycl), 2.40 (1H, dxd, J = 13.1 Hz, 
9.6 Hz, CHCH(H)N), 2.76 (1H, dxd, J = 13.1 Hz, 5.6 Hz, CHCH(H)N), 3.28 (2H, d, J = 13.1 Hz, 2 x 
NCH(H)Ph), 3.61 (3H, s, OCH3), 3.93 (2H, d, J = 13.1 Hz, 2 x NCH(H)Ph), 5.06 (1H, d, J = 12.4 Hz, 
OCH(H)Ph), 5.26 (1H, d, J = 12.4 Hz, OCH(H)Ph), 7.19-7.40 (15H, m, 15 x CHarom), 8.35 (1H, br s, NH). 
13C NMR (50 MHz, CDCl3): δ 20.5 and 22.8 (CHcycl and CH2, cycl), 25.0, 25.4, 26.8 and 27.5 (2 x (CH3)2C), 
40.5 (Cq, cycl), 51.2 (OCH3), 52.2 (CHCH2N), 56.3 and 57.8 (2 x (CH3)2C), 58.1 (2 x NCH2Ph), 66.9 
(OCH2Ph), 127.4, 127.7, 128.5, 128.9, 129.4, 129.5, 129.8 and 130.5 (15 x CHarom), 137.8 (3 x Carom), 
155.9 (NHC=OO), 169.4 and 172.6 (3 x C=O). MS (ES, pos. mode) m/z (%): 629 (M + H+, 100). HRMS 
(ES) calcd for C36H45N4O6
+: 629.3334 MH+; found: 629.3341. 
5.20 Synthesis of tripeptides 231, (±)-250 and (±)-253 
The synthesis of (S)-methyl 2-{(S)-2-[(1S,2S)-1-(benzyloxycarbonylamino)-2-[(dibenzylamino)methyl]-
cyclopropanecarboxamido]propanamido}propanoate and (S)-methyl 2-{(S)-2-[(1R,2R)-1-(benzyloxy-
carbonylamino)-2-[(dibenzylamino)methyl]cyclopropanecarboxamido]propanamido}propanoate 
231a and 231b is representative. To a solution of cis-1-(benzyloxycarbonylamino)-2-
[(dibenzylamino)methyl]cyclopropane-1-carboxylic acid (±)-223 (100 mg, 0.225 mmol) in dry CH2Cl2 (5 
mL) was added HOAt (1 equiv, 0.225 mmol, 30 mg) and the resulting mixture was allowed to stir for 
five minutes at room temperature, after which EDC.HCl (1 equiv, 0.225 mmol, 43 mg) was added in 
one portion. Again the reaction mixture was stirred for five minutes, followed by the addition of H-
(Ala)2-OMe.TFA 236 (2 equiv, 0.45 mmol) and Et3N until a pH ≈ 8 of the solution was obtained. The 
reaction mixture was allowed to stir for 16 hours at room temperature and the solvent was 
evaporated in vacuo. The crude product was purified by column chromatography to yield 24 mg 
(0.040 mmol) and 35 mg (0.058 mmol) of (S)-methyl 2-{(S)-2-[(1S,2S)-1-(benzyloxycarbonylamino)-2-
[(dibenzylamino)methyl]cyclopropanecarboxamido]propanamido}propanoate and (S)-methyl 2-{(S)-
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2-[(1R,2R)-1-(benzyloxycarbonyl-amino)-2-[(dibenzylamino)methyl]cyclopropanecarboxamido]-
propanamido}propanoate 231a and 231b or vice versa. 
(S)-Methyl 2-{(S)-2-[(1S,2S)-1-(benzyloxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropane-
carboxamido]propanamido}propanoate or (S)-methyl 2-{(S)-2-[(1R,2R)-1-(benzyloxycarbonyl-
amino)-2-[(dibenzylamino)methyl]cyclopropanecarboxamido]propanamido}propanoate 231a or 
231b. Rf = 0.22 (CH2Cl2/MeOH 10:0.2). White 
amorphous solid, yield 18%. Mp 54 ± 1.0 °C. [α]D -39.4 
(c 0.5, MeOH). IR (cm-1): νmax 697, 737, 1227, 1452, 
1515, 1644, 1714, 1737, 3312. 1H NMR (200 MHz, 
CDCl3): δ 0.82 (1H, dxd, J = 6.1 Hz, 4.0 Hz, CH(H)cycl), 
1.30-1.43 (6H, m, 2 x CH3CH), 1.87-2.10 (2H, m, CH(H)cycl 
and CHcycl), 2.36 (1H, dxd, J = 12.9 Hz, 9.3 Hz, 
CHCH(H)N), 2.85 (1H, dxd, J = 12.9 Hz, 5.3 Hz, 
CHCH(H)N), 3.21 (2H, d, J = 13.1 Hz, 2 x NCH(H)Ph), 3.73 
(3H, s, OCH3), 3.94 (2H, d, J = 13.1 Hz, 2 x NCH(H)Ph), 
4.42-4.60 (2H, m, 2 x CH3CH), 5.00 (1H, d, J = 12.6 Hz, OCH(H)Ph), 5.14 (1H, d, J = 12.6 Hz, OCH(H)Ph), 
6.70 (1H, br s, NH), 6.76-6.95 (2H, m, 2 x NH), 7.12-7.47 (15H, m, 15 x CHarom). 
13C NMR (50 MHz, 
CDCl3): δ 17.8 (2 x CHCH3), 24.2 (CH2, cycl and CHcycl), 39.2 (Cq, cycl), 48.1 and 49.0 (2 x CHCH3), 52.3 
(OCH3), 53.9 (CHCH2N), 58.4 (2 x NCH2Ph), 67.2 (OCH2Ph), 127.3, 128.1, 128.3, 128.5 and 129.0 (15 x 
CHarom), 136.1 and 138.1 (3 x Carom), 157.0 (NHC=OO), 171.5, 171.6, 172.9 (3 x C=O). MS (ES, pos. 
mode) m/z (%): 601 (M + H+, 100). HRMS (ES) calcd for C34H41N4O6
+: 601.3021 MH+; found: 601.3045. 
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(S)-Methyl 2-{(S)-2-[(1S,2S)-1-(benzyloxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropane-
carboxamido]propanamido}propanoate or (S)-methyl 2-{(S)-2-[(1R,2R)-1-(benzyloxycarbonyl-
amino)-2-[(dibenzylamino)methyl]cyclopropanecarboxamido]propanamido}propanoate 231a or 
231b. Rf = 0.16 (CH2Cl2/MeOH 10:0.2). White amorphous 
solid, yield 26%. Mp 51 ± 1.0 °C. [α]D +19.4 (c 0.2, 
MeOH). IR (cm-1): νmax 697, 737, 1227, 1451, 1514, 1647, 
1737, 3312. 1H NMR (200 MHz, CDCl3): δ 0.86 (1H, dxd, J 
= 6.6 Hz, 4.5 Hz, CH(H)cycl), 1.19 (3H, d, J = 7.1 Hz, CH3CH), 
1.33 (3H, d, J = 7.1 Hz, CH3CH), 1.84-2.10 (2H, m, CH(H)cycl 
and CHcycl), 2.34 (1H, dxd, J = 13.2 Hz, 9.9 Hz, CHCH(H)N), 
2.80 (1H, dxd, J = 13.2 Hz, 5.3 Hz, CHCH(H)N), 3.20 (2H, 
d, J = 13.1 Hz, 2 x NCH(H)Ph), 3.72 (3H, s, OCH3), 3.91 
(2H, d, J = 13.1 Hz, 2 x NCH(H)Ph), 4.45 (2H, quintet, J = 
7.1 Hz, 2 x CH3CH), 5.01 (1H, d, J = 12.4 Hz, OCH(H)Ph), 
5.11 (1H, d, J = 12.4 Hz, OCH(H)Ph), 6.52 (1H, br s, NH), 6.67 (1H, d, J = 6.6 Hz, NH), 6.95 (1H, d, J = 7.6 
Hz, NH), 7.15-7.41 (15H, m, 15 x CHarom). 
13C NMR (50 MHz, CDCl3): δ 17.8 and 17.9 (2 x CHCH3), 23.8 
and 24.5 (CH2, cycl and CHcycl), 39.2 (Cq, cycl), 48.0 and 49.1 (2 x CHCH3), 52.3 (OCH3), 53.7 (CHCH2N), 58.4 
(2 x NCH2Ph), 67.1 (OCH2Ph), 127.3, 128.2, 128.5 and 129.0 (15 x CHarom), 136.2 and 138.0 (3 x Carom), 
156.7 (NHC=OO), 171.5, 171.8, 170.0 (3 x C=O). MS (ES, pos. mode) m/z (%): 601 (M + H+, 100). HRMS 
(ES) calcd for C34H41N4O6
+: 601.3021 MH+; found: 601.3017. 
Ethyl 2-{2-[1-(benzyloxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropanecarboxamido]-
acetamido}acetate (±)-250. Rf = 0.45 (petroleum ether/ethyl acetate 2:8). White amorphous solid, 
yield 78%. Mp 42 ± 1.0 °C. IR (cm-1): νmax 697, 737, 1201, 
1236, 1523, 1661, 1708, 1736, 3329. 1H NMR (200 MHz, 
CDCl3): δ 0.81-0.93 (1H, m, CH(H)cycl), 1.24 (3H, t, J = 7.1 
Hz, OCH2CH3), 1.87-2.03 (2H, m, CH(H)cycl and CHcycl), 2.36 
(1H, dxd, J = 12.6 Hz, 8.6 Hz, CHCH(H)N), 2.84 (1H, dxd, J = 
12.6 Hz, 5.1 Hz, CHCH(H)N), 3.23 (2H, d, J = 13.4 Hz, 2 x NCH(H)Ph), 3.88 (2H, d, J = 13.4 Hz, 2 x 
NCH(H)Ph), 3.71-3.93 (2H, m, NHCH2) 4.14 (2H, q, J = 7.1 Hz, OCH2CH3), 4.00-4.23 (2H, m, NHCH2), 
5.00 (1H, d, J = 12.4 Hz, OCH(H)Ph), 5.08 (1H, d, J = 12.4 Hz, OCH(H)Ph), 6.81 (1H, br s, NH), 7.09-7.42 
(15H, m, 15 x CHarom). 
13C NMR (50 MHz, CDCl3): δ 14.1 (OCH2CH3), 24.3 (CHcycl and CH2,cycl), 39.3 (Cq, 
cycl), 41.0 and 43.3 (2 x NHCH2), 54.3 (CHCH2N), 58.7 (2 x NCH2Ph), 61.4 (OCH2CH3), 67.4 (OCH2Ph), 
127.3, 128.4, 128.6 and 128.9 (15 x CHarom), 135.9 and 138.2 (3 x Carom), 157.4 (NHC=OO), 169.5, 
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169.7, 172.1 (3 x C=O). MS (ES, pos. mode) m/z (%): 587 (M + H+, 100). HRMS (ES) calcd for 
C33H39N4O6
+: 587.2864 MH+; found: 587.2873. 
Methyl 2-{2-[1-(benzyloxycarbonylamino)-2-[(dibenzylamino)methyl]cyclopropanecarboxamido]-2-
methylpropanamido}-2-methylpropanoate (±)-253. Rf = 0.38 (petroleum ether/ethyl acetate 4:6). 
White amorphous solid, yield 50%. Mp 125 ± 1.0 °C. IR (cm-1): νmax 697, 737, 1151, 1245, 1519, 1669, 
1707, 1738, 3345. 1H NMR (200 MHz, CDCl3): δ 0.71-
0.79 (1H, m, CH(H)cycl), 1.36 (3H, s, CH3CNH), 1.45 
(9H, s, 3 x CH3CNH), 1.84-2.04 (2H, m, CH(H)cycl and 
CHcycl), 2.34 (1H, dxd, J = 12.9 Hz, 9.1 Hz, CHCH(H)N), 
2.83 (1H, dxd, J = 12.9 Hz, 5.6 Hz, CHCH(H)N), 3.20 
(2H, d, J = 13.1 Hz, 2 x NCH(H)Ph), 3.67 (3H, s, OCH3), 3.95 (2H, d, J = 13.1 Hz, 2 x NCH(H)Ph), 4.98 (1H, 
d, J = 12.4 Hz, OCH(H)Ph), 5.17 (1H, d, J = 12.4 Hz, OCH(H)Ph), 6.71, 6.83 and 7.12 (3 x 1H, 3 x br s, 3 x 
NH), 7.20-7.42 (15H, m, 15 x CHarom). 
13C NMR (50 MHz, CDCl3): δ 23.6 (CHcycl and CH2, cycl), 24.3, 25.1 
and 26.3 (2 x (CH3)2C), 39.6 (Cq, cycl), 52.3 (OCH3), 53.5 (CHCH2N), 56.0 and 57.2 (2 x (CH3)2C), 58.2 (2 x 
NCH2Ph), 67.1 (OCH2Ph), 127.4, 128.3, 128.4, 128.6 and 129.0 (15 x CHarom), 136.2 and 138.0 (3 x 
Carom), 157.1 (NHC=OO), 171.0, 173.4, 175.0 (3 x C=O). MS (ES, pos. mode) m/z (%): 629 (M + H
+, 100). 
HRMS (ES) calcd for C36H45N4O6
+: 629.3334 MH+; found: 629.3332. 
5.21 Synthesis of methyl 2-(aminomethyl)-1-(tert-butoxycarbonylamino)-
cyclopropanecarboxylate (±)-261 
To a solution of cis-methyl 1-tert-butoxycarbonylamino-2-[(dibenzylamino)methyl]cyclopropane-1-
carboxylate (±)-222 (230 mg, 0.54 mmol) in MeOH was added Pd/C (20% mass fraction, 46 mg) and 
NH4HCO2 (5 equiv, 2.71 mmol, 171 mg). The reaction mixture was stirred for 30 minutes at reflux and 
subsequently filtered through a syringe filter. The organic phase was evaporated in vacuo to yield 
127 mg (0.52 mmol) of methyl 2-(aminomethyl)-1-(tert-butoxycarbonylamino)cyclopropane-
carboxylate (±)-261. 
Methyl 2-(aminomethyl)-1-(tert-butoxycarbonylamino)cyclopropanecarboxylate (±)-261. White 
amorphous solid, yield 96%. Mp 126 ± 1 °C. IR (cm-1): νmax 728, 1161, 1691, 1718, 3225. 
1H NMR (400 
MHz, CD3OD): δ 1.03 (1H, dxd, J = 7.2 Hz, 5.6 Hz, CH(H)cycl), 1.38 (9H, s, t-
Bu), 1.53 (1H, dxd, J = 9.8 Hz, 5.6 Hz, CH(H)cycl), 2.00-2.11 (1H, m, CHcycl), 
2.74 (1H, dxd, J = 13.4 Hz, 9.4 Hz, CH(H)NH2), 3.12 (1H, dxd, J = 13.4 Hz, 
5.2 Hz, CH(H)NH2), 3.61 (3H, s, OCH3). 
13C NMR (100 MHz, CD3OD): δ 
19.2 (CH2, cycl), 24.5 (CHcycl), 27.3 (C(CH3)3), 37.9 (Cq, cycl), 38.7 (CH2NH2), 
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51.9 (OCH3), 80.5 (C(CH3)3), 159.0 (NHC=O), 172.2 (C=O). MS (ES, pos. mode) m/z (%): 245 (M + H
+, 
100). HRMS (ES) calcd for C11H21N2O4
+: 245.1496 MH+; found: 245.1495. 
5.22 Synthesis of methyl 2-[(benzyloxycarbonylamino)methyl]-1-(tert-butoxy-
carbonylamino)cyclopropanecarboxylate (±)-263 
Methyl 2-(aminomethyl)-1-(tert-butoxycarbonylamino)cyclopropanecarboxylate (±)-261 (130 mg, 
0.53 mmol) was dissolved in a 1:1 mixture of an aqueous saturated NaHCO3 solution and Et2O. The 
solution was cooled to 0 °C and benzyl chloroformate (1.1 equiv, 0.59 mmol, 0.08 mL) was added 
dropwise. The reaction mixture was allowed to stir for 15 minutes at 0 °C. The aqueous phase was 
extracted with Et2O and the combined organic phases were dried (MgSO4), filtered, and evaporated 
in vacuo. The crude product was purified by column chromatography to yield 114 mg (0.30 mmol) of 
methyl 2-[(benzyloxycarbonylamino)methyl]-1-(tert-butoxycarbonylamino)cyclopropanecarboxylate 
(±)-263.  
 Methyl 2-[(benzyloxycarbonylamino)methyl]-1-(tert-butoxycarbonylamino)cyclopropane-
carboxylate (±)-263. Rf = 0.25 (petroleum ether/ethyl acetate 7:3). White amorphous solid, yield 
57%. Mp 128 ± 0.5 °C. IR (cm-1): νmax 1158, 1249, 1281, 1508, 1684, 1728, 
3338. 1H NMR (400 MHz, CDCl3): δ 0.87 (1H, dxd, J = 7.2 Hz, 5.4 Hz, 
CH(H)cycl), 1.45 (9H, s, t-Bu), 1.59 (1H, dxd, J = 9.6 Hz, 5.4 Hz, CH(H)cycl), 
1.92-2.02 (1H, m, CHcycl), 2.69-2.83 (1H, m, CH(H)NH), 3.67 (3H, s, OCH3), 
3.72-3.83 (1H, m, CH(H)NH), 5.09 (1H, d, J = 12.8 Hz, OCH(H)Ph), 5.12 
(1H, d, J = 12.8 Hz, OCH(H)Ph), 5.81 and 5.94 (2 x 1H, 2 x s, 2 x NH), 7.26-
7.36 (5H, m, 5 x CHarom). 
13C NMR (100 MHz, CDCl3): δ 20.1 (CH2,cycl), 28.2 
(C(CH3)3), 28.6 (CHcycl), 38.2 (Cq, cycl), 39.9 (CH2NH), 52.5 (OCH3), 66.6 (OCH2Ph), 80.4 (C(CH3)3), 128.0 
and 128.4 (5 x CHarom), 136.7 (Carom), 156.7 and 157.2 (2 x NHC=O), 172.9 (C=O). MS (ES, pos. mode) 
m/z (%): 279 (M + H+ - CO2 - isobutene, 100).  
5.23 Synthesis of 2-[(benzyloxycarbonylamino)methyl]-1-(tert-butoxycarbonyl-
amino)cyclopropanecarboxylic acid (±)-264 
Methyl 2-[(benzyloxycarbonylamino)methyl]-1-(tert-butoxycarbonylamino)cyclopropanecarboxylate 
(±)-263 (84 mg, 0.22 mmol) was treated with 2M aq. NaOH (5 equiv, 0.56 mL) in a 1:3 mixture of 2M 
NaOH/MeOH. The reaction mixture was stirred for 1 hour at reflux, after which MeOH was 
evaporated in vacuo. The aqueous phase was brought to pH = 4 with 2M aq. HCl and extracted with 
EtOAc (3 x 10 mL). The combined organic phases were dried (MgSO4), filtered and evaporated in 
vacuo. Precipitation in diethyl ether afforded 75 mg (0.21 mmol) of 2-
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[(benzyloxycarbonylamino)methyl]-1-(tert-butoxycarbonylamino)cyclopropanecarboxylic acid  
(±)-264. 
 2-[(Benzyloxycarbonylamino)methyl]-1-(tert-butoxycarbonylamino)cyclopropanecarboxylic acid 
(±)-264. White amorphous solid, yield 94%. Mp 82 ± 0.5 °C. IR (cm-1): νmax 1159, 1248, 1518, 1692, 
3329. 1H NMR (400 MHz, CDCl3): δ 0.86-0.94 (1H, m, CH(H)cycl), 1.43 (9H, 
s, t-Bu), 1.59-1.68 (1H, m, CH(H)cycl), 1.94-2.08 (1H, m, CHcycl), 2.68-2.92 
(1H, m, CH(H)NH), 3.61-3.80 (1H, m, CH(H)NH), 5.09 (2H, s, OCH2Ph), 
5.87 and 5.91 (2 x 1H, 2 x s, 2 x NH), 7.25-7.36 (5H, m, 5 x CHarom), 9.87 
(1H, s, OH). 13C NMR (100 MHz, CDCl3): δ 20.7 (CH2, cycl), 28.2 (C(CH3)3), 
29.2 (CHcycl), 37.9 (Cq, cycl), 39.9 (CH2NH), 66.7 (OCH2Ph), 80.6 (C(CH3)3), 
127.0, 127.6, 128.0, 128.4 and 128.5 (5 x CHarom), 136.6 (Carom), 156.8 and 
157.3 (2 x NHC=O), 177.9 (C=O). MS (ES, pos. mode) m/z (%): 265 (M + H+ - CO2 - isobutene, 100).  
5.24 Synthesis of benzyl 2-[(dibenzylamino)methyl]-1-[(R)-1-phenylethyl-
carbamoyl]cyclopropylcarbamate 267 
A flame-dried round-bottomed flask was charged with cis-1-(benzyloxycarbonylamino)-2-
[(dibenzylamino)methyl]cyclopropane-1-carboxylic acid (±)-223 (532 mg, 1.20 mmol) in anhydrous 
THF (10 mL) under a nitrogen atmosphere. To the solution was added HOAt (1.01 equiv, 1.21 mmol, 
165 mg) and EDC.HCl (1.01 equiv, 1.21 mmol, 232 mg) and the solution was stirred for 5 minutes at 
room temperature, after which (R)-(+)-α-methylbenzylamine (2 equiv, 2.40 mmol, 291 mg) and Et3N 
(to pH 8) were added. The reaction mixture was stirred for 16 h, the solvent was evaporated, and the 
crude product was purified by column chromatography to give benzyl 2-[(dibenzylamino)methyl]-1-
[(R)-1-phenylethylcarbamoyl]cyclopropylcarbamate 267 as a 1:1 mixture of diastereomers in 69% 
yield (456 mg, 0.83 mmol). Separation of both diastereomers via preparative TLC afforded 145 mg 
(0.26 mmol) benzyl (1R,2R)-2-[(dibenzylamino)methyl]-1-[(R)-1-phenylethylcarbamoyl]-
cyclopropylcarbamate and 151 mg (0.28 mmol) benzyl (1S,2S)-2-[(dibenzylamino)methyl]-1-[(R)-1-
phenylethylcarbamoyl]-cyclopropylcarbamate 267a and 267b or vice versa. 
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Benzyl (1R,2R)-2-[(dibenzylamino)methyl]-1-((R)-1-phenylethylcarbamoyl)cyclopropylcarbamate or 
benzyl (1S,2S)-2-[(dibenzylamino)methyl]-1-[(R)-1-phenylethylcarbamoyl]cyclopropylcarbamate 
267a or 267b. Rf = 0.30 (petroleum ether/ethyl acetate 7:3). Colorless oil, yield 22%. [α]D +25.7 (c 
0.52, MeOH). IR (cm-1): νmax 696, 736, 1227, 1494, 1656, 1720, 3329. 
1H 
NMR (400 MHz, CDCl3): δ 0.81 (1H, dxd, J = 6.8 Hz, 4.5 Hz, CH(H)cycl), 1.40 
(3H, d, J = 6.9 Hz, CH3), 1.87 (1H, dxd, J = 8.6 Hz, 4.5 Hz, CH(H)cycl), 1.96-
2.06 (1H, m, CHcycl), 2.33 (1H, dxd, J = 12.9 Hz, 9.5 Hz, CHCH(H)N), 2.81 (1H, 
dxd, J = 12.9 Hz, 5.3 Hz, CHCH(H)N), 3.17 (2H, d, J = 13.1 Hz, NCH(H)Ph), 
3.96 (2H, d, J = 13.1 Hz, NCH(H)Ph), 4.91 (1H, d, J = 12.3 Hz, OCH(H)Ph), 
5.00-5.09 (1H, m, CHCH3), 5.13 (1H, d, J = 12.3 Hz, OCH(H)Ph), 6.67-6.78 
(2H, m, 2 x NH), 7.17-7.37 (20H, m, 20 x CHarom). 
13C NMR (100 MHz, 
CDCl3): δ 22.1 (CH3), 23.8 (CH2, cycl and CHcycl), 39.2 (Cq, cycl), 48.8 (CHCH3), 
53.9 (CHCH2N), 58.2 (2 x NCH2Ph), 67.0 (OCH2Ph), 125.8, 127.0, 127.3, 
128.52, 128.55 and 129.1 (20 x CHarom), 138.1 and 143.4 (4 x Carom), 156.8 
(NHC=O), 170.9 (C=O). MS (ES, pos. mode) m/z (%): 548 (M + H+, 100). 
HRMS (ES) calcd for C35H38N3O3
+: 548.2908 MH+; found: 548.2900.  
Benzyl (1R,2R)-2-[(dibenzylamino)methyl]-1-((R)-1-phenylethylcarbamoyl)cyclopropylcarbamate or 
benzyl (1S,2S)-2-[(dibenzylamino)methyl]-1-[(R)-1-phenylethylcarbamoyl]cyclopropylcarbamate 
267a or 267b. Rf = 0.19 (petroleum ether/ethyl acetate 7:3). White 
amorphous solid, yield 23%. Mp 141 ± 0.5 °C. [α]D -36.7 (c 0.51, MeOH). 
IR (cm-1): νmax 694, 747, 1230, 1504, 1525, 1650, 1735, 3244. 
1H NMR (400 
MHz, CDCl3): δ 0.78-0.83 (1H, m, CH(H)cycl), 1.32-1.45 (3H, m, CH3), 1.86-
2.03 (2H, m, CH(H)cycl and CHcycl), 2.31 (1H, dxd, J = 13.0 Hz, 10.3 Hz, 
CHCH(H)N), 2.77 (1H, dxd, J = 13.0 Hz, 4.8 Hz, CHCH(H)N), 3.07 (2H, d, J = 
13.1 Hz, NCH(H)Ph), 3.92 (2H, d, J = 13.1 Hz, NCH(H)Ph), 4.84-5.27 (3H, m, 
OCH2Ph and CHCH3), 6.68 (1H, br d, J = 7.6 Hz, NH), 6.75 (1H, br s, NH), 
7.08-7.40 (20H, m, 20 x CHarom). 
13C NMR (100 MHz, CDCl3): δ 21.8 (CH3), 
23.9 (CH2, cycl and CHcycl), 39.3 (Cq, cycl), 49.1 (CHCH3), 54.1 (CHCH2N), 58.3 (2 
x NCH2Ph), 67.0 (OCH2Ph), 125.9, 127.1, 127.3, 128.58, 128.60 and 129.0 
(20 x CHarom), 136.4, 138.1 and 143.3 (4 x Carom), 156.9 (NHC=O), 170.9 
(C=O). MS (ES, pos. mode) m/z (%): 548 (M + H+, 100). HRMS (ES) calcd for 
C35H38N3O3
+: 548.2908 MH+; found: 548.2909.  
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5.25 Synthesis of α-halo-N-(tert-butanesulfinyl)imines (RS)-282e and (SS)-268c 
As a representative example, the synthesis of (RS)-N-[2-chloro-1-(4-methoxyphenyl)ethylidene]-tert-
butanesulfinamide (RS)-282e is described. In a flame-dried flask was made a solution of 2-chloro-4’-
methoxyacetophenone (1.00 g, 5.42 mmol) and Ti(OEt)4 (2 equiv, 10.8 mmol, 2.47 g) in dry 
tetrahydrofuran (30 mL). (RS)-tert-Butanesulfinamide (1 equiv, 5.42 mmol, 0.65 g) was added and the 
reaction mixture was allowed to stir for 72 hours at reflux. After cooling, brine was added, the 
resulting mixture was filtered over Celite® and the solids were washed with EtOAc (2 x 10 mL). The 
solution was extracted with EtOAc (3 x 25 mL), and the combined organic layers were dried (MgSO4), 
filtered and concentrated. The crude compound was purified by column chromatography to yield 
1.33 g (4.62 mmol) (RS)-N-[2-chloro-1-(4-methoxyphenyl)ethylidene]-tert-butanesulfinamide (RS)-
282e as a yellow liquid. 
 (RS)-N-[2-Chloro-1-(4-methoxyphenyl)ethylidene]-tert-butanesulfinamide (RS)-282e. Rf = 0.22 
(petroleum ether/ethyl acetate 3:1). yellow oil, yield 85%. [α]D -51.5 (c 0.94, 
CH2Cl2). IR (cm
-1): νmax 1071, 1255, 1361, 1586, 2960. 
1H NMR (300 MHz, 
CDCl3): δ 1.35 (9H, s, t-Bu), 3.87 (3H, s, OMe), 4.97 (1H, d, J = 11.3 Hz, 
CH(H)Cl), 5.14 (1H, d, J = 11.3 Hz, CH(H)Cl), 6.95 and 7.87 (2 x 2H, 2 x d, 2 x J = 
8.8 Hz, 4 x CHarom). 
13C NMR (75 MHz, CDCl3): δ 23.1 (C(CH3)3), 35.4 (CH2Cl), 
55.5 (OMe), 59.3 (C(CH3)3), 114.0 (2 x CHarom), 128.5 (Carom), 129.6 (2 x CHarom), 162.7 (Carom), 168.8 
(C=N). MS (ES, pos. mode) m/z (%): 288/290 (M + H+, 100). 
 (SS)-N-{1-([1,1'-biphenyl]-4-yl)-2-bromoethylidene}-tert-butanesulfinamide (SS)-268c. Rf = 0.26 
(petroleum ether/ethyl acetate 4:1). Brown amorphous solid, yield 39%. Mp 
98 ± 0.5 °C. [α]D -35.4 (c 0.54, CHCl3). IR (cm-1): νmax 698, 1065, 1286, 1361, 
1552, 1576. 1H NMR (300 MHz, CDCl3): δ 1.39 (9H, s, t-Bu), 4.89 (1H, d, J = 9.9 
Hz, CH(H)Br), 5.14 (1H, d, J = 9.9 Hz, CH(H)Br), 7.36-7.51 (3H, m, 3 x CHarom), 
7.63, 7.68 and 7.96 (3 x 2H, 3 x d, 3 x J = 7.7 Hz, 6 x CHarom). 
13C NMR (75 MHz, 
CDCl3): δ 21.5 (CH2Br), 23.3 (C(CH3)3), 59.7 (C(CH3)3), 127.2, 127.4, 127.9, 128.2 
and 129.0 (9 x CHarom), 134.8, 139.8 and 144.7 (3 x Carom), 169.1 (C=N). MS (ES, pos. mode) m/z (%): 
378/380 (M + H+, 100). HRMS (ES) calcd for C18H21
79BrNOS+: 378.0522 MH+; found: 378.0517. 
5.26 Synthesis of (SS)-N-[(R)-1-[(SS)-tert-butylsulfinyl]-(2,4-diphenyl-3-pyrrolin-2-
yl)]-tert-butanesulfinamide (SS)-272 
To a stirred solution of (SS)-N-[2-bromo-1-phenylethylidene]-tert-butanesulfinamide (SS)-268a (2 g, 
6.62 mmol) in dry dichloromethane at -78 °C was added two equivalents of vinylmagnesium bromide 
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(1M solution in THF, 13.24 mL, 13.24 mmol) and the reaction mixture was allowed to stir for two 
hours at -78 °C, followed by four hours at -40 °C. The reaction mixture was quenched at this 
temperature by the addition of aq. NH4Cl (5 mL) and extracted with dichloromethane (2 x 10 mL). 
The organic layers were dried over MgSO4, filtered and concentrated. The compound was isolated by 
means of column chromatography, followed by recrystallization from diethyl ether to afford (SS)-N-
[(R)-1-[(SS)-tert-butylsulfinyl]-(2,4-diphenyl-3-pyrrolin-2-yl)]-tert-butanesulfinamide (SS)-272 (0.14 g) 
in 5% yield. Upon standing in the fridge for a longer period, the compound spontaneously 
transformed to (SS)-1-(tert-butylsulfinyl)-2,4-diphenylpyrrole 278. 
 (SS)-N-[(R)-1-[(SS)-tert-butylsulfinyl]-(2,4-diphenyl-3-pyrrolin-2-yl)]-tert-butanesulfinamide (SS)-272. 
White crystals, yield 5%. Mp 130 ± 0.5 °C. [α]D 13.4 (c 0.17, CHCl3). IR (cm
-1): νmax 696, 733, 760, 1041, 
1085, 1453, 1604, 3238. 1H NMR (300 MHz, CDCl3): δ 1.08 (9H, s, t-Bu), 1.33 
(9H, s, t-Bu), 4.02 (1H, dxd, J = 13.8 Hz, 2.2 Hz, CH(H)N), 4.35 (1H, s, NH), 4.96 
(1H, dxd, J = 13.8 Hz, 1.7 Hz, CH(H)N), 6.73 (1H, dxd, J = 2.2 Hz, 1.7 Hz, CHCq), 
7.29-7.43 (6H, m, 6 x CHarom), 7.48-7.59 (4H, m, 4 x CHarom). 
13C NMR (75 MHz, 
CDCl3): δ 23.0 and 24.3 (2 x C(CH3)3), 47.9 (CH2N), 57.4 and 57.5 (2 x C(CH3)3), 
90.9 (CqN), 125.9 (CHCqN), 126.3, 127.6, 128.3, 128.7, 128.8 and 129.0 (10 x CHarom), 132.5, 138.9 and 
140.7 (3 x Cq). MS (ES, pos. mode) m/z (%): 324 (M + H
+ - NH2S(O)t-Bu, 100). Anal. Calcd for 
C24H32N2O2S2: C 64.83; H 7.25; N 6.30. Found: C 64.34; H 7.36; N 6.25. 
 (SS)-1-(tert-butylsulfinyl)-2,4-diphenylpyrrole 278. Colorless crystals. Mp 116 ± 0.5 °C. [α]D -13.3 (c 
0.23, CHCl3). IR (cm
-1): νmax 694, 760, 1028, 1042, 1066, 1084, 1102, 1452, 1602. 
1H 
NMR (300 MHz, CDCl3): δ 1.06 (9H, s, t-Bu), 6.66 (1H, d, J = 1.9 Hz, CqCHCq), 7.33-
7.44 (6H, m, 6 x CHarom), 7.49-7.53 (2H, m, 2 x CHarom), 7.56-7.60 (3H, m, 2 x CHarom 
and CHN). 13C NMR (75 MHz, CDCl3): δ 22.6 (C(CH3)3), 64.8 (C(CH3)3), 110.1 (CqCHCq), 
115.0 (CHN), 125.3, 126.5, 126.9, 127.7, 128.5, 128.8 and 129.4 (10 x CHarom and Cq), 
131.9, 134.3 and 137.2 (3 x Cq). MS (ES, pos. mode) m/z (%): 324 (M + H
+, 100). 
5.27 Synthesis of 3-aryl-N-(tert-butanesulfinyl)-3-pyrrolines 271 
As a representative example, the synthesis of (RS)-N-(tert-butanesulfinyl)-3-(4-methoxyphenyl)-3-
pyrroline (RS)-271e is described. (RS)-N-[2-chloro-1-(4-methoxyphenyl)ethylidene]-tert-
butanesulfinamide (RS)-282e (0.67 g, 2.33 mmol) was dissolved in dry dichloromethane (20 mL) and 
the stirred solution was cooled to -78 °C. Two equiv of vinylmagnesium bromide (1M solution in THF, 
4.66 mmol, 4.66 mL) were added to the solution and the reaction mixture was allowed to stir for two 
hours at -78 °C before prolongation at -40 °C for four hours. The reaction mixture was quenched at 
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this temperature by the addition of aq. NH4Cl (5 mL) and immediately extracted with 
dichloromethane (2 x 10 mL). The organic layers were dried over MgSO4, filtered and concentrated in 
vacuo. The compound was purified by means of recrystallization from diethyl ether to afford 0.44 g 
(1.57 mmol) (RS)-N-(tert-butanesulfinyl)-3-(4-methoxyphenyl)-3-pyrroline (RS)-271e. 
 (RS)-N-(tert-Butanesulfinyl)-3-(4-methoxyphenyl)-3-pyrroline (RS)-271e. White crystals, yield 67%. 
Mp 89 ± 0.5 °C. [α]D -26.3 (c 1.01, CH2Cl2). IR (cm
-1): νmax 1114, 1367, 1512, 
2936. 1H NMR (300 MHz, CDCl3): δ 1.50 (9H, s, t-Bu), 3.33-3.42 (1H, m, 
NCH(H)CH), 3.81 (3H, s, OMe), 3.81-3.88 (1H, m, NCH(H)CH), 4.25-4.32 (1H, 
m, CH(H)N), 4.37-4.46 (1H, m, CH(H)N), 5.92-5.96 (1H, m, CHCH2), 6.85-6.90 
and 7.26-7.31 (4H, 2 x m, 4 x CHarom). 
13C NMR (75 MHz, CDCl3): δ 23.6 
(C(CH3)3), 38.9 (NCH2CH), 46.8 (CH2N), 55.3 (OMe), 58.8 (C(CH3)3), 112.2 
(CHCH2N), 113.8 (2 x CHarom), 126.7 (2 x CHarom), 132.3 (Carom), 139.9 (Cq), 
159.4 (Carom). MS (ES, pos. mode) m/z (%): 280.3 (M + H
+, 100). 
 (SS)-N-(tert-Butanesulfinyl)-3-(4-phenylphenyl)-3-pyrroline (SS)-271c. Brown crystals, yield 28%. Mp 
230 ± 0.5 °C. [α]D 29.6 (c 0.1, DMF). IR (cm-1): νmax 765, 1102, 1195, 1479. 
1H 
NMR (300 MHz, CDCl3): δ 1.51 (9H, s, t-Bu), 3.37-3.44 (1H, m, NCH(H)CH), 3.83-
3.90 (1H, m, NCH(H)CH), 4.31-4.38 (1H, m, CH(H)N), 4.44-4.52 (1H, m, CH(H)N), 
6.05-6.09 (1H, m, CHCH2), 7.32-7.37 (1H, m, CHarom), 7.40-7.46 and 7.56-7.61 (2 
x 4H, 2 x m, 8 x CHarom). 
13C NMR (75 MHz, CDCl3): δ 23.6 (C(CH3)3), 39.0 
(NCH2CH), 46.7 (CH2N), 59.0 (C(CH3)3), 113.7 (CHCH2N), 126.0, 127.0, 127.2, 
127.4 and 128.8 (9 x CHarom), 138.7, 140.1, 140.5 and 140.7 (3x Carom and Cq). MS 
(ES, pos. mode) m/z (%): 326 (M + H+, 100). HRMS (ES) calcd for C20H24NOS
+: 326.1573 MH+; found: 
326.1558. 
5.28 Synthesis of (Rs,S)-1-(tert-butanesulfinyl)-2-isopropenyl-2-phenylaziridine 
282 
A solution of (RS)-N-[2-chloro-1-phenylethylidene]-tert-butanesulfinamide (RS)-281a (0.5 g, 1.94 
mmol) in dry dichloromethane (10 mL) was cooled to -78 °C. 1.2 Equivalents of 
isopropenylmagnesium bromide (0.5M solution in THF, 4.66 mL, 2.33 mmol) was added and the 
reaction mixture was allowed to stir for two hours at -78 °C, followed by four hours at -40 °C. The 
reaction mixture was quenched at this temperature by the addition of aq. NH4Cl (5 mL) and 
immediately extracted with dichloromethane (2 x 10 mL). The combined organic fractions were dried 
over MgSO4, filtered and evaporated in vacuo. The compound was purified by means of column 
chromatography to afford (Rs,S)-1-(tert-butanesulfinyl)-2-isopropenyl-2-phenylaziridine 282 (0.35 g) 
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in 69% yield. When two equivalents of isopropenylmagnesium bromide were used, (RS)-N-(3,5-
dimethyl-2-phenylhexa-2,5-dien-1-yl)-2-tert-butanesulfinamide 283 was isolated in 17% yield next to 
(Rs,S)-1-(tert-butanesulfinyl)-2-isopropenyl-2-phenylaziridine 282 (33%). 
 (Rs,S)-1-(tert-butanesulfinyl)-2-isopropenyl-2-phenylaziridine 282. Rf = 0.28 (petroleum 
ether/EtOAc 3/1). Yellow crystals, yield 67%. Mp 54 ± 0.5 °C. [α]D -394.7 (c 
1.03, CH2Cl2). IR (cm
-1): νmax 696, 1074, 1447, 2961. 
1H NMR (300 MHz, CDCl3): 
δ 1.21 (9H, s, t-Bu), 1.65 (3H, s, CH3), 2.11 (1H, s, CH(H)azir), 3.23 (1H, s, 
CH(H)azir), 4.95 (1H, s, CH(H)=Cq), 5.14 (1H, s, CH(H)=Cq), 7.26-7.47 (5H, m, 
CHarom). 
13C NMR (75 MHz, CDCl3): δ 19.8 (CH3), 22.8 (C(CH3)3), 30.3 (CH2, azir), 
51.1 (Cq, azir), 57.4 (C(CH3)3), 112.9 (CH2=Cq), 128.3 (2 x CHarom), 128.5 (CHarom), 129.7 (2 x CHarom ), 
134.9 (Carom), 145.4 (CH2=Cq). MS (ES, pos. mode) m/z (%): 264.3 (M + H
+, 100). 
 (RS)-N-(3,5-dimethyl-2-phenylhexa-2,5-dien-1-yl)-2-tert-butanesulfinamide
 283. Rf = 0.26 
(petroleum ether/EtOAc 1/1). Yellow oil, yield 17%. IR (cm-1): νmax 730, 1052, 
2958, 3212. 1H NMR (300 MHz, CDCl3): δ 1.09 (9H, s, t-Bu), 1.57 (3H, s, CH3), 
1.86 (3H, s, CH3), 2.61 (2H, s, CqCH2Cq), 3.14 (1H, dxd, J = 7.2 Hz, 5.0 Hz, NH), 
3.98 (1H, dxd, J = 13.2 Hz, 7.2 Hz, CH(H)NH), 4.15 (1H, dxd, J = 13.2 Hz, 5.0 
Hz, CH(H)NH), 4.69 (1H, s, CH(H)=Cq), 4.77 (1H, s, CH(H)=Cq), 7.11-7.36 (5H, 
m, 5 x CHarom). 
13C NMR (75 MHz, CDCl3): δ 17.6 (CH3), 22.6 (CH3 en C(CH3)3), 
44.0 (CqCH2Cq), 47.9 (CH2NH), 55.8 (C(CH3)3), 111.7 (CH2=Cq), 126.7 (CHarom), 128.2 (2 x CHarom), 129.1 
(2 x CHarom), 133.9, 134.3, 141.3 and 143.8 (4 x Cq). MS (ES, pos. mode) m/z (%): 306.3 (M + H
+, 100). 
5.29 Synthesis of (SS)-N-tert-butanesulfinyl 2-methyl-4-phenyl-3-pyrroline 286 
(SS)-N-[2-Chloro-1-ethylidene]-tert-butanesulfinamide (SS)-281a (0.5 g, 1.94 mmol) was dissolved in 
dry dichloromethane (10 mL) and the stirred solution was cooled to -78 °C. Two equivalents of 2-
propenylmagnesium bromide (0.5M solution in THF, 7.76 mL, 3.88 mmol) were added to the solution 
and the reaction mixture was allowed to stir for two hours at -78 °C before prolongation at -40 °C for 
four hours. The reaction mixture was quenched at this temperature by the addition of aq. NH4Cl (5 
mL) and immediately extracted with dichloromethane (2 x 10 mL). The organic layers were dried over 
MgSO4, filtered and concentrated in vacuo. The compound was purified by column chromatography 
to afford (SS)-N-tert-butanesulfinyl 2-methyl-4-phenyl-3-pyrroline 286 (0.07 g) in 13% yield as a 86:14 
mixture of diastereomers.  
Spectroscopic data of the major diastereomer obtained from the mixture of diastereomers 286 (dr 
86:14). 
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 (SS)-N-tert-Butanesulfinyl 2-Methyl-4-phenyl-3-pyrroline 286.
 Rf = 0.24 (petroleum ether/EtOAc 
3/1). Brown oil, yield 13%, dr 86:14. IR (cm-1): νmax 1114, 1367, 1512, 2936. 
1H 
NMR (300 MHz, CDCl3): δ 1.51 (9H, s, t-Bu), 1.53 (3H, d, J = 6.6 Hz, CH3), 3.88-
3.98 (1H, m, CHCH3), 4.20 (1H, dxdxd, J = 18.4 Hz, 3.0 Hz, 1.4 Hz, CH(H)N), 4.39 
(1H, dxdxd, J = 18.4 Hz, 4.1 Hz, 1.9 Hz, CH(H)N), 5.70-5.72 (1H, m, CHCHN), 
7.27-7.37 (5H, m, 5 x CHarom). 
13C NMR (75 MHz, CDCl3): δ 19.2 (CH3), 24.5 
(C(CH3)3), 42.9 (CHN), 46.2 (CH2N), 60.9 (C(CH3)3), 122.1 (CHCHN), 125.7 (2 x CHarom), 127.9 (CHarom), 
128.6 (2 x CHarom), 139.3 and 139.8 (2 x Cq). MS (ES, pos. mode) m/z (%): 264.3 (M + H
+, 100).  
5.30 Synthesis of N-(tert-butanesulfinyl)-3-arylpyrroles 291 
The synthesis of (RS)-N-(tert-butanesulfinyl)-3-(4-methoxyphenyl)pyrrole 291e is representative. 2,3-
Dichloro-5,6-dicyano-1,4-benzoquinone (0.9 equiv, 0.18 mmol, 42 mg) was dissolved in 1,4-dioxane 
(10 mL) and added dropwise to a solution of (RS)-N-(tert-butanesulfinyl)-3-(4-methoxyphenyl)-3-
pyrroline (RS)-271e (57 mg, 0.20 mmol) in 1,4-dioxane (10 mL). After stirring for 16 hours at room 
temperature, the reaction mixture was quenched by the addition of a 10% solution of NaHSO3 (5 mL) 
and immediately extracted with ethyl acetate (2 x 10 mL). The organic layers were dried over MgSO4, 
filtered and concentrated in vacuo. The compound was purified by means of column 
chromatography to afford 49 mg (0.18 mmol) (RS)-N-(tert-butanesulfinyl)-3-(4-methoxyphenyl)-
pyrrole 291e. 
 (RS)-N-(tert-Butanesulfinyl)-3-(4-methoxyphenyl)pyrrole 291e. Rf = 0.29 (petroleum ether/EtOAc 
3/1). Black crystals, yield 87%. Mp 134 ± 0.5 °C. [α]D 28.7 (c 0.09, CH2Cl2). 
IR (cm-1): νmax 665, 823, 1187, 1273, 1591, 2928. 
1H NMR (300 MHz, 
CDCl3): δ 1.45 (9H, s, tBu), 3.82 (3H, s, OMe), 5.86 (1H, dxd, J = 9.9 Hz, 1.7 
Hz, CHCHN), 6.89-6.93 (2H, m, 2 x CHarom), 7.22-7.26 (2H, m, 2 x CHarom), 
7.53 (1H, dxd, J = 9.9 Hz, 2.2 Hz, CHCHN), 7.68-7.70 (1H, m, CCHN). 13C 
NMR (75 MHz, CDCl3): δ 23.2 (C(CH3)3), 55.4 (OMe), 62.1 (C(CH3)3), 88.8 
(CHCHN), 113.8 (Cq), 114.3 (2 x CHarom), 126.6 (2 x CHarom), 131.4 (Cq), 139.8 (NCHCH), 144.9 (CH), 
158.2 (Cq). MS (ES, pos. mode) m/z (%): 278.3 (M + H
+, 100). 
 
 
 
 
Chapter 5   Experimental part 
 
 
120 
 
(RS)-N-(tert-Butanesulfinyl)-3-phenylpyrrole 291a. Rf = 0.22 (petroleum ether/EtOAc 3/1). Green 
crystals, yield 71%. Mp 126 ± 0.5 °C. [α]D 51.6 (c 0.1, CH2Cl2). IR (cm
-1): νmax 698, 820, 1174, 1335, 
1591, 2923. 1H NMR (300 MHz, CDCl3): δ 1.46 (9H, s, t-Bu), 5.88 (1H, dxd, J = 
9.9 Hz, 1.1 Hz, CHCHN), 7.21-7.26 (1H, m, CHarom), 7.31-7.39 (4H, m, CHarom), 
7.59 (1H, dxd, J = 9.9 Hz, 2.2 Hz, CHCHN), 7.76-7.79 (1H, m, CHN). 13C NMR (75 
MHz, CDCl3): δ 23.2 (C(CH3)3), 62.2 (C(CH3)3), 89.0 (CHCHN), 114.0 (Cq), 125.4 
(2 x CHarom), 126.1 (CHarom), 128.9 (2 x CHarom), 138.8 (Cq), 139.8 (NCHCH), 145.8 
(CH). MS (ES, pos. mode) m/z (%): 248.3 (M + H+, 100). Anal. Calcd for C14H17NOS: C 67.98; H 6.93; N 
5.66. Found: C 67.84; H 6.89; N 5.21. 
 (RS)-N-(tert-Butanesulfinyl)-3-(4-fluorophenyl)pyrrole 291d. Rf = 0.29 (petroleum ether/EtOAc 3/1). 
Green crystals, yield 69%. Mp 114 ± 0.5 °C. [α]D 28.2 (c 0.1, CHCl3). IR (cm
-1): νmax 662, 731, 762, 806, 
1167, 1277, 1455, 1510, 1588, 1598. 1H NMR (400 MHz, CDCl3): δ 1.46 (9H, 
s, t-Bu), 5.88 (1H, dxd, J = 10.0 Hz, 1.4 Hz, CHCHN), 7.01-7.07 (2H, m, 2 x 
CHarom), 7.23-7.28 (2H, m, 2 x CHarom), 7.52 (1H, dxd, J = 10.0 Hz, 2.5 Hz, 
CHCHN), 7.70 (1H, dxd, J = 2.5 Hz, 1.4 Hz, CCHN). 13C NMR (75 MHz, CDCl3): 
δ 23.2 (C(CH3)3), 62.2 (C(CH3)3), 89.1 (CHCHN), 113.3 (Cq), 115.7 (d, J = 20.8 
Hz, 2 x CHarom), 127.0 (d, J = 8.1 Hz, 2 x CHarom), 134.9 (d, J = 3.5 Hz, Carom), 
139.7 (NCHCH), 145.5 (CH), 161.7 (d, J = 244.6 Hz, Cq, F, arom). MS (ES, pos. mode) m/z (%): 266 (M + H
+, 
100). HRMS (ES) calcd for C14H17FNOS
+: 266.1009 MH+; found: 266.1011. 
5.31 Synthesis of 3,4-dibromo-3-phenylpyrrolidine 292 
A solution of (RS)-N-(tert-butanesulfinyl)-3-phenyl-3-pyrroline (RS)-271e (0.1 g, 0.40 mmol) in dry 
CH2Cl2 (10 mL) was cooled to 0 °C and Br2 (1.05 equiv, 0.42 mmol, 0.023 mL) was added dropwise. 
After stirring for 1 h, Et3N (1 equiv, 0.06 mL, 0.40 mmol) was added, and the reaction mixture was 
allowed to stir for another 30 minutes at room temperature. Water (10 mL) was added, and the 
reaction mixture was extracted with CH2Cl2 (2 × 10 mL). The combined organic layers were dried 
(MgSO4), filtered, and evaporated in vacuo. The compound was purified by means of column 
chromatography to afford 0.04 g (0.13 mmol) 3,4-dibromo-3-phenylpyrrolidine 292. 
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3,4-dibromo-3-phenylpyrrolidine 292. Rf = 0.18 (petroleum ether/EtOAc 3/1). brown oil, yield 33%. IR 
(cm-1): νmax 1156, 1337, 2359, 3271. 
1H NMR (300 MHz, CDCl3): δ 3.73 (1H, dxd, J = 
15.0 Hz, 3.3 Hz, CH(H)NH), 3.91-3.99 (1H, m, CqCH(H)NH), 4.35 (1H, dxd, J = 15.0 Hz, 
4.1 Hz, CH(H)NH), 4.62 (1H, dxd, J = 15.4 Hz, 11.6 Hz, CqCH(H)NH), 5.11-5.23 (2H, m, 
NH en CHBr), 7.38-7.48 (5H, m, CHarom). 
13C NMR (75 MHz, CDCl3): δ 49.9 (CqCH2N), 
50.8 (CHBr), 53.0 (CH2N), 66.3 (Cq), 126.2 (2 x CHarom), 129.1 (2 x CHarom), 129.6 
(CHarom), 140.0 (Carom). MS (ES, pos. mode) m/z (%): inconclusive MS.   
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6 Summary 
Aziridines, nitrogen-containing three-membered ring heterocycles, are well established useful and 
versatile building blocks in organic synthesis and medicinal chemistry. Next to the fact that some 
naturally occurring compounds, bearing the aziridine functionality, show interesting biological 
activity, the presence of the highly strained ring system makes these heterocycles very useful 
building blocks for chemical bond elaborations and functional group transformations to a variety of 
nitrogen-containing compounds. In that respect, the synthesis of new classes of functionalized 
aziridines, as building blocks for novel nitrogen-containing acyclic, heterocyclic or carbocyclic 
coumpounds, was pursued within this PhD-thesis. In a first approach, substitution of  
2-(bromomethyl)aziridine ii with protected glycine esters i afforded γ,δ-aziridino α-amino acid 
derivatives iii as a 1:1 mixture of diastereomers in good yield.  
 
To date, only one other synthesis resulting in γ,δ-aziridino α-amino acid derivatives in low yield has 
been described in literature (see section 2.2.1)37b and the reactivity of this relatively new class of 
conformationally constrained α,γ-diamino acid derivatives was further investigated. Saponification of 
the ester function, present in aziridine iiib, with NaOH resulted in a ring transformation of the 
obtained carboxylate to the corresponding lactones iv, while treatment with hydrobromic acid 
resulted in ring opening at the unsubstituted carbon atom of the aziridine moiety, followed by 
intramolecular ring closure to the corresponding lactams v. Both lactams v and lactones iv were 
obtained as a mixture of diastereomers in a 1:1 diastereomeric ratio and were separated from each 
other by means of column chromatography.  
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As aziridines already showed their potential as precursors in cyclopropane synthesis, the utility of 
aziridine iiib as substrate for ring transformation to the corresponding cyclopropane derivatives was 
further investigated. Ring opening with benzyl bromide at the more hindered carbon atom of the 
aziridine iiib resulted in the formation of β-bromoamine vi as a 1:1 mixture of diastereomers. 
Subsequent deprotonation with KHMDS or DBU at the α-position of the ester moiety, followed by 
bromide expulsion gave ring closure to cis-cyclopropane cis-vii with excellent diastereoselectivity (dr 
98:2). To allow saponification of the ester function, other appropriate N-protecting groups were 
introduced. The N-diphenylmethylidene group of cyclopropane cis-vii was removed with TFA and the 
free amine viii was reprotected upon reaction with Cbz-Cl or Boc2O to give N-Cbz or N-Boc-protected 
cyclopropanes ix. Saponification of the latter compounds was possible and subsequent coupling of 
the resulting carboxylic acid xa with piperidine resulted in the formation of amide xi. Deprotection of 
the amino functions led to the formation of a new 2,3-methano analogue xii of N-[(S)-2,4-
diaminobutanoyl]piperidine as a possible conformationally constrained inhibitor of the enzyme 
DPPII. 
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The use of conformationally constrained Cα-tetrasubstituted amino acids has gained a lot of attention 
in the field of foldamers in recent years. In this respect, the synthesized 2-aminomethyl-substituted 
1-aminocyclopropane-1-carboxylic acids (ACC) x were used in the synthesis of selected tripeptides to 
study their preferential conformations. Boc-protected carboxylic acid xb was coupled with amino 
esters xiii to the corresponding dipeptides xiv and subsequent removal of the Boc-protecting group 
led to TFA-salts xv. In the next step, the obtained salts were coupled with carboxylic acids xvi to the 
desired tripeptides xvii. In the case of peptides containing alanine (xvic), a 1:1 mixture of 
diastereomers was obtained, which were separated via column chromatography to yield xviic(a) and 
xviic(b) as pure compounds in 26% and 21% yield, respectively. 
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Tripeptides containing the 2-aminomethyl-ACC derivative at the N-terminus were also synthesized 
and therefore N-Cbz-protected carboxylic acid xa was coupled with dipeptides xviii to the 
corresponding tripeptides xix in 50-80% yield. Again both diastereomers of the tripeptide xixc 
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containing alanine were separated via column chromatography to give xixc(a) and xixc(b) as optically 
active compounds. 
 
In a second part, the synthesis of unreported chiral N-sulfinyl 2-aryl-2-alkenylaziridines was 
envisioned via addition of alkenylmagnesium bromides across aromatic N-sulfinyl α-haloketimines. 
Analysis of the crude reaction mixtures after reaction of α-chloroketimines (RS)-xx with 
vinylmagnesium bromide revealed the presence of both 2-vinylaziridines xxii and 3-pyrrolines xxiii, 
next to dehalogenated starting materials xxi. Upon recrystallization of the crude reaction mixtures, 
however, aziridines xxii spontaneously rearranged to the corresponding 3-aryl-3-pyrrolines xxiii, 
which were isolated in 65-91% yield. 
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To confirm their structural identity, pyrrolines xxiii were oxidized to the corresponding pyrroles xxv 
in the presence of DDQ, while reaction with Br2 afforded 3,4-dibromopyrrolidine xxvi in moderate 
yield with spontaneous cleavage of the protective group at nitrogen. 
 
To extend the scope of this reaction, reaction of α-chloroketimine (RS)-xxa with 
isopropenylmagnesium bromide was investigated. This time, formation of 3-aryl-3-pyrroline was not 
observed and 2-isopropenylaziridine xxiv was isolated as a stable compound in 69% yield. The 
sluggish reaction of α-chloroketimine (SS)-xxa with 1-propenylmagnesium bromide further indicates 
that the rate of rearrangement of 2-alkenylaziridines is influenced by subtle steric effects exerted by 
the substituents on the double bond. Next to a significant amount of unreacted and dehalogenated 
starting material (SS)-xxa and (SS)-xxia, both aziridine xxvii and 3-pyrroline xxviii were present in the 
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crude reaction mixture. However, after purification only 3-pyrroline xxviii was isolated in low yield 
(13%, dr 86:14). 
 
In conclusion, the synthesized 2-(carboxyethyl)aziridines proved to be a valuable addition to the 
arsenal of functionalized aziridines as synthetic building blocks, since the high synthetic potential of 
these 2-(carboxyethyl)aziridines was further demonstrated by means of their elaboration into 
different types of heterocyclic and carbocyclic compounds, including γ-lactones, γ-lactams and 
cyclopropanes.  
The synthesized 2-aminomethyl-substituted 1-aminocyclopropane-1-carboxylic acid derivatives 
proved to be excellent precursors for the synthesis of a new conformationally constrained analogue 
of (S)-2,4-diaminobutanoylpiperidine (Dab-Pip) and were used as alternative α-amino acids in small 
peptides to study their conformational preferences. 
Finally, chiral N-(tert-butanesulfinyl)-3-pyrrolines and -2-(isopropenyl)aziridine were obtained via a 
straightforward synthesis starting from aromatic N-sulfinyl α-chloroketimines. 
Chapter 6   Summary 
 
 
130 
 
Chapter 7   Samenvatting 
 
 
131 
 
7 Samenvatting 
Aziridinen, stikstofbevattende drieringstructuren, zijn bruikbare en veelzijdige bouwstenen in de 
organische synthese en medicinale chemie. Naast het feit dat sommige natuurproducten, die de 
aziridine functionaliteit bevatten, interessante biologische activiteit vertonen, maakt de 
aanwezigheid van de gespannen driering deze heterocyclische verbindingen tot geschikte 
bouwstenen voor de verdere omzetting naar een waaier van stikstofhoudende verbindingen. In dit 
opzicht werd de synthese van nieuwe klassen van gefunctionaliseerde aziridinen, als bouwsteen voor 
nieuwe stikstofbevattende acyclische, heterocyclische en carbocyclische verbindingen, nagestreefd 
binnen dit doctoraatsonderzoek. In een eerste luik gaf de substitutie van 2-(broommethyl)aziridine ii 
met beschermde glycine esters i aanleiding tot de vorming van γ,δ-aziridino α-aminozuurderivativen 
iii in een 1:1 mengsel van diastereomeren in goed rendement.  
 
Tot op heden is slechts één andere synthese in de literatuur beschreven die aanleiding geeft tot γ,δ-
aziridino α-aminozuurderivativen in laag rendement (zie sectie 2.2.1)37b en de reactiviteit van deze 
relatief nieuwe klasse van conformationeel beperkte α,γ-diaminozuurderivaten werd verder 
onderzocht. Verzeping van de esterfunctie aanwezig in aziridine iiib met NaOH leidde tot een 
ringtransformatie van het gevormde carboxylaat tot de overeenkomstige lactonen iv, terwijl 
behandeling met waterstofbromide resulteerde in ringopening aan het niet-gesubstitueerde 
koolstofatoom van de aziridine groep, gevolgd door intramoleculaire ringsluiting naar de 
overeenkomstige lactamen v. Zowel lactamen v als lactonen iv werden gevormd als een mengsel van 
diastereomeren in een 1:1 diastereomere verhouding en konden van elkaar gescheiden worden via 
kolomchromatografie.  
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Gezien aziridinen hun potentieel als precursor in de synthese van cyclopropanen reeds hebben 
bewezen, werd het gebruik van aziridine iiib als substraat voor ringtransformatie tot de 
overeenkomstige cyclopropaanderivaten verder onderzocht. Ringopening met benzylbromide aan 
het meer gehinderde koolstofatoom van aziridine iiib gaf aanleiding tot de vorming van  
β-broomamine vi als een 1:1 mengsel van diastereomeren. Deprotonering met KHMDS of DBU van 
de α-positie van de estergroep, gevolgd door uitstoot van bromide gaf ringsluiting tot cis-
cyclopropaan cis-vii met uitstekende diastereoselectiviteit (dr 98:2). Om verzeping van de 
esterfunctie mogelijk te maken dienden andere geschikte N-beschermende groepen geïntroduceerd 
te worden. De N-difenylmethylideengroep van cyclopropaan cis-vii werd verwijderd met TFA en het 
vrije amine viii werd opnieuw beschermd via reactie met Cbz-Cl of Boc2O en gaf aanleiding tot N-Cbz 
of N-Boc-beschermde cyclopropanen ix. Verzeping van de laatstgenoemde verbindingen was 
mogelijk en daaropvolgende koppeling van het bekomen carbonzuur xa met piperidine leidde tot de 
vorming van amide xi. Ontscherming van de aminofunctionaliteiten gaf aanleiding tot een nieuw  
2,3-methanoanaloog xii van N-[(S)-2,4-diaminobutanoyl]piperidine als een potentiële 
conformationeel beperkte inhibitor van het enzym DPPII. 
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Het gebruik van conformationeel beperkte Cα-tetragesubstitueerde aminozuren heeft de laatste 
jaren aan belang gewonnen binnen het domein van de foldameren. In dit opzicht werden de 
gesynthetiseerde 2-aminomethyl-gesubstitueerde 1-aminocyclopropaan-1-carbonzuren (ACC) x 
gebruikt in de synthese van geselecteerde tripeptiden om hun preferentiële conformaties te 
onderzoeken. Boc-beschermd carbonzuur xb werd gekoppeld met aminoesters xiii tot de 
overeenkomstige dipeptiden xiv en daaropvolgende verwijdering van de Boc-beschermende groep 
leidde tot TFA-zouten xv. In een volgende stap werden de verkregen zouten gekoppeld met 
carbonzuren xvi tot de gewenste tripeptiden xvii. In het geval van de alanine-bevattende peptiden 
(xvic) werd een 1:1 mengsel van diastereomeren verkregen, die van elkaar gescheiden werden via 
kolomchromatografie om xviic(a) en xviic(b) te bekomen in 26% en 21% rendement, respectievelijk. 
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Tripeptiden met het 2-aminomethyl-ACC derivaat aan de N-terminus werden ook gesynthetiseerd en 
daartoe werd N-Cbz-beschermd carbonzuur xa gekoppeld met dipeptiden xviii tot de 
overeenkomstige tripeptiden xix in 50-80% rendement. Opnieuw konden beide diastereomeren van 
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het alanine-houdende tripeptide xixc gescheiden worden via kolomchromatografie tot xixc(a) and 
xixc(b) als optisch actieve verbindingen. 
 
In een tweede luik werd de synthese van ongerapporteerde chirale N-sulfinyl 2-aryl-2-
alkenylaziridinen vooropgesteld via additie van alkenylmagnesium bromiden aan aromatische N-
sulfinyl α-haloketiminen. Analyse van de ruwe reactiemengsels na reactie van α-chloorketiminen 
(RS)-xx met vinylmagnesium bromide toonde de aanwezigheid aan van 2-vinylaziridinen xxii en  
3-pyrrolinen xxiii, naast gedehalogeneerd uitgangsproduct xxi. Tijdens omkristallisatie van de ruwe 
reactiemengsels vond echter een spontane omlegging van aziridinen xxii plaats tot de 
overeenkomstige 3-aryl-3-pyrrolinen xxiii, die geïsoleerd konden worden in 65-91% rendement. 
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Om hun structurele identiteit te bevestigen werden pyrrolinen xxiii geoxideerd tot de 
overeenkomstige pyrrolen xxv in de aanwezigheid van DDQ, terwijl reactie met Br2 aanleiding gaf tot 
de vorming van 3,4-dibroompyrrolidine xxvi in matig rendement met spontane afsplitsing van de 
beschermende groep op stikstof. 
 
Om het toepassingsgebied van deze reactie uit te breiden, werd de reactie van α-chloorketimine  
(RS)-xxa met isopropenylmagnesium bromide onderzocht. Deze keer werd de vorming van 3-aryl-3-
pyrroline echter niet waargenomen en 2-isopropenylaziridine xxiv kon geïsoleerd worden als een 
stabiele verbinding in 69% rendement. De moeilijke reactie van α-chloorketimine (SS)-xxa met  
1-propenylmagnesium bromide geeft verder aan dat de graad van omlegging van 2-alkenylaziridinen 
beïnvloed wordt door subtiele sterische effecten uitgeoefend door de substituenten op de dubbele 
binding. Naast een aanzienlijke hoeveelheid gedehalogeneerd en niet gereageerd startmateriaal  
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(SS)-xxia en (SS)-xxa, waren zowel aziridine xxvii en 3-pyrroline xxviii aanwezig in het ruwe 
reactiemengsel. Na opzuivering echter, kon enkel 3-pyrroline xxviii geïsoleerd worden in laag 
rendement (13%, dr 86:14). 
 
Samengevat kan gesteld worden dat de gesynthetiseerde 2-(carboxyethyl)aziridinen een waardevolle 
toevoeging zijn tot het arsenaal van gefunctionaliseerde aziridinen als synthetische bouwstenen, 
gezien het hoog synthetisch potentieel van deze 2-(carboxyethyl)aziridinen verder werd aangetoond 
via hun omzetting tot verschillende heterocyclische en carbocyclische verbindingen zoals γ-lactonen, 
γ-lactamen and cyclopropanen.  
De gevormde 2-aminomethyl-gesubstitueerde 1-aminocyclopropaan-1-carbonzuurderivaten bleken 
excellente precursoren te zijn voor de synthese van een nieuw conformationeel beperkt analoog van 
(S)-2,4-diaminobutanoylpiperidine (Dab-Pip) en konden gebruikt worden als alternatieve  
α-aminozuren in korte peptiden om hun conformationele voorkeuren te onderzoeken. 
Tenslotte konden chirale N-(tert-butanesulfinyl)-3-pyrrolinen en een 2-(isopropenyl)aziridine 
verkregen worden, startende van aromatische N-sulfinyl α-chloorketiminen. 
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